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Abstract 
 
Fatty acids, in the form of triglycerides, are the main constituent of the class of 
dietary lipids. They not only serve as a source of energy but can also act as potent 
regulators of gene transcription. It is well accepted that an energy rich diet 
characterized by high intakes of dietary fat is linked to the dramatic increase in 
the prevalence of obesity in both developed and developing countries in the last 
several decades. Obese individuals are at increased risk of developing the 
metabolic syndrome, a cluster of metabolic abnormalities that ultimately increase 
the risk of developing vascular diseases and type 2 diabetes. Many studies have 
been performed to uncover the role of fatty acids on gene expression in different 
organs, but integrative studies in different organs over time driven by high 
throughput data are lacking. Therefore, we first aimed to develop integrative 
approaches on the level of individual genes but also pathways using genome-wide 
transcriptomics datasets of mouse liver and small intestine that are related to 
fatty acid sensing transcription factor peroxisome proliferator activated receptor 
alpha (PPARα). We also aimed to uncover the behavior of PPARα target genes and 
their corresponding biological functions in a short time series experiment, and 
integrated and modeled the influence of different levels of dietary fat and the 
time dependency on transcriptomics datasets obtained from several organs by 
developing system level approaches.  
We developed an integrative statistical approach that properly adjusted for 
multiple testing while integrating data from two experiments, and was driven by 
biological inference. By quantifying pathway activities in different mouse tissues 
over time and subsequent integration by partial least squares path model, we 
found that the induced pathways at early time points are the main drivers for the 
induced pathways at late time points. In addition, using a time course microarray 
study of rat hepatocytes, we found that most of the PPARα target genes at early 
stage are involved in lipid metabolism-related processes and their expression level 
could be modeled using a quadratic regression function. In this study, we also 
found that the transcription factors NR2F, CREB, EREF and RXR might work 
together with PPARα in the regulation of genes involved in lipid metabolism. By 
integrating time and dose dependent gene expression data of mouse liver and 
white adipose tissue (WAT), we found a set of time-dose dependent genes in liver 
and WAT including potential signaling proteins secreted from WAT that may 
  
induce metabolic changes in liver, thereby contributing to the pathogenesis of 
obesity. 
Taken together, in this thesis integrative statistical approaches are presented that 
were applied to a variety of datasets related to metabolism of fatty acids. Results 
that were obtained provide a better understanding of the function of the fatty 
acid-sensor PPAR, and identified a set of secreted proteins that may be 
important for organ cross talk during the development of diet induced obesity. 
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Fatty acids and PPARα 
 
Fatty acids are the most important macronutrient components for mammals that 
function as a fuel in the cell to provide energy. After digestion and absorption of 
dietary fat in the small intestine, chylomicrons are formed that are packaged with 
triacylglycerol (TG), cholesterol esters, phospholipids, free cholesterol, and 
apoproteins [1]. Chylomicrons are then secreted by the intestinal epithelial cells 
and transported via the lymphatic system to the blood. The chylomicrons then 
circulate throughout the blood stream and reaches capillaries where LPL 
(lipoprotein lipase) captures these particles and hydrolyzes the TG. As a result 
tissues such as the adipose tissue and muscle take up the free fatty acids (FFA), 
which are then converted into cellular energy. Excess FFAs may cause obesity and 
its associated diseases like type 2 diabetes mellitus, dyslipidemia, atherosclerosis, 
hypertension and hepatic steatosis [2,3]. If adipose tissues exceed their capacity 
to store the FFA as TG, then it may travel to the liver where it may cause NAFLD 
(nonalcoholic fatty liver disease) [4,5]. The chylomicron remnants that remain 
after the hydrolysis of TG ultimately travel to the liver (Figure 1). 
 
 
Figure 1: Digestion and metabolism of dietary fat 
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                                                                                                                                  Chapter 1 
 
13 
 
The FFAs derived from dietary fat, or any synthetic component, enter the cell and 
can bind specific transcription factors after which gene expression can be 
activated or suppressed [6]. The peroxisome proliferator-activated receptors 
(PPARs, NR1C) [7] is a family of transcription factors which are activated by dietary 
fatty acids. There are three PPAR isotypes: PPARα (NR1C1), PPAR δ (also called β) 
(NR1C2) and PPAR γ (NR1C3). All are targets for treating type 2 diabetes, 
dyslipidemia and obesity [8]. Fatty acids and their derivatives bind to PPARα with 
the greatest attraction [9]. Every PPAR heterodimerizes with the retinoid X 
receptor (RXR) and subsequently binds to specific regions on the DNA of target 
genes [10,11]. Since early 1990s, when the peroxisome PPARα was discovered, 
the function of PPARα has been studied broadly [12]. Currently PPARα is well-
known for its control of metabolism in response to diet. PPARα is highly expressed 
in tissues with a high catabolic rate such as the liver, kidneys, heart, intestine and 
skeletal muscle [13,14]. The identification PPARα target genes have concentrated 
mostly on cellular lipid metabolism in the context of the hepatocyte.  
A comprehensive expression profiling analysis of PPARα dependent regulation of 
hepatic lipid metabolism was done by [15], using the synthetic ligand WY14643. 
They found that the role of PPARα in hepatic lipid metabolism was much more 
extensive than previously envisioned and uncovered novel PPARα regulated genes 
and pathways, after 24 hours and 5 days exposure to WY14643. A genome wide 
analysis of PPARα activation in murine small intestine was performed by [16]. 
They showed that PPARα influences the immune and inflammatory response in 
the mouse intestine, which may be of particular importance for the development 
of fortified food and valuable for patients with inflammatory bowel diseases. A 
comparative analysis of gene regulation by the transcription factor PPARα 
between mouse and human was conducted by [17], they showed that PPARα 
regulates a mostly divergent set of genes in mouse and human hepatocytes. 
Taken together, PPARα is considered a crucial fatty acid sensor that mediates 
effects of numerous fatty acids and its derivatives on gene expression and 
therefore is a master regulator of lipid metabolism in mouse and human [18]. 
Although much is already known about the PPARs, still gaps in our knowledge 
remain. The biological role of PPARα, its target genes, pathways and biological 
processes have merely been investigated at only one or two time points after 
activation in isolated systems (tissues). However, no studies have been performed 
to integrate and model the different time points- and tissue-related gene 
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expression data. Therefore, system approaches are needed to integrate and 
model different datasets of PPARα dependently regulated genes and pathways at 
different time points, as well as with different dietary fat doses to explore the 
more functional behavior of dietary fat among the different organs. By applying 
microarray tools one can collect whole genome information and then multivariate 
statistical analytical tools can be applied to get better insights in the biological 
function. 
 
Multivariate data analysis 
 
A microarray study provides expression data on thousands of genes 
simultaneously in several conditions. Basically this can be considered as 
multivariate data. To find out differentially expressed genes and then to evaluate 
the association between them and other (supplementary) information (internal or 
external factors), univariate and multivariate analysis approaches can be applied. 
This kind of association and research can be performed not only at the level of 
individual genes, but also at the level of groups of genes and at the level of 
tissues. In biological sciences, researchers collect lots of data to fully explore their 
study. A main purpose of microarray data analysis is the identification of 
differentially expressed genes and corresponding biological processes. To this end 
mainly univariate techniques are utilized for hypothesis testing; these include 
Student’s t-test, F test, ANOVA or mixed models have been applied for each gene. 
Transcriptomics data involve many tested genes (variables) and the control of the 
false positives rate is not enough, besides, there are not enough replications to 
obtain good estimations.  
Generally, in an experiment with small number of replications for each gene, 
variances can be poorly estimated and therefore the results of the classical t- or F 
statistics can lead to an increase of false positives. However, it is well noticed that 
genes do not act alone; therefore, there is mutual information within microarray 
data that could be used to improve variances estimates. Borrowing information 
from the collective of genes can assist in the inference about each individual gene. 
Tusher et al developed a modification of the t-statistic by adding a constant in its 
denominator which improves the estimation of the variance, the method is 
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known as significance analysis of microarrays (SAM) [19]. Another method is 
known as linear models for microarrays data (LIMMA), and is based on empirical 
Bayes approach taking moderated t-statistic [20]. Recently, the package limma is 
one of the most used programs for microarray data [21]. To analyze factorial time 
course microarrays data with capturing dynamic gene expression profiles, the 
time course analysis of variance (TANOVA) method can be applied [22]. For 
pathway level analysis, several methods have already developed and the most 
used programs are gene set enrichment analysis (GSEA) [23], DAVID [24,25] and 
Ingenuity Pathway Analysis (IPA) [26]. The multiple testing problem is one of the 
most challenging topic in microarray data as well. To handle the false discovery 
rate, many methods have already developed but the most useful method was 
developed by [27].  
 
To adjust the relationships between genes in each pathway, still proper and 
suitable methods need to be discovered. The univariate techniques assume that 
genes are independent, but in reality this is not the case. Furthermore, the 
univariate methods are not able to handle the relationships between several 
genes (responses), therefore, multivariate statistical techniques are becoming 
popular to perceive the more explorative analysis in systems biology [28]. For 
instance, the multivariate statistical software package FactoMinerR [29] is a 
powerful tool to handle and analyze several groups of datasets which based on 
principal component analysis (PCA), factor analysis (FA) or partial least squares 
(PLS). PCA is a dimension reduced approach which produces a set of orthogonal 
principal components (linear combinations of original variables) to account for the 
maximum variation of the data. Observing then the loading plot of the top 
principal components one can find out the most influential genes/variables. The 
more absolute value of loading indicates that the corresponding gene is more 
important or influential. Of course, it is important to see in which treatment 
groups the influential genes are located. For this, one can compare the parallel 
comparison between the score plot (individual plot) and the loading plot 
(correlation circle). The genes and the samples/group(s) located in the same 
quadrant shows the importance of the genes in that samples/group(s).  
Like PCA, FA also involves the description of a set of observed variables in terms of 
a reduced number of latent variables which is known as explanatory factor 
analysis (EFA). The main difference between PCA and FA is that PCA represents 
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the latent variables as functions of the original variables whereas FA represents 
the observed variables as function of the factors or latent variables. Usually the 
use of PCA or EFA appeals more to an explanatory data analysis perspective 
whereas FA is also considered as a model building approach and hypothesis 
testing which is known as confirmatory factor analysis (CFA). However, PCA or FA 
cannot handle the causal relationships as well as more noisy and numerous 
predictor variables between the two or more groups (blocks) of variables. To 
overcome this problem, partial least squares path model (PLSPM) [30,31] was 
developed using partial least squares (PLS) [32,33] to structural equation 
modeling (SEM) which is also known as SEM-PLS or soft modeling. The PLSPM or 
soft modeling does not depend on any distribution pattern and a few cases can 
suffice [34]. Furthermore, it is a components based approach and robust against 
missing values, misspecification and multicollinearity problems. The maximum 
likelihood method in SEM is known as SEM-ML or hard modeling. It is a covariance 
based approach and depends on a specific distribution pattern and need more 
cases [35]. PLS has widely been used in high-dimensional genomic data [36,37] to 
find out the influential genes that highly correlate with the response variable(s) 
and recently PLSPM has also been applied for genome wide association studies 
[38]. The PLSPM is able to handle several groups of data to identify inter- and 
intra- relationships based on inner and outer measurement model respectively, 
and it can be applied for microarray data in multivariate pathway levels. Applying 
several multivariate statistical tools in the different microarray experiments to 
elucidate the biological relation between organs may enable the generation of 
new hypotheses in biology. 
 
 
Systems Biology 
 
Systems biology is a holistic approach merging various experimental data, from 
the genome, proteome and metabolism in single cells and organs with the use of 
computational methods and predictive mathematical models [39,40]. Recently, 
systems biology has been referred to as a ‘burgeoning field’ [41] and ‘executable 
biology’ [42]. At first, a systems approach to biology was predicated on theoretical 
considerations of complex systems. Wiener introduced mathematical models of 
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complex systems control and communication in the 1940s [43]. In the 1960s and 
1970s, Biochemical Systems Theory and Metabolic Control Theory were 
attempted to create simple mathematical models of biological systems [44]. 
However, such systems level approaches were not able to handle to connect the 
experimental molecules; molecules could be gene, modules/pathways, organs etc. 
In 1990s various omics platforms were developed to collect quantitative 
molecular data [45]. In 2002, Kitano mentioned that one should examine the 
structure and dynamics of cellular and organismal function instead of isolated 
parts of cell and organ to understand biological systems and this may have an 
impact on the future of medicine [46]. The combination of computational, 
experimental and observational enquiry in systems biology is highly relevant to 
drug discovery [47]. Basically, from 2002 the modern systems biology has started 
its modeling and network in different parts of the research. In order to 
understand biological systems, Aderem mentioned three basic concepts: 
emergence, robustness, and modularity. The details of these three concepts are 
mentioned in [48]. Systems biology is the combination of omics measurements, 
bioinformatics, statistics, metabolic engineering, computational sciences and 
mathematics. It is an attempt to detect a more integrated and hierarchical pattern 
that facilitates to build new biological pathways and networks at the cellular level 
[49].   
 
Top-down and Bottom-up systems biology 
In systems biology, two distinct approaches have evolved (i) bottom-up systems 
biology, namely computationally-based systems biology [50,51]  and (ii) top-down 
systems biology, namely data-driven systems biology [51,52].  
The bottom-up systems biology depends on computational modeling and 
simulation tools. The ultimate targets of bottom-up approach are to integrate and 
formulate the molecules in order to predict systems behavior and to combine 
pathway models into a global model for the entire systems under consideration.  
The top-down approach mainly utilizes datasets that are mined in a discovery 
manner for new knowledge using a variety of bioinformatics and statistical tools. 
This inductive approach aims to determine new molecular mechanisms employing 
integrated data acquisition and analysis based on correlation [53]. Data-driven 
systems biology [54] has attempted to develop a more applied methodology for 
systems biological analysis. In this approach, researchers have been used a variety 
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of omics platforms with sophisticated statistical and bioinformatics tools to 
transform the discovery process in complex relationships among genetic, 
genomic, proteomic and metabolic pathway and networks. Recently, Martins dos 
Santos et al mentioned in their review of systems biology of the gut that systems 
biology is an integrated, modular modeling framework that cross-links top-down 
and bottom-up approaches for the various levels of biological organs [55].  
 
Regulatory network and modeling 
Generally systems biology handles three major topics (i) dynamic modeling of 
biological systems [56], (ii) reconstruction of regulatory networks [57] and (iii) 
integration as well as molecular interaction [58]. The keystone of systems 
biological research is mostly the focus on molecular interaction and this can easily 
be analyzed and visualized by tools such as Cytoscape [59] and R-spider [60]. 
Recently, an application of graph theory and network theory of biology has 
proven to be a powerful approach to gain insights into biological complexity and 
the advancement of systems biology [61]. Regulatory network analysis provides a 
powerful tool for describing complex systems, their components and their 
interactions in order to identify their topology, as well as the structures and 
functions of the components in broad way. This approach has been successfully 
applied to the representation of various systems in different kinds of data, such as 
in engineering and technology [62], life sciences [63,64], and social studies [65]. 
Xu et al identified and verified critical components of a transcriptional network 
directing lipogenesis, lipid trafficking and surfactant homeostasis in the mouse 
lung [66]. 
 
Biological types of data can be related to one another. In the Gaggle Genome 
Browser [67], heterogeneous data are joined by their location on the genome to 
create information-rich visualizations yielding transcription and its regulation. 
Systems biology is a rising consciousness of the composite dynamics of existing 
systems. Some computational methods have already been developed that can 
deal with the nonlinearity in signaling pathways in relationships between 
genotypes and phenotypes [68]. Although systems biology tends to focus on 
molecular networks, it utilizes analytic techniques designed to account for 
mounting properties arising from the background, flexibility and plasticity of the 
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function [69] in signaling pathways that contribute to disease phenotypes and 
treatment awareness.  
Regulatory networks are the most emerging part of the systems biology. These 
are modeled as graphs, where nodes can be a gene/protein/module and directed 
edges represent transcriptional regulatory interactions. The reconstructions of 
these networks identify the spatial and temporal regulatory interactions between 
transcription factors (TFs) and their targets [70]. For exploiting the causal gene-
gene temporal relationships, time series gene expression data are essential. These 
provide the dynamical properties of the molecular networks. Time-series gene 
expression data can also help to detect the dynamical properties of molecular 
networks, by exploiting the causal gene-gene temporal relationships. In the recent 
literature several dynamic models, such as TimeDelay-ARACNE [71]; ARACNE [72]; 
Dynamic Bayesian Networks [73]; Hidden Markov Model [74]; Ordinary 
Differential Equations [75,76]; and pattern signal processing approaches [77] have 
been proposed for reconstructing regulatory networks from time-course gene 
expression data.  
 
Computational models of intracellular networks as well as a quantitative 
predictive model of gene expression are a foundation of systems biology.  The 
Dialogue on Reverse Engineering Assessment and Methods (DREAM) project is 
working with the current state of systems biology modeling and it organizes 
reverse-engineering challenges to infer the connectivity of the molecular 
networks underlying the measurements, or related reverse-engineering [78-80]. 
Researchers have developed various methods/algorithms to figure out the 
structure of different biological and artificial networks [81]. Recently, high-
throughput experimental techniques have resulted in rapid accumulation of a 
wide range of omics data of various forms, providing in-depth understanding of 
biological processes. It is widely renowned that systems and network biology has 
the potential to increase our understanding of how nutrition influences metabolic 
pathways and homeostasis and how this regulation is disturbed in a diet-related 
diseases. 
 
Nutritional systems biology (NSB) 
Systems biological analysis with focusing on nutrition is known as nutritional 
systems biology. After a nutrient or other dietary component enters a cell, it may 
General introduction 
 
 
 
20 
 
 
influence gene expression by activation of specific transcription factors [6]. These 
TFs are therefore also called nutrient sensors. As a result metabolism may be 
modified. So it’s important to understand this whole process- how it works and 
what the influences on the function of the living beings are. This process can be 
modulated by a number of internal (disease) or external (environmental) factors. 
Also important to consider is the association between omics data and these 
internal or external factors [82] as well as multilevel computational models [83] 
that integrates physiological mechanisms and different space-time scales related 
data. In order to see the nutrient control of eukaryote cell growth, Gutteridge et 
al conducted a comprehensive study  of transcriptome, proteome and metabolism 
responses of chemostat cultures of the yeast and in four different nutrient-
limiting conditions [84]. Every omics dataset represents the complexities of 
nutrition, physiology and cell biology. These datasets have been acquired and 
analyzed to get insight on the biological processes such as homeostasis, disease 
onset and optimal nutrition. For instance, even at the cellular level, simple 
pathways are highly interconnected [50,85]. The emergence of systems biology is 
also referred to as pathway, network, or integrative biology [46,49]. The aim of 
understanding the behavior of the system is to see as a whole rather than the 
behavior of the individual components [86-88]. Systems biology is the integrated 
approach for studying biological systems at the level of cells, organs or organisms 
by measuring and integrating genomics, proteomics and metabolomics data [89]. 
Furthermore, it’s also useful to find out the promoter/transcription factor binding 
sites (TFBS) associations [90], which so far has been most successful in the yeast 
system [91]. 
 
The potential of systems biology is to provide a new dynamic for investigating 
personalized medicine and nutrition [92]. Systems biology has opened up a new 
outlook in our understanding of complex biological systems together with 
information technology, bioinformatics, statistical knowledge, and mathematical 
models. The expansion and use of omics platforms, particularly transcriptomics, 
proteomics and metabolomics, was discussed in detail by [93]. Transcriptome and 
proteome analyses were conducted by [94] to identify the fundamental molecular 
changes in hepatic lipid metabolism in zinc-deficient rats. They provided evidence 
for a rather complex regulatory network of zinc-dependent alterations in hepatic 
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metabolism. An integrated analysis to identifying molecular effects of diet was 
done by [95] using transcriptome data from three tissues (liver, muscle and 
adipose tissue) of mice with metabolic disease. They used low-density lipoprotein 
receptor-deficient (Ldlr -/-) mice which were fed a high fat diet to mimic a 
westernized diet. The diets were supplemented with herring. Transcriptome data 
was collected from the above three organs with some phenotype measurements 
(body composition, plasma lipids and aortic lesion). They found that the effect of 
diet on metabolic function in different tissues shows very clear effects that have 
implication for disease development. 
A systems approach to identify early molecular signatures predicting genetic risk 
to metabolic diseases (Type 2 diabetes and obesity) using two strains of mice was 
done by [96]. They integrated different metabolic characterization, gene 
expression, protein-protein interaction networks, RT-PCR and flow cytometry data 
of adipose, skeletal muscle, and liver tissue of diabetes-prone C57BL/6NTac mice 
and diabetes-resistant 129S6/SvEvTac mice at 6 weeks and 6 months of age. They 
found that insulin resistance in mice with differential susceptibility to diabetes 
and metabolic syndrome is preceded by differences in the inflammatory response 
of adipose tissue.  
A study to the pathogenesis of obesity-related nonalcoholic fatty liver disease 
(NAFLD) [2] using reverse phase protein microarrays (RPA) for multiplexed cell 
signaling analysis of adipose tissue from patients with NAFLD was done by [97]. 
They found that PKC (protein kinase C) delta, AKT (protein kinase B), and SHC 
phosphorylation changes occur in patients with simple steatosis. They also found 
that the amounts of cleaved caspase 9 and pp90RSK S380 were positively 
correlated in patients with nonalcoholic steatohepatitis (NASH) using Pearson 
correlation coefficient and specific insulin pathway signaling events are altered in 
the adipose tissue of patients with NASH compared with patients with non-
progressive forms of NAFLD. 
 
Metabolomics of the interaction between PPARα and age in the PPARα -null 
mouse was done by [98]. They used a combined (1)H nuclear magnetic resonance 
(NMR) spectroscopy and gas chromatography-mass spectrometry metabolomics 
approach to examine metabolism in the liver, heart, skeletal muscle and adipose 
tissue in PPARα -null mice and wild-type controls during ageing between 3 and 13 
months. Their metabolomics study, using multivariate statistical techniques: 
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partial least squares (PLS) and partial least squares discriminate analysis (PLS-DA), 
demonstrated that a loss of PPARα results in a marked reduction in hepatic 
glucose/glycogen and subsequent hepatic steatosis with age.  
 
It is important to know the association/integration among the nutrients/diets, 
transcriptomics, proteomics, metabolomics and phenotypes such as weight and 
disease status etc. The following Figure 2 shows an overview of such integration 
among the different kinds of data. This kind of study belongs to the top-down 
systems biology to detect the association among the multi datasets using 
multivariate data mining techniques. 
 
 
Figure 2: Integrate different omics datasets with phenotypes. 
 
To identify the association between transcriptomics and proteomics data, the R 
package mixOmics can be applied by using regularized canonical correlation or 
sparse partial least squares [99]. Another way to integrate different datasets is by 
using the FactoMineR package [100], that is based on multiple factor analysis. In 
this package, one can handle different sets of high-throughput data with 
supplementary variables (e.g., plasma measurements, weight status etc.) To 
Nutrients/Diets
Transcriptomics
Proteomics
Metabolomics
Phenotypes
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uncover the causal relationships among the different blocks of variables partial 
least squares path model is very well known in chemometrics, econometrics and 
sociological data, and its relevance for the analysis of high throughput biological 
data such as microarray data is being reported [38,101]. This is a multivariate 
technique to collect the path coefficients and the loadings of the variables, and it 
is easy to analyze by plspm package [30] in R program. 
 
Dynamic modeling of gene expression and gene regulatory network are the most 
useful terms in the field of systems biology. But it is also important to build meta 
gene modeling as well meta gene network using systems biological techniques to 
elucidate how biological process evolve over time instead of individual gene. This 
kind of meta gene or eigen gene modeling and network can be done using some 
data reduction technique like PCA (principal component analysis) to find out meta 
gene expression in different homogeneous genes cluster or modules. Afterwards, 
some models, for instance: statistical (linear or non-linear regression model), 
kinetic or mechanistic model can be built by repeated approach as well as meta 
gene network. These kinds of analyses can also be done for protein or 
metabolites. The types of models completely depend on data and the objectives 
of the research. Prifti et al developed an R package FunNet as well as web based 
tools to explore the transcriptional network on gene co-expression based on 
correlation [102]. But their approach does not cover the causal relationship 
between the gene co-expression networks; therefore, after creating meta gene 
expression by multivariate techniques the causal meta gene network can be done 
by TDARACNE [71]. 
 
Software tools 
In order to implement the different approaches in the different fields, we need 
software and statistical tools. Of course, researchers like to analyze their data 
using valid tools that are freely available. Many software tools are available and 
almost every week some new tools are coming in this area. Among them some are 
easy to handle by biologists, some are free and some are not free. In this limited 
overview (Table 1), we list some useful software tools, mostly R packages 
(because these are free and easy to handle) and its function that are related to 
systems biological analyses. Some of these tools have already discussed above. 
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Table 1: Some useful and related software tools in the systems biological field 
 
Software Function Reference 
Top-down 
TDARACNE ( R package) 
Reverse engineering of gene network from time 
course data 
[71] 
GeneTS ( R package) 
Gene association network based on an empirical 
Bayes approach. 
[103] 
VAR network ( R code) 
Causal networks based on the vector autoregressive 
(VAR) process. 
[77] 
pcalg (R package) 
Standard and robust estimation of the equivalence 
class of a Directed Acyclic Graph (DAG) via the PC-
Algorithm. Predicting causal effects in large-scale 
systems from observational data. 
[104] 
Deal (R package) 
Bayesian networks with continuous and/or discrete 
variables can be learned and compared from data. 
[105] 
BNArray (R package) 
Constructing gene regulatory networks 
from microarray data by using Bayesian network 
[106] 
rHVDM (R package) 
Hidden variable dynamic modeling to predict the 
activity and targets of a transcription factor 
[107] 
SysNet 
For interactive analysis of molecular expression 
information in systems biology based on correlation 
[108] 
PathVisio Presenting and exploring biological pathways  [109] 
Cytoscape* 
Integrate models of biomolecular interaction 
networks and visualization tool. 
[59] 
payao 
It is a community-based, collaborative web service 
platform for gene-regulatory and biochemical 
pathway model creation 
[110] 
MetNet 
Enable to visualize, statistically analyze and model a 
metabolic and regulatory network map of 
Arabidopsis, combined with gene expression 
profiling data. 
[111] 
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VitisNet 
"Omics" integration through grapevine molecular 
networks 
[112] 
GeneNet (R package) Gene network based on partial correlation  [113] 
MetNetGE 
Visualization tool that organizes biological networks 
according to a hierarchical ontology structure 
[114] 
FactoMineR* (R 
package) 
Able to handle multifactor data as well as to ingrate 
between them using multivariate statistical tools 
[100] 
integrOmics /mixOmics 
(R package) 
Integrate two different datasets like transcriptomics 
and proteomics. 
[99] 
Simca-p 
Able to handle multivariate normal and non-normal 
data by using PCA and PLS techniques 
[115] 
Unscrambler 
Able to handle multivariate data as well as to 
integrate between them using different kinds of 
statistical tools 
[116] 
Plspm* (R package) 
Handle several groups of multivariate data with 
causal relationships. 
[117] 
FunNet (R package as 
well as web based tool) 
Transcriptional network ( gene co-expression based 
on correlation) 
[102] 
Minet (R package) 
Transcriptional network (gene to gene based on 
mutual information) 
[118] 
GeneAnswers  (R 
package) 
Provide an integrated tool for biological or medical 
interpretation of the given one or more groups of 
genes 
[119] 
CoGAPS (R package) 
To identify patterns and biological process activity in 
transcriptomic data 
[120] 
iPath Visualize the metabolic pathways [121] 
R spider* Pathway network based on KEGG and Reactome [60] 
Ingenuity* 
Pathway analysis and visualization of the interaction 
among the molecules 
[26] 
Genomatix* 
Transcription factor binding sites and promoter 
analysis 
[122] 
Bottom-up 
Celldesigner A modeling tool of biochemical networks [123] 
SBML (Matlab tool box) Facilitates importing and exporting models [124] 
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represented in the Systems Biology Markup 
Language (SBML) 
Inferelator (R code) 
Gene regulatory network based on sigmoidal, or 
Logistic model with the help of kinetic equation. 
[125] 
COPASI 
For simulation and analysis of biochemical networks 
and their dynamics based ODE 
[126] 
 
DIPSBC 
Data integration platform for systems biology 
collaborations by XML  data format 
[127] 
*Used in this thesis 
 
The primary purpose of many biological research projects is to identify the 
gene(s), protein(s) or molecule(s) that are potentially related to a certain 
biological problem (disease). Once a list of potential target genes has been found 
using the proper statistical methods, the next task is to see the pathways or 
networks where these genes are significantly over-represented or not. Besides 
these, another most important thing is to visualize the output, for instance: gene-
gene interactions, protein-protein interactions, pathway networks, metabolic 
pathways, visualize multivariate data and their interpretation to get better insight 
of biological function which leads to create another hypothesis. Recently, 
Ghelenborg et al have nicely been discussed  how to visualize of omics data for 
systems biology [128]. 
The most of the packages and software in the above list are useful for both top-
down and bottom-up approaches. CellDesigner, SBML, and COPASI are very useful 
for kinetic/mechanistic modeling. CellDesigner [123] is very handy to draw 
pathway/biological model and to produce SBML file, afterwards this SBML file can 
be used to simulate model and predicting by COPASI [126]. 
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Perspectives 
 
Until the end of last century, no significant developments occurred in the area of 
systems biology, although some modeling approach were conducted in 1960s and 
70s. Initially, it was meant only in biological area. Recently, this concept is applied 
by other research fields as well, such as ecology, sociology, and medicine. In the 
eve of this century, some significant reviews and studies were published with 
software tools and approaches in systems biological field. However, it’s not 
enough yet to uncover the function of whole organ in the livings beings. To 
integrate different datasets, it’s very essential to use the proper statistical tools. 
Here we mentioned some well-known statistical tools for univariate and 
multivariate data analysis of microarray studies. Some PPARα related articles also 
discussed in this overview to know the function of this transcription factor on the 
gene expression in different organs of mice. Especially, here we focused on the 
top-down systems biological literature on nutritional studies as well as some 
useful analytical software tools for systems biological analyses.  
Based on literature, we may conclude that very few integrative analyses were 
performed by top-down systems biological approach focusing transcriptomics 
data of dietary fat in different organs or integrating omics data. Still more ideas 
and studies are necessary to reveal the function of nutrition in whole living 
beings. Here, we mentioned a schematic overview to integrate not only different 
omics data related with the nutrients but also with phenotype data. Besides the 
interaction among the transcriptomics, proteomics, metabolism and phenotypes, 
we need to know their behavior over time. Therefore, it would be more 
meaningful to produce such kind of omics data over time to reveal the evolution 
of nutritional components in the living beings. Still the research in nutritional 
systems biological is at its infancy, so many things need to be explored this aspect. 
However, this overview might be given us some clue to analyze nutritional 
systems biological analysis in future. 
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Aim and outline of this thesis 
 
Although the function of the fatty acid sensor PPARα has been extensively studied 
at the level of different organs, less is known about the systems-wide functional 
implications of PPARα activation for metabolic health and plasticity of organs as 
well as its behavior over time under nutritional relevant conditions. Since the 
average Western diet, but also that increasingly more in developing countries, 
contains high amounts of fat, a comprehensive systems-wide understanding of 
the role of fatty acid-sensing mechanisms such as PPARα is of great importance 
[46,49,92]. Applying or developing NSB approaches might help to interpret new 
experimental nutrigenomics data on transcriptional responses to dietary fat and 
may provide better insight into the biological implications of fat-specific responses 
in different metabolic organs as relevant for homeostasis, metabolic plasticity and 
prevention of metabolic diseases such as morbid obesity or diabetes type 2 [6] . 
 
The aim of the research described in this thesis was to integrate and model 
different organ-specific transcriptomics datasets related to lipid-sensing by 
nutritional systems biological approaches, especially to characterize the function 
of PPARα. 
 
The different effect sizes (Fold Changes, i.e., mean differences between treatment 
and control groups) in experiments are a big challenge in the analysis of high 
throughput genomics studies and, therefore, in chapter 2 an integrated statistical 
approach is presented to identify transcription factor target genes from 
transcriptomics data across different experiments. Chapter 3 deals with the 
integration and modeling of multivariate data, an important challenge in top-
down systems biology. An approach to characterize a pathway score and to 
integrate different time course and organ specific transcriptomics data by a path 
model are described here. In chapter 4 characterization and modeling of acute 
effects of PPARα activation in rat liver cells is investigated. In chapter 5, we 
focused to detect the time and dose dependently regulated genes in liver and 
white adipose tissue during the development of high-fat diet induced obesity in 
mice. Moreover, we studied the correlation of these genes with the different 
plasma factors (glucose, leptin, adiponectin, resistin, Il6 and tPAI-1) and weight 
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status indicators (BW at start of intervention, BW at section, BW gain, absolute 
liver weight, and relative liver weight). Finally, the general discussion and 
conclusions are presented in chapter 6. 
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Abstract 
  
An effective strategy to elucidate the signal transduction cascades activated by a 
transcription factor is to compare the transcriptional profiles of wild type and 
transcription factor knockout models. Many statistical tests have been proposed 
for analyzing gene expression data, but most tests are based on pair-wise 
comparisons. Since the analysis of microarrays involves the testing of multiple 
hypotheses within one study, it is generally accepted that one should control for 
false positives by the false discovery rate (FDR). However, it has been reported 
that this may be an inappropriate metric for comparing data across different 
experiments. Here we propose an approach that addresses the above mentioned 
problem by the simultaneous testing and integration of three hypotheses 
(contrasts) using the cell means ANOVA model. These three contrasts test for the 
effect of a treatment in wild type, gene knockout, and globally over all 
experimental groups. We illustrate our approach on microarray experiments that 
focused on the identification of candidate target genes and biological processes 
governed by the fatty acid sensing transcription factor PPARα in liver. Compared 
to the often applied FDR-based across experiment comparison, our approach 
identified a conservative but less noisy set of candidate genes with similar 
sensitivity and specificity. However, our method had the advantage of properly 
adjusting for multiple testing while integrating data from two experiments, and 
was driven by biological inference. Taken together, in this study we present a 
simple, yet efficient strategy to compare differential expression of genes across 
experiments while controlling for multiple hypotheses testing.  
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Introduction 
 
Genome-wide transcriptional profiling, or transcriptomics, is extensively used to 
study how cells respond to certain stimuli or to diagnose and predict clinical 
outcomes [129-132]. Transcription factors (TFs) are the key effectors which 
control gene expression. From a variety of research fields, including nutrition 
sciences, there is a major interest in characterizing the genes and networks that 
are controlled by transcription factors. Advances in genome-wide expression 
profiling methodologies and the availability of model systems offered new, 
powerful tools to address this [6,133-138]. 
An effective strategy to elucidate the signal transduction cascades activated by 
transcription factors is through transcriptional profiling. Transcription profiling can 
be applied on gain- and loss-of-function TF mutants, and changes in global gene 
expression that are associated with the various phenotypes could then be used 
for a comprehensive understanding of TF function [133,134,138-140]. To this end, 
transcription factor target genes have to be efficiently and accurately identified 
from the transcriptomics dataset. It is important to realize that from a biological 
perspective, TF target genes are only those genes that do significantly respond 
upon treatment with a potent agonist or gain of function, in wild type but not 
mutant (knockout) models. However, from a statistical inference point of view the 
identification of biological relevant target genes from such 2x2 factorial 
experiments is less straight-forward. 
It is generally accepted that statistical testing is required to reliable identify 
differentially expressed genes (reviewed in e.g. Allison et al [141]). Moreover, 
since the statistical analysis of microarrays involves the testing of multiple 
hypotheses (genes) within one study, it is necessary to control for false positives. 
A frequently used metric to quantify the level of confidence any particular gene is 
differentially expressed, that takes into account multiple testing, is the false 
discovery rate (FDR) [141]. Therefore in many studies a cutoff based on the FDR 
rather than p-value is used to select significantly regulated genes within 
experiments, which subsequently are compared across experiments to identify 
transcription factor target genes. However, Higdon et al [142] reported that the 
use of the FDR and its associated q-value may result in inconsistent and 
misleading interpretation of the comparisons across different experiments, 
especially when the effect sizes of the experiments vary dramatically, as for 
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example is the case when comparing effects of potent agonists in wild type and TF 
knockout models.  
Therefore, the purpose of the work described in the current paper is to present a 
strategy that optimally integrates and controls for multiple hypotheses testing 
using data obtained from two biological systems that respond completely 
different to a treatment. We outline our approach using one of our datasets on 
the mouse peroxisome proliferator-activated receptor alpha (PPARα) [15]. PPARα 
is a TF belonging to the nuclear receptor superfamily, and is activated by a variety 
of compounds, including dietary fatty acids and their derivatives as well as 
synthetic agonists [7,9,143]. 
 
 
Material and Methods 
 
Experimental data 
We illustrate our approach (Figure 1) on one of our publicly available datasets 
(Gene Expression Omnibus (GEO) accession: GSE8295). This dataset was 
generated to identify PPARα target genes in mouse liver [15], and was also used 
by Higdon et al [142] to illustrate the inappropriateness of using the FDR as cut-off 
metric when comparing two transcriptomics experiments with different effect 
sizes. 
Briefly, pure bred wild type (129S1/SvImJ) and PPARα-null (129S4/SvJae-
Pparatm1Gonz/J) mice [144] were fed chow or chow supplemented with 0.1% 
WY14643 (Chemsyn, Lenexa, KS) for 5 days (n = 4 mice per group). WY14643, ({4-
Chloro-6-[(2,3-dimethylphenyl)amino]-2-pyrimidinyl}sulfanyl)acetic acid (CAS: 
50892-23-4), is a chemical that was developed by the pharmaceutical industry to 
lower serum cholesterol. It is not used in clinical applications, but it is rather used 
as prototype chemical to induce peroxisome proliferation. WY14643 is a highly 
specific and potent agonist for PPAR and is therefore often used in studies on 
this nuclear receptor [12,145]. On the sixth day, mice were anaesthetized and 
livers were excised. Total RNA was prepared using TRIzol reagent (Invitrogen, 
Carlsbad, CA) followed by purification using the RNeasy mini kit (Qiagen, Hilden, 
Germany). RNA integrity was checked by chip analysis (Agilent 2100 Bioanalyzer, 
Agilent Technologies, Amsterdam, the Netherlands) according to the 
manufacturer's instructions. RNA was judged as suitable for array hybridization 
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only if samples exhibited intact bands corresponding to the 18S and 28S ribosomal 
RNA subunits, and displayed no chromosomal peaks or RNA degradation 
products, and had a RNA integrity number (RIN) above 8.0). The Affymetrix 
GeneChip RNA One cycle Amplification Kit (Affymetrix, Santa Clara, CA) was used 
to prepare labeled cRNA from 5 μg of total RNA, which subsequently was 
hybridized on Affymetrix Mouse Genome 430 2.0 plus arrays. The animal study 
was approved by the Local Committee for Care and Use of Laboratory Animals. 
 
Cell Means ANOVA Model 
The dataset on the identification of PPARα target genes in mouse liver has a 2x2 
factorial design; that is factor ‘treatment’ has 2 levels (WY, Control), as has the 
factor ‘genotype’ (wild type, knockout). Analysis of variance (ANOVA) is commonly 
used for analyzing data from experiments with multiple categorical factors 
[146,147]. To appropriately identify candidate PPARα target genes, we propose to 
perform and integrate three comparisons using the cell means ANOVA model 
[148]. For every probeset the model was defined as follows: 
                                                                 Yijk= µij + εijk 
 
where Yijk is the expression of a probeset at i
th treatment (1 for WY, 2 for Control) 
in jth strain of genotype (1 for WT, 2 for KO) and kth replication (n=4), µij is the 
mean value of ith treatment and jth strain of each gene, and εijk is a random error 
term which follows normal distribution with mean = 0 and variance = σ2.  
Formally, the definition of a contrast C is expressed below, using the notation µj 
for the jth treatment mean:  
C = c1µ1 + c2 µ 2 + … +cj µ j  + .. .+ck µ k 
Where, c1 + …+ cj +…+ ck =

k
1j
jc =0 
As stated before, from a biological perspective, candidate PPARα target genes are 
only those genes that do significantly respond upon treatment with the potent 
PPARα agonist WY14643 in wild type but not in PPARα knockout mice. Therefore 
three different contrasts (comparisons) from this 2x2 factorial experiment were 
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combined to infer the probesets that were significantly and PPARα-dependently 
regulated. The different contrasts tested were (Table 1): 
Contrast 1: H0: µ11 - µ21=0 versus H1: µ11 - µ21 ≠ 0, returning all probesets regulated 
in the wild type mice by the agonist WY; 
Contrast 2: H0: µ12 - µ22=0 versus H1: µ12 - µ22 ≠ 0, returning all probesets regulated 
in the PPARα knockout mice by the agonist WY; and 
Global Contrast: H0:( µ11 - µ21 ) - (µ12 - µ22 ) = 0 versus H1: ( µ11 - µ21 ) - (µ12 - µ22 )  ≠ 
0, returning the overall differential expressed probesets in wild type versus 
knockout mice groups after treatment with WY compared to control. 
Table 1: The contrasts defining the different hypotheses. 
µij Levels 
Contrast 1 
H0: µ11 -µ21=0 
Contrast 2 
H0: µ12 -µ22=0 
               Global Contrast 
H0:( µ11 - µ21 ) - (µ12 - µ22 ) = 0 
µ11 WY, WT 1 0 1 
µ12 WY, KO 0 1 -1 
µ21 Con, WT -1 0 -1 
µ22 Con, KO 0 -1 1 
 
The PPARα-dependently regulated probesets were then identified by extracting 
those probesets that were only significantly regulated in both Contrast 1 and 
Global Contrast, and subsequently corrected for multiple testing. 
 
Implementation 
All analyses were performed in R [149], using packages from the Bioconductor 
project [150]. Probesets were redefined according to Dai et al [151]. In this study, 
probes were reorganized based on Entrez Gene database, build 36, version 2 
(remapped CDF version 12). Our workflow was as follows (note that since we used 
a remapped chip definition file based on the Entrez Gene database, the terms 
probeset and gene are used interchangeably): 
1. Expression estimates were obtained by GC-robust multiarray (GCRMA) 
normalization, using the empirical Bayes approach to adjust background 
[152].  
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2. For each of the three above-mentioned contrasts, differentially expressed 
probesets (genes) were identified using linear models, as implemented in 
limma [153]. For each contrast probesets were selected based on p <0.05. 
3. Probesets that were common only in Contrast 1 and the combined Global 
Contrast were identified. This set of probesets represented only 
transcription factor regulated genes, and was designated X.  
4. Multiple testing was corrected by using a false discovery rate method 
[27], based on the Global Contrast considering the output of all probesets. 
Probesets in X that satisfied the criterion FDR < 5% were considered to be 
transcription factor target genes. 
 
A schematic overview of our implementation is also given in the Figure 1, and the 
R-code and other required files are available as supplemental material 
(http://www.la-press.com/an-integrated-statistical-approach-to-compare-
transcriptomics-data-acr-article-a3222). 
 
Validation 
To validate our integrated approach, obtained results (Figure 2) were compared 
to results from the across experiment comparison (Figure 3) using two sets of 
well-established PPARα target genes obtained from a recent review (Table 1 from 
Rakhshandehroo et al [18]).  
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Figure 1: Overview of our integrated strategy. After normalization, transcriptome data 
are analyzed for differentially expressed probesets (genes) using three contrasts (comparisons): 
Contrast 1, representing probesets regulated by a specific treatment in wild type mice; Contrast 2, 
representing probesets regulated by the same treatment but in knockout mice, and Global Contrast, 
representing genes differentially regulated by the treatment between the WT and KO mice. 
Biologically irrelevant probesets, i.e., probesets that are also regulated by the treatment in the KO 
mice, are discarded, resulting in a set of probesets called X. To correct for multiple testing, FDR 
values of the probesets in X are calculated using the p-values obtained in Global Contrast for all 
probesets. A robust set of putative target genes regulated by the knocked-out gene is obtained by 
selecting those probesets from X that fulfill a Global Contrast-based FDR cutoff, e.g. FDR <0.05. This 
set can subsequently be divided in up- and down-regulated genes. 
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Figure 2: Application of the integrated approach on PPARα dataset GSE8295. 
Expression estimates were calculated by GCRMA normalization. Differentially expressed probesets 
were identified using three contrasts using p-value <0.05. Contrast 1, representing probesets 
regulated by the specific PPARα agonist WY in wild type mice; Contrast 2, representing probesets 
regulated by WY14643 in PPARα knockout mice, and Global Contrast, representing probesets 
differentially regulated by WY14643 between the WT and PPARα KO mice. Biologically irrelevant 
probesets, i.e., those 854 probesets that were regulated by WY14643 in both WT and PPARα KO 
mice, were discarded, resulting in a set of probesets called X of size 3345 that were only regulated in 
Contrast 1 and Global Contrast. To correct for multiple testing, FDR values (Benjamini Hochberg 
procedure) of the probesets in X were calculated based on the p-values for all probesets obtained in 
Global Contrast. A robust set of candidate PPARα target genes was obtained by selecting those 2432 
probesets from X that had Global Contrast-based FDR value <0.05. This set was divided in 1325 up- 
and 1107 down-regulated probesets. 
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These sets are available as supplemental material. The true positive rate 
(sensitivity) as function of the false positive rate (1-specificity) for different cutoff 
points was plotted for both the across experiment comparisons and our 
integrated approach using the R-library ROCR [154].  
 
 
Figure 3: The FDR based across experiment comparison of PPARα dataset 
GSE8295. Expression estimates were calculated by GCRMA normalization. Differentially expressed 
probesets were identified in each contrast. Using a FDR value < 0.05 criterion, 4324 probesets were 
regulated in the wild type experiment (Contrast 1), whereas 12 genes were changed in the knockout 
experiment (Contrast 2). Of these 12 genes, 10 were also regulated in the wild type experiment. 
Thus, when comparing across experiments with a FDR value cutoff level of 0.05, 4314 genes were 
considered PPARα target genes.  
 
The partial area under the ROC curve was calculated using p=0.2 (thus 1-
specificity = 0.2) as cutoff. This cutoff value was chosen because for the 
identification of transcription factor target genes a high specificity is required 
(>80%) before considering its sensitivity [155]. In addition, the biological features 
that were overrepresented in the lists of candidate PPARα target genes that were 
generated on the basis of both approaches were analyzed with the software tool 
Ontologizer [156], applying the ‘parent-child-union’ (PCU) algorithm and using the 
biological process ontology of Gene Ontology.  
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Results and Discussion 
 
Identification of candidate PPARα target genes 
The application of transcriptomics to compare the effects of specific agonists, 
such as WY14643, in wild type and PPARα knockout mice is a powerful approach 
to identify candidate PPARα target genes [139,140]. However, when comparing 
across different experiments the use of FDR cutoff values may result in 
inconsistent and misleading interpretation of the data [142]. In this study we 
propose a simple yet effective strategy that avoids comparing probesets across 
experiments based on FDR values while still controlling for multiple testing. 
Testing three different hypotheses (contrasts) for each probeset allowed the 
robust identification of transcription factor target genes. Since only the 
interaction effects are of interest for identifying candidate target genes, the cell 
means ANOVA model was used to infer this 2x2 factorial design. 
 
The number of probesets significantly regulated (p<0.05) upon PPARα activation 
by WY14643 in wild type mice (= Contrast 1) equaled to 5458, whereas in PPARα-
/- mice (Contrast 2) this number was only 1540 (Figure 2). Such a large difference 
was expected since the KO mice do not express any functional PPARα. The Global 
Contrast, incorporating expression information for all probesets in all groups, 
identified 4282 significantly regulated probesets (p<0.05) (Figure 2), representing 
genes that from an inferential perspective are differentially regulated by WY 
between the two mouse strains. However, these included genes that for example 
were only regulated in the KO mice, or were regulated in wild type and, although 
to a lesser extent, still in KO mice. To filter out these ‘biological irrelevant’ genes, 
only probesets that were common in Contrast 1 and Global Contrast were 
retained, resulting in a set of 3345 probesets, which was called set X. Thus, this set 
X contained only probesets that from a biological perspective fulfill the criterion 
of being candidate PPARα target genes. To correct for multiple testing, FDR values 
of the 3345 genes in X were calculated based on all 16392 genes in Global 
Contrast, since in this comparison statistical inference was simultaneously 
adjusted for both experiments in wild type and knockout mice. Finally, a robust 
set of PPARα target genes was obtained by selecting those 2432 probesets from 
set X that fulfilled the criterion FDR < 0.05 (Figure 2). Of these, 1325 probesets 
were induced and 1107 probesets were suppressed.  
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For comparison, we also generated a list of candidate PPARα target genes that 
were generated on the basis of directly comparing the wild type and knockout 
experiment using a FDR cutoff (Figure 3). Note that this frequently used approach 
is criticized [142] and that it is in essence identical to the analysis strategy 
published and interpreted by Rakhshandehroo et al [15], except that these 
authors also employed a fold change cutoff. Using a FDR cutoff of 0.05, we 
identified 4324 probesets that were regulated in the wild type experiment 
(Contrast 1), whereas 12 probesets were changed in the knockout experiment 
(Contrast 2). Of these 12 probesets, 10 were also regulated in the wild type 
experiment. Thus, the FDR based comparison of these two experiments identified 
4314 probesets that should be considered PPARα target genes. 
 
The number of FDR based selected probesets was about twice as large as the list 
of probesets obtained using our integrated approach (4314 versus 2432 
probesets). Comparison of these two sets of candidate genes revealed that almost 
all (i.e., 99%) of the probesets obtained by our integrated approach were also 
identified when using a FDR cutoff (Figure 4). This indicates that while Global 
Contrast is more conservative it will identify similar if not identical biological 
features (see also section on validation). 
 
 
Figure 4: Venn diagram of the identified candidate PPAR target genes obtained 
by our integrated approach or the FDR based across experiment comparison of 
PPARα dataset GSE8295. Almost all (99%) of the candidate target genes identified by our 
proposed approach were also identified in the FDR based across experiment comparison.  
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It is important to realize that the results of statistical hypothesis testing are never 
free of error. Two types of error are distinguished: type I error, i.e., rejecting the 
null hypothesis when it is in fact true, and type II error, i.e., not rejecting the null 
hypothesis when in fact the alternative hypothesis is true. In other words, 
occurrence of the former leads to inclusion of false positives whereas the latter 
leads to inclusion of false negatives. Consequently, we cannot exclude that the set 
of 1911 probesets that were discarded by Global Contrast contained false 
negatives that otherwise would have been retained. However, especially within 
the context of genome-wide screening studies for candidate genes, we believe 
that limiting type I error is of primary concern, and that of type II error is of 
secondary importance. Thus, to err on the safe side we prefer to control for false 
positives rather than for false negatives. Moreover, the probesets that were 
discarded by Global Contrast were characterized by a relatively low effect size 
compared to the probesets that were still included. The mean of the absolute 
coefficients (log2 of the fold-change) of the excluded probesets was 0.36 
(equaling to a mean fold change of 1.28), and was 0.87 (mean FC = 1.83) for the 
included probesets. Taken together, we showed that compared to the FDR based 
across experiment comparison our approach identified a conservative set of more 
robustly regulated candidate PPARα target genes. We believe this is advantageous 
because a clear overview of candidate genes and corresponding biological 
processes normally is aimed for.  
 
Validation 
To compare the performance of our integrated approach with that of the FDR 
based across experiments comparison, we first performed sensitivity versus 
specificity analysis. To this end two benchmark sets of well-established PPARα 
target genes were selected from a review that summarized the latest literature on 
this topic [18]. We created two benchmark sets; one set containing only 32 genes, 
and another set containing 189 genes. The smaller benchmark set contained only 
genes that were demonstrated to be bona fide PPARα target genes in both human 
and mouse liver and that do contain a functional PPAR response element (PPRE) 
in the regulatory regions. The larger benchmark set contained all genes that were 
demonstrated to be PPARα-dependently regulated in mouse liver but for which 
no functional PPRE has yet been identified. We next plotted the true positive rate 
(sensitivity) as function of the false positive rate (1-specificity) for different cutoff 
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points for both our integrated approach and the across experiment comparison 
(Figure 5).  
 
Figure 5: Sensitivity versus specificity of our proposed method and the across 
experiment comparison. The sensitivity versus specificity was analyzed using two benchmark 
lists of established PPARα target genes derived from literature. Panel A: ROC curve for both methods 
using a set of 32 benchmark genes that were demonstrated to be PPARα target genes in both human 
and mouse liver and that do contain a functional PPAR response element (PPRE) in the regulatory 
regions. Panel B: ROC curve for both methods using a set of 189 benchmark genes that were 
demonstrated to be PPARα-dependently regulated in mouse liver but for which no functional PPRE 
has been identified yet. Red lines: ROC curves of our integrated approach; Black lines: ROC curves of 
the across experiment comparison. 
 
Even though our approach identified a conservative list of candidate genes, we 
observed that it performed very similar to the across experiment comparison in 
identifying known PPARα target genes, which was also reflected by almost 
identical partial area under the ROC curve (pAUC; p=0.2) for both methods. Values 
were 0.129 and 0.121, respectively for the across experiment comparison and our 
integrated approach when the smaller set of 32 PPARα target genes was used, 
whereas these numbers were 0.128 and 0.124, respectively, for the larger set of 
189 putative PPARα target genes. 
Next we detected and compared the biological features that were 
overrepresented in the lists of candidate PPARα target genes that were either 
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generated by our approach or the across experiment comparison. Enriched 
biological processes were identified by overrepresentation analysis based on 
Gene Ontology (GO) categories, which is a generally accepted procedure to 
achieve this [141]. To this end the software tool Ontologizer was used [156], 
applying the ‘parent-child-union’ (PCU) algorithm. This algorithm takes the graph 
structure of GO into account, thereby reducing false-positive and biologically 
misleading results [157]. We ran the PCU algorithm on the biological process 
ontology of GO. Using the Benjamini-Hochberg correction for multiple testing and 
a cutoff of 0.05, 27 significantly enriched categories (out of 172 annotated 
categories) were returned in the list of 4314 putative PPARα target genes 
obtained by comparing the wild type and knockout experiment (Figure 6A). 
 
Figure 6: Significantly enriched Gene Ontology categories found in the two lists 
of candidate PPARα target genes. Enriched biological processes were identified in the two 
lists of candidate PPARα targets genes generated by the across experiment comparison (panel A), or 
our integrated approach (panel B). All significant probesets identified by the respective 
methodologies were used as input. The ‘parent-child-union’ algorithm was applied followed by the 
Benjamini-Hochberg correction for multiple testing to identify enriched GO categories. In both lists 
the same underlying biology was identified. Abbreviations: NSP: name space (sub ontology), B: 
Biological process. 
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Similarly, using the same criteria 28 significantly enriched categories (out of 169 
annotated categories) were scored in the list of 2432 genes generated by our 
integrated approach (Figure 6B). Twenty-five identified enriched biological 
processes were identical in both sets of genes. As expected, many processes that 
were enriched have been functionally demonstrated to be controlled by PPARα, 
including cellular ketone metabolic process, lipid metabolic process, cellular 
amino acid and derivative metabolic process, peroxisome organization, and 
mitochondrion organization [9,13,158]. Thus, despite the drastically reduced 
number of candidate PPARα target genes identified by our approach, GO 
enrichment analysis demonstrated a very similar functional characterization of 
these genes, again demonstrating the validity of our strategy.  
 
 
Conclusions  
 
Taken together, in this study we present a simple, yet efficient strategy to 
compare genes across experiments that controls for multiple testing and is able to 
properly detect differentially expressed genes. Compared to the conventional 
used FDR based across experiment comparison, our approach is more 
conservative and less noisy. Our approach is in particular suitable to identify 
candidate target genes of a transcription factor or signaling route from functional 
genomics experiments, but can be applied to any genomics experiment in which 
the effects of a treatment are compared between two genotypes.  
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Abstract  
 
Systems biology approaches aim to discover biological systems in which the 
components work together and are connected to one another within and 
between organs. These components can be either genes or set of genes or organs. 
The peroxisome proliferator-activated receptor alpha (PPARα) is a ligand activated 
nuclear receptor, which is activated by free fatty acids and their derivatives. Here, 
we propose a nutritional systems biology approach to identify and integrate 
PPARα dependent pathways in mouse liver and small intestine from information 
obtained in different experiments using an array-wise pathway score. We also 
developed a partial least squares path model (PLSPM) to infer the effect of 
pathways’ activities at early time points on late time points. We show that our 
approach enabled the identification of PPARα dependent pathways as well as the 
type of regulation in mouse liver and small intestine, and that acutely induced 
pathways are the main drivers for regulation of pathways after long-term 
activation. Taken together, we show that our proposed methodology successfully 
identifies biological relevant PPARα regulated processes and provides clues on the 
underlying mechanisms. 
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Introduction 
 
The peroxisome proliferator-activated receptor alpha (PPARα) is a ligand-
activated transcription factor with diverse functions and is activated by a variety 
of synthetic compounds, including drugs used for the treatment of dyslipidemia 
and type 2 diabetes [13,159,160]. High affinity natural ligands include eicosanoids, 
unsaturated as well as long-chain fatty acids, and their activated derivatives (acyl-
CoA esters) [161-166]. In analogy with other nuclear receptors, when activated, 
PPARα forms obligate heterodimers with the retinoid X receptor and stimulates 
gene expression by binding to peroxisome proliferator response elements (PPREs) 
located in the promoter regions of target genes [13]. For efficient transcriptional 
regulation by PPARα also co-regulators are required. These are molecules that 
assist PPARα to positively or negatively influence the transcription of target genes, 
and thereby comprise an integral part of the transcriptional circuitry [167-169]. 
PPARα is also able to repress transcription by directly interacting with other 
transcription factors and interfere with their signaling pathways, a mechanism 
commonly referred to as transrepression [13,170]. PPARα is expressed in a variety 
of tissues, including liver and small intestine [14,16,171].  
In liver PPARα is critical for the coordinate transcriptional activation of genes 
involved in nutrient metabolism [13,159] and it is suggested that PPARα is an 
important regulator of the hepatic acute phase response [172]. Even though the 
small intestine expresses PPARα at high level and is frequently exposed to high 
levels of PPARα agonists via the diet, the role of PPARα in this organ was not 
investigated until recently. The intestinal PPARα plays an important role, 
governing diverse processes ranging from numerous metabolic pathways and lipid 
handling to the control of apoptosis and cell cycle genes [16]. Thus, although 
PPARα activation and target gene regulation has been studied in a range of 
organs, gaps in our knowledge remain.  
 
In so far as the biological role of PPARα is directly coupled to the function of its 
target genes, probing PPARα-regulated genes via the application of genomics 
tools can greatly improve our understanding of PPAR function. By combining 
transgenic animal models with elaborate microarray analyses, a comprehensive 
understanding of the in vivo role of PPARα can be obtained [139]. As a result 
many PPARα target genes and PPARα responsive pathways have been identified, 
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but it should be noted that these have been determined mainly after relatively 
long-term exposure (5 days and more) to potent PPARα agonists. However, we 
have long term mixed effects by WY activation of PPAR leading to direct and 
indirect activation of numerous pathways. 6h treatment largely will lead to mainly 
PPARα activation.  
  
In the current study, we aimed to model the relation between PPARα responsive 
genes and pathways in mouse liver and intestine using pathway scores. To this 
end, array data was used from acute (6h) and long-term (5d) exposure in 
combination with partial least squares path modeling.  
 
 
Materials and methods 
 
Experimental data 
In this study we used datasets that were generated previously in our laboratory to 
identify PPARα target genes in mouse liver and intestine [15,139,166,173]. Briefly, 
pure bred wild type (129S1/SvImJ) and PPARα-null (129S4/SvJae-Pparatm1Gonz/J) 
mice [144] were dosed by oral gavage with 400 μl of a 0.1% WY14643 suspension 
in 0.5% carboxymethyl cellulose (acute experiment), or fed chow or chow 
supplemented with 0.1% WY14643 (Chemsyn, Lenexa, KS) (long-term 
experiment). WY14643 is a highly specific and potent agonist for PPARα and is 
therefore often used in studies on this nuclear receptor [12,145]. After 6 h (acute 
experiment) or 5 days (long-term experiment), mice were anaesthetized and livers 
and intestines were excised. Total RNA was prepared using TRIzol reagent 
(Invitrogen, Carlsbad, CA) followed by purification using the RNeasy mini kit 
(Qiagen, Hilden, Germany). RNA integrity was checked by chip analysis (Agilent 
2100 Bioanalyzer, Agilent Technologies, Amsterdam, the Netherlands) according 
to the manufacturer's instructions. RNA was judged as suitable for array 
hybridization only if samples exhibited intact bands corresponding to the 18S and 
28S ribosomal RNA subunits, and displayed no chromosomal peaks or RNA 
degradation products, and had a RNA integrity number (RIN) above 8.0). The 
Affymetrix GeneChip RNA One cycle Amplification Kit (Affymetrix, Santa Clara, CA) 
was used to prepare labeled cRNA from 5 μg of total RNA, which subsequently 
was hybridized on Affymetrix Mouse Genome 430 2.0 plus arrays. For each 
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treatment, tissue and time point 4 replicate arrays were performed, so in total 64 
arrays were included in this study. The animal study was approved by the Local 
Committee for Care and Use of Laboratory Animals. 
 
NutriSysPath approach 
It is well known that genes belonging to the same pathway (gene set) are related 
to each other, obviously from a biological but also statistical point of view. A large 
variety of pathway overrepresentation methodology has been published, and 
these include tools such as gene set enrichment analysis (GSEA) [23], MaxMean 
statistic [174], interaction-based gene set analysis (IB-GSA) [175], Hotelling’s T2-
statistic [176], Global Test [177], and so on [178]. A drawback of these 
methodologies is that from a statistical perspective they don’t adjust for 
correlation between the genes [178]. Based on the first eigenvector from singular 
value decomposition that reflects pathway activity level, a method has been 
developed by [179] for pathway analysis, considering the correlation between the 
genes, and applying a t-test or analysis of variance to infer the significantly 
regulated pathways. As an alternative approach we propose to use principal 
component analysis (PCA) in combination with correlation analysis to identify 
‘relevant’ pathways, an approach which we called NutriSysPath (Nutritional 
Systems Biology of Pathway Analysis).  
Gene sets representing Gene Ontology categories, metabolic pathways or 
signaling transduction routes were extracted from well-recognized pathway 
databases (GO, KEGG, NCI, Biocarta, Pfam, Reactome and WikiPathways). A 
reference set of well-established PPARα targets genes was derived from [18]. We 
limited our analyses to gene sets that contained at least 15, and maximally 500 
genes, as very small or very large classes are unlikely to be as informative (either 
too specific or too general) [180]. In total 4588 pathways were included in the 
analysis. For each pathway (gene set), PCA was performed using the expression 
data of all samples. PCA involves a mathematical procedure that transforms a 
number of possibly correlated variables, in this case expression of genes, into a 
smaller number of uncorrelated variables considering the relationships among the 
variables, called principal components (meta genes) [128,181]. The first principal 
component accounts for as highest variation in the dataset. We considered the 
dominant principal component (PC1) as the pathway activity level, as was also 
done by [179]. It should be noted that a pathway activity level, i.e., PC1 score, is 
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calculated for each single sample. Next the correlation of all array-wise pathway 
activity scores with that of the reference set was calculated using the non-
parametric Spearman correlation coefficient and the corresponding p-value. In 
this study, the cut-off point was considered P-value ≤ 10-6 and absolute 
correlation coefficient (r) ≥ 0.90. The non-parametric Spearman correlation was 
used because it is more robust against outliers compared to parametric 
correlation measure [182]. Ultimately, this resulted in a list of pathways that had 
similar behavior as the reference set, and these were used as input for further 
analysis. An overview of this approach is given in Figure 1, and the R code used to 
calculate the pathway activity scores is available as supplemental data.  
 
 
Figure 1:   Overview of the NutriSysPath approach. After normalization the microarray 
data, genes were grouped based on the pathways or gene sets. Principal component analysis was 
applied at each pathway and collected  principal component 1 (PC1) as array wise pathway activity 
level or pathway score. Afterwards, ran the Spearman correlation between the standard gene set or 
reference gene set (PPARα target genes) and all other pathways scores and then identified the 
induced or suppressed pathways. The pathways that were positively correlated with the reference 
gene set were considered as PPARα induced  whereas the negatively correlated pathways were 
considered as suppressed pathways. The similar process was applied at each time point and each 
organ.  
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Implementation of the NutriSysPath approach 
In the current study the NutriSysPath approach was implemented as follows: (i) 
expression estimates were obtained by GC-robust multiarray (GCRMA) 
normalization, using the empirical Bayes approach to adjust for background [152], 
(ii) for each pathway the expression data of contributing genes was extracted, (iii) 
PCA was used to calculate the PC1 score per sample for each pathway [29], and 
(iv) the correlation between PC1 scores for the reference set of well-established 
PPARα target genes and all other pathways was calculated using Spearman 
correlation, and finally pathways that significantly correlated with the reference 
set (p≤10-6, r ≥ |0.90|) were retained. Pathways that had a positive correlation 
with the reference set were considered induced pathways, whereas anti-
correlated pathways represented suppressed pathways. This procedure was 
applied in both organs for both time points. Results were visualized using 
heatmaps, and pathway interaction networks were created in Cytoscape using the 
Enrichment Map plugin [59,183]. 
 
Partial least squares-path model 
Partial least squares-path modeling (PLSPM) proposed by [117] is a multivariate 
data analysis technique which provides a framework for analyzing multiple 
relationships between a set of blocks of variables. The PLS is robust against of 
missing values, model misspecification and violation of the statistical 
assumptions: normality and multicollinearity [184,185]. The PLSPM is an 
extension of the PLS. A detailed explanation about the PLSPM can be found in 
[31,34,117]. We used reflective way in the outer model and PLS regression in the 
inner model of the PLSPM with standardizing manifest variables (pathway scores). 
Analysis was performed in R using the library plspm [30]. In this study, we 
evaluated how PPARα-induced and -suppressed pathways that were regulated at 
120h depended on the pathways regulated at 6h. After calculating the pathway 
scores, pathways were grouped in induced or suppressed pathways depending on 
their correlation with the reference set. Thus, in this study we had 8 groups of 
pathways scores, the groups details were as follows: 
 
Y1=UP_Late_I  ;  all induced pathways in small intestine 120h after intervention. 
Y2=Down_Late_I ;  all suppressed  pathways in small intestine 120h after 
intervention. 
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Y3=Up_Late_L ;  all induced pathways in liver 120h after intervention. 
Y4=Down_Late_L ; all suppressed pathways in liver 120h after intervention. 
X1= Up_Early_L ;  all induced  pathways in liver 6h after intervention. 
X2= Down_Early_L ; all suppressed pathways in liver 6h after intervention. 
X3=Up_Early_I  ;  all induced pathways in small intestine 6h after intervention. 
X4=Down_Early_I ; all suppressed pathways in small intestine 6h after 
intervention. 
The PLSPM thus becomes: 
 
Y1= β1 X1+ β2 X2 + β3 X3 + β4 X4 +β5 Y3+β6 Y4 
Y2= β7 X1+ β8 X2 + β9 X3 + β10 X4 
Y3= β11 X1+ β12 X2 + β13 X3 + β14 X4 
Y4= β15 X1+ β16 X2 + β17 X3 + β18 X4 
 
Where, βs  are the path coefficients. 
 
 
Results 
 
We applied the proposed NutriSysPath approach followed by PLSPM on datasets 
that aimed to identify PPARα target genes in mouse liver and intestine, and which 
were generated previously in our laboratory [15,139,166,173]. After 
normalization, pathway activity scores were calculated for each using PCA as 
indicated in the Methods section. Part of the output is represented in Figure 2. 
The heatmap represents pathway activity scores of the reference set 
(PPARα_targets) and 50 GO categories (rows) of the 16 liver samples that were 
120h after start of the intervention (columns). It is clear that pathway activity 
scores varied within and between experimental groups (Figure 2A). As expected 
the activity score for the reference set was highest in the wild type mice treated 
with WY14643. Some GO categories displayed similar behavior as the reference 
set, whereas others behaved oppositely. In Figure 2B the loading plot for a GO 
category is displayed, which represented the contribution of each gene to the 
pathway score; the higher the loading, the more it contributed. This parameter 
can be used to identify genes that were most responsive to treatment with 
WY14643.  
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Figure 2: Array-wise pathway scores. (A) A sample pathway scores of liver 120h data. 
Yellow and blue colors indicated the high and low pathway scores respectively. Rows were the 
pathways and columns were the samples. (B) The loadings (correlation between the pathway scores 
and gene expressions) of the genes in a pathway. Higher bars indicated the more importance of the 
genes in the pathway. 
 
 
Selected pathways in liver and small intestine at 6h and 120h 
To select the pathways in liver and small intestine that were regulated both after 
acute (6h) and long-term (120h) treatment with WY14643, Spearman correlation 
analysis was performed. Pathways were selected if they highly and significantly 
(anti-)correlated with the reference set (absolute correlation coefficient (r ≥ 0.90, 
p ≤ 10-6). Positively correlated pathways were considered to be induced by PPARα, 
whereas negatively correlated pathways were considered to be suppressed. Using 
these cut-off criteria we found that in small intestine after acute activation PPARα 
induced the activity of 80 pathways, and suppressed the activity of 27 pathways. 
After long-term activation the activity of 131 pathways was increased, and of 99 
suppressed in small intestine. Similarly, acute activation of PPARα resulted in the 
induction resp. suppression of 446 and 723 pathways in liver, and long-term 
activation induced resp. suppressed the activity of 115 and 229 pathways. 
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Pathway interaction networks for the induced pathways after acute a long-term 
activation for both organs are presented in Figure 3.  
 
 
Figure 3A: Interaction map of PPARα induced pathways in small intestine after 
acute and long-term activation. Red and white colors indicate pathways that were induced 
or not by PPARα respectively. The inner circle and outer circle indicated the effects of acute (6h) and 
long-term (120h) activation, respectively. The sizes of the nodes is based on the number of genes 
belonging to the pathway; the bigger the nodes the more genes. Edges indicated the overlapped 
genes between the pathway; the thicker the edge, the more the pathways overlap. The network 
contains 162 nodes (pathways) and 353 edges. 
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Figure 3B: Interaction map of PPARα induced pathways in liver after acute and 
long-term activation. Red and white colors indicate pathways that were induced or not by 
PPARα respectively. The inner circle and outer circle indicated the effects of acute (6h) and long-term 
(120h) activation, respectively. The sizes of the nodes is based on the number of genes belonging to 
the pathway; the bigger the nodes the more genes. Edges indicated the overlapped genes between 
the pathway; the thicker the edge, the more the pathways overlap. The network contains 521 nodes 
(pathways) and 1427 edges. 
 
 
These networks revealed that in small intestine (Figure 3A) many pathways 
related to ‘fatty acid metabolic processes’ were induced at both time points, as 
was ‘peroxisome’ and ‘fatty acid binding’. Other processes such as ‘steroid 
metabolic processes’ and ‘digestion’ were induced only after acute treatment, 
whereas ‘nuclear receptor’, ‘pyruvate’, and ‘xenobiotic response’ were only 
induced after long-term activation.  
Similar to the small intestine, many pathways related to ‘fatty acid metabolic 
processes’ and  ‘peroxisome’ were induced in liver after both acute and long-term 
activation (Figure 3B). In addition to these, many pathways related to 
‘morphogenesis’, ‘cell development’, ‘cell differentiation’ and ‘hormone secretion’ 
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were induced after acute activation. We also observed that some pathways 
related to ‘cell cycle’ and ‘transporter activity processes’ were induced either after 
acute or long term activation. In general we observed for both time points that 
the number of significantly regulated pathways was higher for liver than small 
intestine, which suggested the activity of PPARα in liver is higher than small 
intestine. In total 32 pathways were found to be commonly induced in liver and 
small intestine after acute activation, and this were 50 pathways after long term 
activation. The 20 pathways that were found to be induced in both time points 
and both organs are listed in Table 1, and functionally these reflect ‘fatty acid 
metabolic processes’, ‘fatty acid oxidation’ and ‘peroxisome’. 
 
Table 1: Common 20 PPARα induced pathways in liver and small intestine after 
both acute and long-term activation. 
 
Name Description 
GO:0000038 Very long-chain fatty acid metabolic process 
GO:0006631 Fatty acid metabolic process 
GO:0006633 Fatty acid biosynthetic process 
GO:0006637 Acyl-CoA metabolic process 
GO:0009062 Fatty acid catabolic process 
GO:0019217 Regulation of fatty acid metabolic process 
GO:0019395 Fatty acid oxidation 
GO:0030258 Lipid modification 
GO:0032787 Monocarboxylic acid metabolic process 
GO:0034440 Lipid oxidation 
GO:0035383 Thioester metabolic process 
GO:0044242 Cellular lipid catabolic process 
GO:0046320 Regulation of fatty acid oxidation 
GO:0072329 Monocarboxylic acid catabolic process 
GO:0005777 Peroxisome 
GO:0042579 Microbody 
GO:0033293 Monocarboxylic acid binding 
KEGG_Peroxisome KEGG: Peroxisome 
KEGG_PPAR signaling pathway KEGG: PPAR signaling pathway 
KEGG_Fatty acid metabolism KEGG: Fatty acid metabolism 
GO: Gene Ontology category identifier 
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Partial least squares-path modeling 
To infer causal effects on pathway regulation, a PLSPM was designed that 
integrated the inter-organ regulation after acute and long-term PPARα activation. 
To this end, pathways that included in this study were grouped per time point and 
organ based on pathway scores in blocks of induced or suppressed pathways. This 
resulted in 8 blocks groups of pathways, Up early liver (1807 pathways), Down 
early liver (2781 pathways), Up early intestine (1614 pathways), Down early 
intestine (2974 pathways), Up late liver (1079 pathways), Down late liver (3509 
pathways), Up late intestine (1014 pathways) and Down late intestine (3574 
pathways). We assumed that the pathway activity scores after long-term 
activation were (partially) driven by the pathway activity scores after acute 
activation, and that pathways in intestine and liver could influence each other. 
Next multivariate PLSPM was performed. The path coefficients that were 
obtained indicate how much of the regulation observed after long-term activation 
can be effected by the acute activation. For instance, the path coefficient of the 
model for Up_Early_I -> Up_Late_I was 0.94, and that of Up_Early_L -> Up_Late_I 
was 0.53 (Figure 4). This implies that induced pathways in intestine after long-
term activation were more effected by the acutely induced pathways in intestine 
than in liver.  
 
 
 
Figure 4: PLS-path coefficients (total effects) of PLS- path models for liver and 
small intestine by path-diagram. *path coefficients were significant at 5% level by bootstrap 
simulation. 
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We observed that the path coefficient of the model for Up_Early_I -> Up_Early_L 
was 0.88, indicates that acutely induced pathways in small intestine had a 
significant positive influence on acutely induced pathways in liver.  
Moreover, we found no significant effects of the acutely suppressed pathways in 
intestine on any of the long-term regulated pathways in intestine or liver. We 
noticed that up regulated early pathways in liver had positive path coefficients on 
the up regulated late time point in small intestine (0.53), up regulated late time 
point in liver (0.55). On the other hand, acutely induced pathways in liver 
negatively influenced the long-term regulation of suppressed pathways in small 
intestine and in liver. We also noticed that acutely suppressed pathways in small 
intestine had no significant effect on long-term regulation in liver and small 
intestine. 
 
 
Discussion 
 
A key purpose of systems biology is to provide a systems level understanding by 
integrating, interconnecting and modeling of high-throughput datasets [186]. 
Here we applied this approach to a key nutrient sensing transcription factor and 
its target pathways. Multivariate data such as gene expression data is commonly 
generated in modern biology, and many tools have been developed to analyzed 
and visualize this kind of data [128]. To date many studies have examined the 
effect of PPARα activation using  gene expression profiling or metabolomics (see 
e.g. [17,187,98,179]). However, no systematic comparisons of the whole genome 
effects of PPARα activation in mouse liver and small intestine have been reported. 
Here we presented a systematic comparison on PPARα dependently regulated 
pathways utilizing array-wise pathway scores after acute and long-term activation 
in liver and intestine. Three main conclusions can be drawn from our work. First, 
our data support a more important role of PPARα in mouse liver than in small 
intestine, as is evidenced by larger number of the list of significant pathways that 
were identified by our NutriSysPath approach at both time points. Secondly, 
acutely induced pathways in small intestine are suggested to major influence on 
acutely induced pathways in liver. Third, acutely induced pathways are the main 
drivers for regulation of pathways after long-term activation. To the best of our 
knowledge, we are one of the first to use PLSPM to infer the causal effect of early 
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measurement of the groups of up and down regulated pathways scores on that of 
the late measurements.   
In conclusion, the approach used here allows to analyze different datasets either 
several time points or different omics datasets. When applied on PPARα datasets, 
we obtained new insights on organ-specificity and time-dependency of PPARα 
activation.  
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Supplementary  
 
 
Table S1:  The R code of our approach. 
 
 
# Define some variables 
Expression_File <- "int5_n.txt"  #  the input file where rows are the genes and columns are 
samples/array after normalization. 
GMT_File <- "GO_K_NCI_BIOC_PF_REACT_WIP_Mm_symbol.txt" # File saved via Excel to 
make it square 
 
PCA_Scores_File <- "int_5_pca_score_GMT-n.txt" 
Gene_loadings_Output_File = "Gene_Loadings_int55-n" 
Species_Annotation_Library <- "mouse4302mmentrezg.db" 
Lower_Limit_Extracted_Genes_in_Pathway <- 15  # this number depends on researcher, it can be 
changed 
Upper_Limit_Extracted_Genes_in_Pathway <- 500  # this number depends on researcher, it can be 
changed 
 
 
# Remove extensions; these will be added automatically later on 
# for multiple files 
Gene_loadings_Output_File <- gsub("\\.","_", Gene_loadings_Output_File) 
 
# Load the input file first. 
 
# Assumptions: 
# 1. The first row contains the columns names that is samples/array! 
# 2. The first column contains the gene identifiers! 
##  One can calculate the pathways score per array using our code just replacing there input file. If 
one wants to calculate another species or another  annotation or another choice of  extraction limit, 
s/he has to define it on the  variables. 
x <- as.matrix(read.delim(file=Expression_File, row.names=1)) 
 
# Load the GMT File 
gmt <- read.delim(file=GMT_File, header=F, stringsAsFactors = FALSE) 
pathways <- gmt[,3:dim(gmt)[2]] 
rownames(pathways) <- gmt[,1]  
 
# Load the utilized PCA library 
library(FactoMineR) 
library(Species_Annotation_Library, character.only = T) 
 
# Replace the affy IDs with the symbols (if possible) 
rownames(x) <- make.unique(toupper(mget(rownames(x), get(sprintf("%sSYMBOL", sub(".db", "", 
Species_Annotation_Library))), ifnotfound=NA))) 
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# Open the PDF-file 
pdf(file = paste(Gene_loadings_Output_File, ".pdf", sep=""), paper = "a4r", onefile=TRUE) 
 
# Now extract the genes for each individual pathway 
# We use a loop to do the calculations per pathway 
Count <- 0 
Rejected <- 0; 
Final_loadings_Matrix <- vector("list", length(pathways)) 
for (i in 1:dim(pathways)[1]) 
{ 
  cat(sprintf("pathway %g: %s...", i, rownames(pathways[i,]))) 
 
  # Extract the matrix with the selected pathway intensities 
  Current_Pathway_Indices <- which(nchar(pathways[i,]) > 1) 
  # Some identifiers are not available. Filter them out here... 
  Indices <- match(as.character(pathways[i, Current_Pathway_Indices]), rownames(x)) 
  if (sum(is.na(Indices)) > 0) 
    Current_Pathway_Indices <- c(Current_Pathway_Indices[-which(is.na(Indices))]) 
 
  Number_Of_Valid_Genes_in_Current_Pathway <- length(Current_Pathway_Indices) 
  if ((!(Number_Of_Valid_Genes_in_Current_Pathway < 
Lower_Limit_Extracted_Genes_in_Pathway)) && (!(Number_Of_Valid_Genes_in_Current_Pathway 
> Upper_Limit_Extracted_Genes_in_Pathway))) 
  { 
    cat("Included!\n") 
    Count = Count + 1 
    x.pathway <- x[as.character(pathways[i, Current_Pathway_Indices]),] 
    transposed_matrix <- t(x.pathway) 
    res <- PCA(transposed_matrix, scale.unit=TRUE, graph=FALSE) 
    if (Count == 1) 
    { 
      Final_PCA_Matrix <- as.data.frame(res$ind$coord[,1]) 
      colnames(Final_PCA_Matrix)[Count] <- rownames(pathways)[i] 
    } else { 
      Final_PCA_Matrix <- cbind(Final_PCA_Matrix,  as.data.frame(res$ind$coord[,1])) 
      colnames(Final_PCA_Matrix)[Count] <- rownames(pathways)[i] 
    } 
Final_loadings_Matrix[[Count]] <- as.list(res$var$coord[,1]) 
 
    plot(res$var$coord[,1], main=sprintf("%s (%s)", rownames(pathways)[i], gmt[i,2]), xlab = "Genes 
in pathway", ylab = "loadings (gene contributions)", type="h", xaxt="n", cex.axis=0.75) 
 
    # Define the proper graph labels... 
    labels.genenames <- sprintf("%s (%s)", names(res$var$coord[,1]), pathways[i, 
Current_Pathway_Indices]) 
 
    axis(1, at=1:length(names(res$var$coord[,1])), labels=labels.genenames, las=3, cex.axis=0.2) 
  } else { 
    Rejected <- Rejected + 1 
    cat("Skipped!\n") 
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  } 
} 
 
# Close the PDF-file 
dev.off() 
 
# Write the final file 
cat(sprintf("\nWriting PCA Scores file: %s.\n", PCA_Scores_File)) 
write.table(Final_PCA_Matrix, file = PCA_Scores_File, sep="\t") 
cat("Script has succesfully ended!\n")  
### the end 
#################################################################################
############## 
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Abstract 
  
The peroxisome proliferator activated receptor alpha (PPARα) is a transcription 
factor which is activated by natural and synthetic agonists. Studies in mouse, 
human and rat have shown that PPARα plays an important role in liver and other 
organs. However, little is known on the genes and processes that are acutely 
regulated by PPARα, and how these evolve over time. We therefore performed a 
time-course microarray study in rat hepatocytes to characterize the genome-wide 
effects of acute PPARα activation. In this study, mRNA expressions in rat 
hepatocytes were measured at up to five time points (0, 1, 2, 3, and 4h) upon 
stimulation with WY14643. Including all time points, in total 386 genes were 
significantly induced by WY14643. Already 1h after stimulation, gene expression 
increased, and this stabilized after 3h. Several transcription factor binding sites 
were predicted to be involved with PPARα activation, and these included 
recognition elements for NRF2 and RXR. Many genes were found that followed a 
quadratic model and were involved in lipid metabolic processes. Taken together, 
our systems approach identified a set of similar behaving genes with the evolution 
of gene network over time at early stage in rat hepatocytes and their potential 
common transcription factors with PPARα. This information provides new details 
on the molecular mechanisms involved in PPAR-dependent gene regulation.  
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Introduction 
 
Dietary lipids, one of the main nutritional components, are able to excite their 
own catabolism through a set of nuclear receptors called the peroxisome 
proliferator activated receptors (PPARs) [188,189]. Among the three PPAR 
isoforms that exist (PPARα, PPAR δ (also called β) and PPAR γ), fatty acids bind to 
PPARα with highest affinity [9]. PPARα is highly expressed in tissues with a high 
catabolic rate such as the liver, kidneys, heart, skeletal muscle and small intestine 
[14,139]. PPARα is accountable for control lipid metabolism in many tissues, but 
its role has been best investigated in liver [190]. The liver plays an important role 
in the coordination of lipid metabolism and it actively metabolizes fatty acids as 
fuel. It is responsible for hepatic triglycerides export via synthesis of very low 
density lipoproteins (VLDL). An imbalance between lipid anabolic and catabolic 
processes may lead to triglycerides accumulation and as a consequence of hepatic 
steatosis [17]. Genes encoding peroxisomal and microsomal fatty acid oxidation in 
liver are transcriptionally regulated by PPARα [13,191].  
Hepatocyte performs most important function of the liver including lipid 
metabolism, regulation of urea and production of plasma proteins. To identify the 
temporal gene  expression in toxicology of monolayer cultured rat hepatocytes 
cultures study has been done in 5 different time points (4, 12, 24, 48, and 72h) by 
[192]. In order to identify the effect of WY14643 at different markers of 
inflammation a study has been done by [193] at one time point (8 days) in a rat 
model of ligature-induced periodontitis. Several studies have been performed to 
detect the effect of WY14643 in gene expression level in time, such as: at two 
time points (6h and 120h) in mouse and human hepatocytes by [17], at 3 time 
points (1d, 7d, and 28d) by [194] in mouse liver and in one time point (5d) in 
mouse small intestine by [139]. To detect the effect on the expression of c-met, c-
myc and PPAR-alpha in liver and liver tumors from rats has been done by [195]. 
Another study has been performed by [196] to see the differences between the 
promoting activities of the peroxisome proliferator agonist WY14,643 and 
phenobarbital in rat liver at 3 time points (11, 22, or 54 wk). Recently a study has 
been done by [197] for inferring statin-induced gene regulatory relationships in 
primary human hepatocytes over time (0, 6, 12,24, 48, and 72h). Usually, after 4h 
or 6h it’s difficult to detect the direct effect of a treatment. Therefore, to avoid 
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toxicity and to detect the direct effect of WY14643, it’s necessary to run the 
experiments at early stage. Until now such studies haven’t been performed to 
detect the effect of WY14643 (a strong PPARα agonist) of gene expression in rat 
hepatocytes at early time points using a nutritional systems biological approach. 
To fill this gape, we demonstrated an experiment using rat hepatocytes cell 
culture based on microarray experiments. In this study, we aimed to characterize 
the genome-wide effects of acute PPARα activation by detecting the similar 
behavior genes which are activated by synthetic ligand WY14643, their biological 
functions and network at early stage (0-4h). Overall, the results reveal that PPARα 
regulates a several profiles of genes over time in rat hepatocytes and most of the 
potential genes behave a quadratic model. Furthermore, several common 
transcription factors (TFs) also predict to bind with PPARα, for instance: RXR, 
NR2F, EREF and CREB.  
 
Materials and Methods 
 
Cell culture 
Rat hepatoma FAO cells were grown in DMEM containing 10% fetal bovine serum, 
100U/ml penicillin and 100μg/ml streptomycin. FAO cells were seeded in 6-well 
culture plates at a 70% density. After 24 hrs cells were treated with the PPARα 
agonist WY14643 (5μM) dissolved in DMSO (0.1% v/v). Incubations continued for 
1, 2, 3, 4 hours. At each time point, including t=0 h, cells were harvested for RNA 
isolation from both WY14643 and DMSO treated cells; the latter served as control. 
 
RNA isolation and quality control 
Total RNA was isolated from FAO cells using Trizol reagent (Invitrogen, Brede, the 
Netherlands), followed by total RNA cleanup using RNEasy microkit (Qiagen, 
Venlo, the Netherlands). RNA quantity and quality was assessed 
spectrophotometrically (ND-1000, NanoDrop Technologies, Wilmington, USA) and 
with 6000 Nano chips (Bioanalyzer 2100; Agilent, Amstelveen, The Netherlands), 
respectively. RNA was judged as being suitable for array hybridization only if 
samples showed intact bands corresponding to the 18S and 28S ribosomal RNA 
subunits, displayed no chromosomal peaks or RNA degradation products, and had 
a RIN (RNA integrity number) above 8.0. 
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Microarray experiments and data processing 
The Affymetrix GeneChip RNA One cycle Amplification Kit was used to prepare 
labeled cRNA from 5 μg of total RNA (Affymetrix, Santa Clara). Samples were 
hybridized on Affymetrix GeneChip Rat Genome 230 2.0 arrays. Hybridization, 
washing and scanning of the arrays was performed according to the 
manufacturer’s recommendations. The raw intensity values applying the robust 
multiarray analysis (RMA) pre-processing algorithm [198,199] is not adjusted by 
background correction. Therefore normalized expression estimates were obtained 
from the raw intensity values using the GC-robust multi array (GCRMA) 
normalization, using the empirical Bayes approach to adjust background [152]. 
Probesets were redefined according to Dai et al [151]. In this study probes were 
reorganized based on the Entrez Gene database, build 37, version 1 (remapped 
CDF v14).  
 
Identification of differentially expressed genes 
Differentially expressed genes were determined by time course analysis of 
variance (TANOVA) [22]. TANOVA is a method to evaluate factor effects by 
pooling information across the time course while accounting for multiple testing 
and non-normality of microarray data.  
After detecting differentially expressed genes by TANOVA, these were used for 
two complementary approaches, as depicted in Figure 1.  Firstly, we focused on 
the induced genes on the basis of a fold change cut-off (FC≥1.2). This was done 
since PPAR activation directly results in induced expression of target genes, 
whereas PPAR-dependent suppression of gene expression is known to go 
through indirect mechanisms [170]. Per cumulative time point we performed 
pathway overrepresentation analysis and identification of cis-regulatory modules, 
i.e., combinations of transcription factor binding sites (TFBS). 
Secondly, in a complementary approach we performed unsupervised clustering of 
the genes selected by TANOVA to identify genes that behaved similarly over time. 
This cluster analysis was performed to study the dynamics of the response (i.e., 
early and late response) to identify the corresponding genes. Afterwards, selected 
gene expression clusters were characterized with respect to biological function 
and polynomial model.  
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Figure 1: Overview of the experimental design and our analysis strategy. 
After normalization the mRNA expression, the significant genes were selected by TANOVA. 
Afterwards, the analysis was done in two complementary ways. At first WY14643 induced were 
identified to detect the gene interaction network and to identify cis-regulatory modules (CRM). 
Secondly, a cluster analysis was performed by STEM using the all significant genes to find out the 
similar behavior of genes. The clusters that were mostly overlapped with the selected genes at the 
first step, were selected as final selected clusters. Finally, polynomial regression model was fitted for 
each selected cluster by adjusting parameters. 
 
Clustering 
Clustering or grouping the similar patterns of the gene expressions is a key issue 
to analyze the time series microarray data. Short Time-series Expression Miner 
(STEM) was used in this study to detect set of co-expressed genes [200]. STEM 
was specially designed for the analysis short time series gene expression data. 
This method implements to cluster, compare and visualize such data with its 
integration with the Gene Ontology [201]. The algorithm provides significant 
number of clusters whereas within profile genes are highly correlated according 
to Pearson correlation coefficient (r≥0.80) and correct the multiple tests by FDR. 
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In the STEM clustering method, we also assumed maximum number of model 
profiles is 50 and the maximum unit change in model profiles between time points 
is 2. To find out the effected biological processes, i.e., GO overrepresentation 
analysis for each significant profile, we assumed default option for minimum GO 
level and minimum number of genes and number of samples for randomized 
multiple hypothesis correction. 
 
Modeling 
Gene co-expression clusters were fitted using a polynomial regression model 
taking the average gene expression of the respective cluster. We ran the model 
several times considering different order and then selected the best model based 
on the root mean sum square of error (RMSE) and the adjusted R-square. A small 
RMSE with high adjusted R-square provides the best model for the respective 
cluster. Here, we only fitted the model for the most overlapped significant 
profiles. Fitting regression models was performed to enhance the biological 
interpretation of the gene expression cluster, since these models describe the 
shape of each gene expression cluster as a function of time. As a consequence, 
this provides insight into the underlying processes rather than simply identifying 
significant differences. 
 
Gene interaction network analysis 
Genes that were differentially expressed or co-expressed at several time points 
were used to infer gene interaction networks based on combining metabolic 
pathways from Reactome and KEGG databases using Rspider [60]. Interaction 
networks were visualized in Cytoscape [59].  
 
Transcription factor binding sites  
Identification of cis-regulatory modules (CRMs) in promoter regions of regulated 
genes was performed using the Genomatix software suite [122]. The Genomatix 
software suite is a collection of on-line tools for the retrieval and analyses of well 
annotated promoter sequences. In this study, at first we used Gene2Promoter to 
retrieve the promoter regions of regulated genes. Afterwards, FrameWorker [202] 
was used to identify common patterns of TF binding sites in the promoters.  
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Results 
 
Differentially expressed genes 
A nutritional systems approach, combining several statistical and bioinformatics 
tools, was used in this study to identify the temporal behavior of candidate PPAR 
target genes and their corresponding biological function. After normalizing the 
microarray data, usually the first task is to find out the significantly regulated 
genes. In this study, we performed cross-sectional time-course study with two 
different conditions (Control [DMSO] and WY14643) at different time points. 
Sacrificing the time dependency, one can analyze this kind of data using 
conventional analysis of variance (ANOVA) to infer significantly regulated genes. 
Therefore, to capture the dynamic gene expression profiles, we used TANOVA to 
detect significant genes by pooling information across time points accounting for 
non-normality and multiple testing (FDR). Overall, we found 1177 significant 
genes with FDR-adjusted p-values<0.05. Statistically significant does not always 
indicate biologically relevant. We therefore further refined our dataset by 
including only the genes that at one of each time point was more than or equal to 
1.2-fold increased. This showed that the number of relevant significant genes 
increased over time (Figure 2). Total 79 genes were found common in all four time 
points, which represented highly sensitive genes that rapidly respond to WY14643 
treatment. In total 386 genes were found to be increased in all four time points 
(Figure 2A). The temporal behavior of these 386 genes revealed that especially 
after 2h activation there was a strong response which leveled off at the later time 
points (Figure 2A). Moreover, most of the genes induced after 1h were also 
regulated after 2h, and this trend continued for the later time points (Figure 2B). 
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Figure 2: Differentially expressed genes. (A) Venn diagram of relevant regulated genes 
(FC≥1.2, FDR<0.05) at four time points after stimulation with WY14643. (B) Bar diagram of 
cumulative gene regulation and at the four time points and their overlap. 
 
Gene interaction network based on pathways  
After having identified the genes that were regulated, we next analyzed per time 
point the functional implications of this regulation by analyzing which pathways 
were overrepresented in the sets of regulated genes (Table 1). These results were 
then combined with biochemical data to generate gene interaction networks. 
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Table 1: Pathways overrepresented in the sets of regulated genes 
Pathways 1h  
(t=1h) 
1h+2h 
(t=1 to 2h) 
1h+2h+3h 
(t=1 to 3h) 
1h+2h+3h+4h 
(t=1 to 4h) 
Lipid Metabolic Process 1 1 1 1 
Glycerophospholipid Metabolism  4 5 2 
Fatty Acid Biosynthetic Process   6 3 
Retinal Metabolism  2 2 4 
Valine, Leucine and Isoleucine 
Degradation 
2 5 3 5 
Primary Bile acid Biosynthesis  3 4 6 
Steroid Hormone Biosynthesis  7 8 7 
Response to Glucose Stimulus   9 8 
Histidine Metabolism   10 9 
Lipid catabolic Process  8 11 10 
Regulation of Fatty Acid Oxidation  6   
Transport  9 7 11 
The 1
st
 column indicated the name of the pathways which were found in the gene network. The 
columns 1h, 1h+2h, 1h+2h+3h and 1h+2h+3h+4h were indicated the existence of the pathways and 
their ranking based on the number of input genes in the network for the cumulative time points: 1h, 
1h+2h, 1h+2h+3h and 1h+2h+3h+4h respectively. The number 1 meant the highest in the rank, 2 
meant second highest and so on.  
 
We identified only two pathways that were overrepresented in the genes induced 
after 1h, i.e., lipid metabolic process and valine, leucine and isoleucine 
degradation. This indicated that although a substantial number of genes were 
regulated, they likely were involved in a broad range of biological functions that 
therefore did not reach statistical significance. At later time points more pathways 
were identified, that almost all represent parts of lipid metabolism, and the 
number increased over time. The interaction network generated at 1h expanded 
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over time and always incorporated lipid metabolic process. The most evolved 
interaction network is presented in Figure 3 (the networks of the individual time 
points are available in the supplemental Figures).  
 
Figure 3: Gene interaction network at t=1 to 4h based on the metabolic 
pathways from Reactome and KEGG databases. The rectangular nodes indicated 
regulated genes; triangles represent intermediate genes used to link regulated genes; edges 
indicated biochemical reactions; and circles indicated chemical compounds that are reaction 
intermediates. Different colors indicated different pathways. 
 
Transcription factor binding sites (TFBS) 
To get more insight in the transcription factors that in addition to PPAR are 
involved in the early induction and evolution of genes functionally related and 
represented by lipid metabolic process, we aimed to identify CRMs, i.e., the 
combinations of transcription factor binding sites, in promoter regions of 
regulated genes. We specifically aimed to identify CRMs since usually co-
regulation of mammalian genes depends on sets of transcription factors rather 
Characterization and modeling of acute effects of PPARα activation in rat liver cells 
 
 
78 
 
than individual factors alone [203,204]. Since WY14643 is a specific agonist for 
PPAR, we searched for combinations putative TFBSs that included the TFBS 
V$PERO in co-regulated genes (V$PERO is the name of the PPAR response 
element in the Genomatix database). When promoter regions of five regulated 
genes at 1h that were annotated with lipid metabolic process (Ehhadh, Acot1, 
Acot2, Acot3, Acaa1a) were analyzed for CRMs, we found a framework that 
contained a recognition site termed CLOX in addition to the mandatory PERO 
element (Figure 4A). CLOX represented binding of CLOX and CLOX homology (CDP) 
factors, transcription factors known to be suppress transcription [205]. At 2h, 4 
additional genes annotated with lipid metabolic process were found to be 
regulated (Crat, Acadvl, Hadh and Acaa2), and these were jointly analyzed with 
the 5 genes identified at 1h. By doing so we found two CRMs with 3 frameworks 
containing 3 elements each. The first consisted of binding sites for NR2F (nuclear 
receptor subfamily 2 factors) and HAND (twist subfamily of class B bHLH 
transcription factors) with the mandatory PERO element (Figure 4B). The NR2F 
motif corresponds to binding site for NRF2, which is a TF known to induce 
expression of antioxidant enzymes [206], and the HAND motif is recognized by a 
variety of TFs with basic function that induce transcription. 
 
The second CRM contained RXR (RXR hetrodimer binding sites) and CREB (cAMP-
responsive element binding proteins) together with PERO (Figure 4C). RXR is the 
obligatory heterodimeric partner for PPAR [10], and CREB proteins are 
important intracellular signaling factors [207]. An additional 4 genes (Acadl, 
Hadhb, Acadm and Sgms1) that were regulated at 3h and 4h were subsequently 
added to the analysis. We then found 2 CRMs with 5 major frameworks each 
containing 2 elements. The first one again contained RXR (Figure 4D) and second 
consisted of EREF (estrogen response elements) (Figure 4E) with PERO. 
Interestingly, in the framework identified at 1h the physical distance between two 
TFs was much larger than at the later time points. 
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Figure 4: Cis regulatory modules that were identified genes participating in lipid 
metabolic process at different time points. (A) CRM for 1h, TF CLOX bound with PERO in 
the promoters of Ehhadh, Acot3, and Acot4 genes. (B) CRM-1 for 1h+2h, the TFs NR2F and HAND 
were bound with PERO in the promoters of Sgms1, Acadvl and Acaa2 genes (C) CRM-2 for 1h+2h, the 
TFs RXR and CREB were bound with PERO in the promoters of Acot2, Acadvl and Acaa2 genes. (D) 
CRM-1 for 1h+2h+3h and 1h+2h+3h+4h, the TFs EREF was bound with PERO in the promoters of 
Acot2, Sgms1, Acadvl, Acadm and Hadhb genes (E) CRM-2 for 1h+2h+3h and 1h+2h+3h+4h, the RXR 
transcription factor was bound with PERO in the promoter of Acot2, Sgms1, Acadvl, Acaa2 and 
Acadm genes. In all CRMS the deep purple color indicated the mandatory PERO transcription factor. 
Clustering and modeling  
Time series expression data can be presented using a hierarchy of four systematic 
levels: experimental design, data analysis, pattern recognition and networks. 
Every level deals with a specific biological and computational issues, and also 
A
B C
D E
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provides as a pre-processing step for higher levels in the hierarchy [208]. 
Modeling is the key aspect of systems biology and it can comprise reaction 
models, mechanistic models, statistical models and stochastic models [209]. In the 
current study we aimed to model the evolution of gene expression over time, and 
we therefore used statistical non-linear regression models [210]. Since modeling 
of each individual gene is from a computational perspective challenging, we first 
searched for similar expression profiles using the STEM algorithm in the set of 
1177 genes identified by TANOVA. We found 10 significant clusters (profiles), 
which are presented in Figures S4A and S4B. For example, cluster 1 contained the 
most genes (152), and its temporal pattern showed that expression of genes in 
this cluster increased up to 3h and then remained constant. In contrast, genes 
belonging to cluster 2, first decreased at 1h but the increased up to 3h and then 
remained constant. The other clusters likewise showed different behavior.  
Gene Ontology overrepresentation analysis revealed that genes in cluster 1 were 
functionally involved in cellular lipid metabolic process, fatty acid metabolic 
process, lipid metabolic process, peroxisome, and fatty acid oxidation. No distinct 
biological functions could be associated with the other clusters.  
 
To further characterize the different clusters, we uncovered how many genes 
were overlapped between the selected 386 genes (Figure 2A) and the selected 
clusters (Figure S4B). We found that again most of the overlapped genes were 
found in cluster 1 (132 out of 152), followed by cluster 6 (55 out of 63). We 
observed that 4 clusters out of 10 showed comparatively higher overlap, and 
therefore we investigated their expression pattern by polynomial regression 
model (Figure 5C). To do this, we first calculated the average expression of all 
genes in each of the clusters and then fitted a regression model with different 
orders. Initially a simple regression model was fitted and then the adjusted R-
square and root mean sum of square (RMSE) was calculated, after which this was 
repeated with a 2nd order model, and so on. The model with the highest adjusted 
R-square and the lowest RMSE was selected as a best predictive model. As 
expected, polynomial regression model gives better interpolation and better 
fitted pattern of the clusters than linear regression. We found that cluster 1 was 
best fitted using a quadratic model (R
2 
(adj) = 0.987 and RMSE=0.047), indicating 
that 98.7% of the variation could be explained by the model. Likewise, we found 
that in clusters 2, 6, and 10 were the best fitted as a cubic, quadratic and cubic 
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model, respectively, with the highest adjusted R-square and the lowest RMSE 
(Figure 5C). The name of the genes with cytogenetic location of the overlapped 
genes in the four selected profiles were presented in the Figure S5.  
 
 
 
Figure 5: Overlapping genes between the selected 386 genes (with FC>1.2 and 
FDR<0.05) and the 10 selected clusters. (A) the selected 386 genes, (B) number of 
overlapping genes for each cluster (Profile) , and (C) the fitted polynomial regression model of the 
four clusters. Profile 1: the fitted model is Ŷ=6.375+0.359*t-0.022*t
2
, R
2
(adj)=0.987 and RMSE=0.047, 
Profile 2: the fitted model is Ŷ=6.469-0.383*t+0.305*t
2
-0.047*t
3
, R
2
(adj)=0.995 and RMSE=0.014 , 
Profile 6: Ŷ=5.704+0.438*t-0.075*t
2
, R
2
(adj)=0.899 and RMSE=0.084 and Profile 10: 
Ŷ=4.984+1.017*t-0.385*t
2
+0.045*t
3
, R
2
(adj)=0.982 and RMSE=0.047. The dashed line indicates the 
95% confidence interval of the fitted model. 
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Discussion 
 
Microarray technology has facilitated studies on the details of the gene expression 
data in a comprehensive way [129-132], and it has become a popular high-
throughput screening platform in the area of systems biology [211]. Observing the 
change in expression patterns over time provides detailed information of different 
types of conditions instead of just observing at the terminal points of one or two 
time points [212]. Data from time series microarray experiments allows the 
unbiased comprehensive study of evolution, complex dynamics and interaction of 
regulated [208]. Although time-series microarrays experiments are highly 
relevant, still most temporal microarray data set contain only a limited number of 
time points, and these type of experiments are known as short-time-series data 
[213].  
PPARα governs the expression of a large set of genes and many of which are 
involved in fatty acid metabolism [15,18,166,214]. Although many studies have 
been performed on PPAR regulation, no study has been performed using early 
time points in hepatocytes to identify the kinetics of PPAR activation on target 
genes. Hence, our time-course study in rat hepatocytes represents an important 
advancement in our understanding of PPARα function in hepatocytes. 
A number of general conclusions can be drawn from our work. First, several sets 
of potential direct PPAR target genes were identified in different profiles over 
time and most of them are significantly expressed already 2h after activation. 
Second, some novel candidate TFs were found that jointly with PPAR regulate 
gene expression. Third, lipid metabolic process and valine, leucine and isoleucine 
degradation are the most important PPARα target metabolic pathways. Fourth, 
most of the selected genes followed a quadratic model.  
Genes coding for proteins which are involved in the same step of a metabolic 
pathway, are usually co-regulated and these genes mostly share common 
regulatory elements in their promoter sequences—so-called cis-regulatory 
modules (CRMs) [203,204]. A time course study [197] for inferring statin-induced 
gene regulatory relationships in primary human hepatocytes revealed a novel 
relationships of nuclear receptors NR2C2 and PPARα on CYP3A4. In our study, the 
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results showed that lipid metabolic process is the most important pathways at all-
time points in gene network analysis. Using the genes annotated with this 
functional process, we identified that the NR2F sequence was consistently closely 
located to the PERO recognition site in promoters of Sgms1, Acadvl and Acaa2. 
NR2F is bound by the TF NRF2 which plays an important role in controlling the 
response against oxidants [206]. Since activation of PPAR induces fatty acid 
oxidation, hence increases oxidative stress, this would be expected. For three 
other genes (Acot2, Acadvl and Acaa2) we found RXR binding site closely located 
with PERO. This was envisioned since it is well known that PPAR forms an 
obligatory heterodimer with RXR to function [215,216], and illustrates the 
biological validity of our approach. 
 
The results from the clustering and polynomial regression modeling provide 
insight in the more subtle differences in temporal behavior of gene expression. 
Each gene cluster was reduced to a smaller set of parameters that are less noisy. 
The elimination of inherent variability in the data through the regression modeling 
approach allows a more precise comparison of the expression profiles of the 
various clusters. This enhances the generation of hypothesis on the molecular 
mechanisms that drive the observed gene expression responses [210].  
Taken together, we conclude that our systems approach contributes to a better 
understanding of PPARα function in rat hepatocytes. However, a series of future 
studies are required to investigate the different scientific issues in more detail.  
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Supplementary 
 
Figure S1: Gene network at 1h based on the metabolic pathways from Reactome 
and KEGG databases by Rspider. The rectangle nodes indicated the input genes from our list, 
circles were the compound, triangles were the intermediate genes, the edges indicated the 
biochemical reaction and different colors indicate the different pathways. 
 
Figure S2: Gene network at 1h+2h based on the metabolic pathways from 
Reactome and KEGG databases by Rspider. The rectangle nodes indicated the input genes 
from our list, circles were the compound, triangles were the intermediate genes, the edges indicated 
the biochemical reaction and different colors indicate the different pathways. 
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Figure S3: Gene network at 1h+2h+3h based on the metabolic pathways from 
Reactome and KEGG databases by Rspider. The rectangle nodes indicated the input genes 
from our list, circles were the compound, triangles were the intermediate genes, the edges indicated 
the biochemical reaction and different colors indicate the different pathways. 
 
Figure S4: Clustering standardized WY14643 data of the selected genes by STEM. 
(A) Significant profiles (clusters) were shown by colors. (B) The details profiles of the significant 
profiles. 
Cluster-9 Cluster-10
Cluster-4 Cluster-5
Cluster-6 Cluster-7 Cluster-8
Cluster-1 Cluster-2 Cluster-3
A
B
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Figure S5: The genes with cytogenetic location of the overlapped genes in the 
four selected profiles. Cytogenetic locations were found by using ‘rat2302rnentrezg.db’ 
package in R program. 
 
 
 
 
 
 
 
 
Gene Location Gene Location Gene Location Gene Location
Vnn1 1p12 Ttll9 3q41 Lactb2 5q11 Eci1 10q12
Pex3 1p13 Slc27a2 3q36 Acer2 5q32 RGD1307222 10q24
Dact2 1q12 Mybl2 3q42 Calb1 5q13 Aldh3a2 10q22
RGD1359349 1q51 Arhgap11a 3q34 Acot1 6q31 Decr2 10q12
Pex11a 1q31 Pdrg1 3q41 Acot2 6q31 Acadvl 10q24
Cyp17a1 1q55 Cat 3q32-q34 Acot4 6q31 Nsf 10q32.1
Tmem160 1q21 Crot 4q12 Acot3 6q31 Asgr1 10q24
Cpt1a 1q43 Gnat3 4q11 Hectd1 6q22 Setd4 11q11
Aldh1a1 1q51 Fabp1 4q32 RGD1562284 6q11 Fbxo21 12q16
Ech1 1q21 Retsat 4q33 Entpd5 6q31 Cldn4 12q12
Ppp2r2d 1q41 Abcb4 4q11-q12 Pnpla8 6q21 Hsd17b11 14p22
Ucp2 1q32 Mgll 4q34 Hadhb 6q14 Nudt9 14p22
Slc22a1 1q11-q12 Abcg2 4q24 Creb3l3 7q11 Hsd17b13 14p22
Slc22a3 1q11 Pik3c2g 4q44 RGD1305928 7q36 Scarb2 14p22
Il4ra 1q36 St3gal5 4q33 Gpd1 7q36 Sult1b1 14p21
Pvrl2 1q21 Mdfic 4q21 Oplah 7q34 Fermt2 15p14
Hsd3b6 2q34 Lpcat3 4q42 Acaa1a 8q32 RGD1308772 15q11-q12
Them4 2q34 Abcb1a 4q12 Clpx 8q24 Slc25a42 16p14
Hmgcs2 2q34 Pex1 4q13 Slc25a20 8q32 Slc27a1 16p14
Mttp 2q44 Iqub 4q22 Acat1 8q24.1 Hacl1 16p16
Abcd3 2q41 Adfp 5q32 Cul5 8q24 Acsl1 16q11
Dab2 2q16 Cyp4a3 5q36 Fbxo9 8q31 Slc25a4 16q11
Etfdh 2q32 Hsdl2 5q24 Inpp1 9q22 RGD1305679 17p12
Pgrmc2 2q26 Cpt2 5q35 Acsl3 9q33 Fbp2 17p14
Hadh 2q43 Slc31a2 5q24 Acadl 9q32 Slc22a23 17p12
Acadm 2q45 Decr1 5q13 Sult1c3
9q11.2-
q12.1 Fastkd3 17p14
Glrx1 2q11 Ccdc30 5q36 Hibch 9q22 Eci2 17p12
Mocs2 2q14 Aco1 5q22 Trpm8 9q35 Myo5b
18q12.2-
q12.3
Crat 3p12 Nbn 5q13 G6pc 10q32.1 Acaa2 18q12.3
Pxmp4 3q41 Acot7 5q36 Slc22a5 10q22 Hsd17b4 18q11
Gk Xq22
Gene Location
Sgms1 1q52
Etfb 1q22
Srek1ip1 2q13
Nhlrc3 2q26
Narg1 2q26
Ppp2r4 3p12
Gpd2 3q21-q23
Chgb 3q36
Abhd12 3q41
Hipk2 4q22
Rnf103 4q33
Hmgcl 5q36
Thap3 5q36
Fam76b 8q11
Por 12q12
Gpn3 12q16
Impa2 18q12.1
Gene Location Gene Location
Pnpla2 1q41 Cdc25a 8q32
Slc25a22 1q41 Trim25 10q26
Tbc1d10c 1q42 Slc5a3 11q11
Smarca2 1q51 Pptc7 12q16
Dgat2 1q32 LOC305052 13q26
Ccnd1 1q42 Btc 14p22
Dhx36 2q31 Btd 16p16
Rapgef4 3q22 Optn 17q12.3
Lmo2 3q32 Tpst2 19p11
Trmt6 3q36 Siah1a 19p11
Fitm2 3q42 Slc12a3 19p14-p12
Pex16 3q24 Mlycd 19q12
Tp53inp2 3q42 Rab9a Xq21
Cttnbp2 4q21
RGD1309621 4q44
RGD1562323 4q11
Il17re 4q42
Ppcs 5q36
Cyp4b1 5q36
RGD1307983 5q24
Slc30a2 5q36
Lzic 5q36
Tnfrsf9 5q36
Atpaf1 5q36
Ypel5 6q13
RGD1307704 6q31
Fam82a1 6q11
Fstl3 7q11
Cpt1b 7q34
Nr2c1 7q13
Gene Location
Whamm 1q31
Smc5 1q51
RGD1304580 1q21
Txnip 2q34
Palmd 2q41
Pdk4 4q13
Cidec 4q42
Angptl4 7q12
Gadd45b 7q11
Galnt4 7q13
Chpt1 7q13
Fam135a 9q13
Slc40a1 9q22
Stk25 9q36
Ehhadh 11q23
Bace2 11q12
Hspc159 14q22
Colq 16p16
Abhd13 16q12.5
Pkib 20q12-q13
Cluster-1 Cluster-2 Cluster-6 Cluster-10
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Abstract 
 
Obesity is one of the main health problems world-wide. Excess dietary fat is 
stored in adipose tissue, but it has been suggested that this storage capacity is 
limited. Consequently, adipose tissue failure or dysfunction may drive progression 
of hepatic steatosis toward non-alcoholic steatohepatitis (NAFLD). However, 
knowledge on the functional link between adipose tissue dysfunction and NAFLD 
is currently limited. In this study we aimed to integrate and model the 
relationships between gene expression in white adipose tissue (WAT) and liver, 
weight status indicators as well as different plasma factors during the 
development of diet-induced obesity (DIO) in mice. Multiple factor analysis was 
used to determine the association between gene expressions in WAT and liver 
jointly with body weight gain and selected plasma proteins. Partial least squares-
path modeling (PLSPM) for putative inter-organ signaling was used to reveal 
cause-effect relationships among the different blocks of multivariate 
observations. In both tissues a time and dose dependent effect on gene 
expression was observed that was most pronounced in WAT. A set of genes in 
both tissues and plasma leptin and insulin were found to be positively associated 
with body weight gain during the development of DIO. The PLSPM revealed that 
changes in WAT gene expression encoding for potentially secreted proteins were 
best explained by changes in the weight status indicators. In contrast, changes in 
liver gene expression were best explained by changed expression of potentially 
secreted proteins in WAT. Taken together, we showed that the development of 
DIO resulted in major changes in WAT and hepatic gene expression. The inter-
organ PLSPM model identified a potential set of genes from WAT that may predict 
around 50% of induced metabolic changes in liver, thereby contributing to the 
pathogenesis of obesity.  
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Introduction 
 
A vast body of literature has been published on the association between diet and 
chronic disease risk (see e.g. [217,218]). It is well known that an energy rich diet 
characterized by high intakes of dietary fat has been linked to the dramatic 
increase in the prevalence of obesity in both developed and developing countries 
in the last several decades [217-219]. Obese individuals are at increased risk of 
developing the metabolic syndrome, a cluster of metabolic abnormalities that 
ultimately increase the risk of developing vascular disease and type 2 diabetes 
[220-222]. 
In healthy situations excess energy is mainly stored as triglycerides in white 
adipose tissue (WAT). However, complications of obesity may in part be traced to 
aberrant storage of lipids in non-adipose tissues, such as liver, which can 
profoundly disturb organ function [223-225]. Moreover, it has been suggested 
that obesity starts to cause metabolic problems only when WAT cannot fully meet 
demands for additional storage of lipids [4,5]. As a consequence, the metabolic 
syndrome is often characterized by non-alcoholic fatty liver disease (NAFLD), 
which therefore is commonly considered as the hepatic manifestation of the 
metabolic syndrome [225,226].  
Recently, it has been well accepted that WAT does not only serve as a storage 
organ, but also has an important endocrine function [225,227]. Adipokines 
secreted from WAT may have an important role in control of metabolism in 
organs other than WAT [228]. A well-known example of such an adipokine is 
leptin, which controls appetite in the central nervous system. Other adipokines 
include adiponectin, resistin, plasminogen activator inhibitor-1 (PAI-1), tumor 
necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and estradiol. Their influence is 
not limited to modulation of metabolism, but includes regulation of inflammatory 
responses and hormone production [225,227]. However, the extent and means of 
inter-organ signaling between WAT and liver remains to be elucidated [228].  
Genome-wide expression profiling allows an unbiased approach to the 
identification of genes regulated by a dietary intervention [6,139]. From the 
perspective of inter-organ communication, in addition to measuring levels of 
known adipokines, identification of potentially secreted factors whose expression 
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is regulated in WAT could identify novel molecules that may play a role during the 
development of diet-induced obesity (DIO) and its complications. 
Therefore, in the present study we investigated the effects of development of DIO 
on gene expression in liver and WAT, and on plasma levels of selected adipokines. 
To this end, mice were fed 4 diets that differed in fat content for up to 12 weeks, 
body weight characteristics and selected adipokines were measured, and liver and 
WAT were subjected to microarray analysis. The various datasets were integrated 
using multivariate statistical tools, and specific focus was given on the interaction 
between WAT and liver by potentially secreted factors. We found that changes in 
weight status indicators mainly explained changes in plasma adipokines and gene 
expression in WAT, but not in liver, and we also identified a set of potentially 
secreted factors in WAT that explained most of the variation in hepatic gene 
expression. 
 
 
Materials and Methods 
 
Ethics statement 
The institutional and national guidelines of the animal experiments were followed 
and the experiment was approved by the Local Committee for Care and Use of 
Laboratory Animals at Wageningen University. 
 
Animals and diets 
The animal study described here was conducted within the framework of the 
European Nutrigenomics Organisation NuGO, and has been described in detail by 
Baccini et al [229]. Briefly, male C57BL/6J mice were obtained from Charles River 
(Maastricht, The Netherlands) at three weeks of age and were housed in pairs. At 
twelve weeks of age, all mice received a low-fat control diet as a run-in for four 
weeks. This control diet contained 10 energy % (10 E%) of fat. After this run-in 
period, at t=0 week, mice were divided in four groups and fed diets containing 45, 
30, 20, or the control diet of 10E % of dietary fat. Palm oil was the main fat source 
in the diets. The only other variable in the diets was the amount of corn starch. 
Mice were culled at the beginning of the study, after one week and four weeks. 
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After four weeks we continued with the 10 E% and 45 E% groups only until week 
12 (n=7 to 10 per group). Body weight and food intake was recorded every week 
starting from t=0. Liver and WAT were harvested and subjected to transcriptomics 
analysis, and plasma samples were analyzed for glucose, insulin and adipokines.  
 
Plasma adipokines and insulin 
Plasma glucose concentrations were determined using a commercial device (Accu-
Chek, Roche, Almere, the Netherlands). Plasma levels of insulin, leptin, resistin, 
monocyte chemoattractant protein-1 (MCP-1), interleukin 6 (IL-6), tumor necrosis 
factor alpha (TNF-α), total PAI-1 (tPAI-1), and adiponectin were measured using 
the mouse plasma multiplex Lincoplex Kit and Adiponectin singleplex (Linco 
Research, Nuclilab, Ede, the Netherlands), respectively, according to Van 
Schothorst et al [230] with slight modifications. Briefly, plasma samples were 
diluted 4x in HPE buffer (Sanquin, Amsterdam, the Netherlands) for the multiplex 
analysis and subsequently another 1,000x for the Adiponectin measurements. 
Assays were conducted according to the manufacturer’s protocol and measured 
using the BioPlex X200 system and software (BioRad, Veenendaal, the 
Netherlands). All individual samples were analyzed in duplicate and averaged 
when the difference between the 2 measurements was ≤5%. Plasma levels of 
TNF-α and MCP-1 were below the detection levels of 3 pg/ml and 44 pg/ml, 
respectively, and were therefore not used in this study. 
 
Transcriptome analysis 
High quality total RNA was extracted from liver and white adipose tissue with 
TRIzol reagent (Invitrogen, Carlsbad, CA) and subsequently purified on columns 
with the RNeasy Mini Kit (Qiagen, Venlo, The Netherlands) including DNase 
treatment. RNA integrity was checked on an Agilent 2100 Bioanalyzer (Agilent 
Technologies, Amsterdam, The Netherlands) with 6000 Nano Chips. 
After isolation, RNA was labeled using the Affymetrix One-Cycle Target labeling 
Assay kit (Affymetrix, Santa Clara, CA). Due to the large number of samples, RNA 
labeling was performed in multiple rounds in a complete block design. Samples 
were hybridized on Affymetrix NuGO mouse arrays, washed, stained, and scanned 
on an Affymetrix GeneChip 3000 7G scanner. In total, 186 arrays from 93 mice 
were used in this study. Quality control of the datasets obtained from the scanned 
Affymetrix arrays was performed using Bioconductor packages [150], integrated in 
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an on-line pipeline [231]. Various advanced quality metrics, diagnostic plots, 
pseudo-images and classification methods were applied to ascertain only 
excellent quality arrays were used in the subsequent analyses [232]. An extensive 
description of the applied criteria is available upon request. Probesets were 
redefined according to Dai et al [151] utilizing current genome information. In this 
study probes were reorganized based on the Entrez Gene database, build 37, 
version 1 (remapped CDF v13). As a result, each array assays the expression of 
15,501 unique genes. Normalized expression estimates were obtained from the 
raw intensity values using the GC-robust multi array (GCRMA) normalization, 
using the empirical Bayes approach to adjust background [152]. ComBat [233], an 
empirical Bayes method, was used to correct for the systematic error (batch 
effect) introduced during labeling. Differentially expressed probesets were 
subsequently identified using linear models, applying moderated t-statistics that 
implement intensity-dependent Bayes regularization of standard errors [20,234]. 
Only genes with a fold-change of at least 1.5 and a p-value < 0.01 were considered 
to be significantly regulated. Annotation information regarding biological function 
and cellular location of genes was analyzed through the use of IPA (Ingenuity 
Systems, Redwood City, CA)). The microarray dataset is deposited in the Gene 
Expression Omnibus (GEO) with accession number. 
 
Multivariate data analysis 
Multiple factor analysis (MFA) is an exploratory approach of multivariate data 
analysis to identify the association between two or more groups of sets of 
variables [235,236]. When more than one response variable are measured, 
multivariate data analysis is preferred over univariate data analysis to study how 
all variables are related to one another, and how they work in combination to 
distinguish between the cases on which the responses are made. In the current 
study we used three multivariate data sets; i.e., the transcriptome data from liver 
and WAT, and plasma levels of selected factors. The weight status indicators 
(body weight (BW) at start of intervention, BW at section, BW gain, absolute and 
relative liver weight) were used as supplementary variables. MFA was performed 
in R [149] using the library FactoMineR [29]. Before performing MFA, we filtered 
the transcriptome datasets by including per dataset (tissue) only those genes that 
were significantly different between the 11 dietary groups using ANOVA (limma, 
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moderated F-test, p<0.01). Genes were considered to be associated with 
supplementary variable BW if their absolute correlation coefficient was significant 
(p<0.05) and larger than 0.40.  
 
Partial least squares path modeling 
Partial least squares path modeling (PLSPM) [31,34], also known as structural 
equation modeling by partial least squares approach, is a methodology of 
multivariate data analysis that allows for modeling complex cause-effect 
relationships involving latent (unobserved) and observed variables. Generally 
speaking, these models seek to analyze the underlying causal process that is 
assumed to generate some phenomenon of interest. PLSPM is robust against 
missing values, model misspecification and violation of the statistical assumptions 
regarding normality and multicollinearity [184,185]. Initially, the PLSPM 
methodology was developed to analyze data from the chemometrics, 
econometrics and sociological fields, but more recently it has also been used to 
analyze high-throughput genomics data [36-38]. A detailed explanation on PLSPM 
can be found in [31,34,117]. In the current study PLSPM was used to investigate 
the cause-effect relationships between blocks of multiple regulated genes in 
adipose and liver tissues, plasma factors and weight parameters. Within PLSPM, 
three types of parameters were defined: (i) latent variable scores; representing 
‘Liver Activity’, ‘WAT Activity’, ‘plasma factors’ and ‘weight status’ that were 
operationalized by reflective manifest variables, (ii) path coefficients between the 
endogenous and exogenous latent variables. These were the standardized 
regression coefficients by PLS regression of the output of inner model in PLSPM, 
and (iii) loadings of each block of manifest variables by reflective way; these were 
the output of the outer model and indicated the association between manifest 
and its latent variables. The significance of the path coefficients were analyzed by 
bootstrap sampling technique using 100 bootstrap samples. The contribution to 
coefficient of determination (R2) [34] were calculated for each of the explanatory 
variables for predicting liver and WAT Activities. Analysis was performed in R 
using the library plspm [30].  
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An overview of our analysis strategy is presented in Figure 1.  
 
 
Figure 1: Overview of our analysis strategy. After normalization by GCRMA and correction 
for batch effects, pair-wise comparisons with the reference group (10 E% at week 0 [C0]) were made 
to identify genes in liver and WAT that were regulated during the development of diet-induced 
obesity. For each comparison, genes with moderated p-value <0.01 were considered to be 
significantly regulated. The number of samples for each tissue in each diet group is listed in the table. 
For integrative multiple factor analysis, transcriptome data was first filtered based on p-value<0.01 
of the moderated F-test. These filtered transcriptome datasets were then combined with plasma 
factors (all as active variables) and weight status indicators (as supplementary variables). In 
addition, we also attempted to elucidate the cause-effect relationships between the blocks of 
variables using PLSPM.  
 
Data representation 
Weight and plasma factors are reported as mean (± standard deviation). 
Differences between the mean values of the groups (combination of diet and 
time) were tested for statistical significance by ANOVA with an additional 
Bonferroni post-hoc test (PASW Statistics 17.0 software, Chicago, Illinois). P-
values<0.05 were considered to be statistically significant.  
 
liver
Transcriptomics
Normalization by GCRMA and
correction for batch effects,
followed by pair-wise
comparisons and analysis of
variance for each gene.
Integration of the two
transcriptome datasets
with plasma factors and
weight status indicators
using multiple factor
analysis and partial least
squares-path modeling to
explain changes in gene
expression, and to identify
potential causal
relationships between
WAT, liver and plasma
factors.
…
s1 s2 s93
Normalization by GCRMA and
correction for batch effects,
followed by pair-wise
comparisons and analysis of
variance for each gene.
Transcriptomics
Selected genes
Selected genes
white adipose tissue
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Results 
 
Physiological measurements 
To determine the relationship between the hepatic and WAT transcriptome, 
physiological data (weight status indicators) and selected plasma factors during 
the development of DIO, mice were fed four diets containing increasing amounts 
of dietary fat for various time points up to 12 weeks. Mice were killed at the start 
of the diet intervention (10 E% at t=0) served as reference. Compared to the 
reference group, BW at section and as a result also BW gain were significantly 
different in 30 E% and 45 E% at 4 weeks and in 45 E% at 12 weeks (Table 1). These 
results show that body weight increased with energy percentage and time of 
intervention. A similar gain in body weight over time was observed between the 
10 E% and 20 E% as well as 30 E% and 45 E% diet groups. Absolute liver mass was 
only significantly increased in 45 E% at 12 weeks, but this was not reflected in an 
altered liver to BW ratio. Recently, Duval et al [5] have showed that the hormone 
leptin plays an important role in the development of DIO in male C57BL/6J mice. 
Regarding the plasma factors, we only observed significant changes for leptin and 
glucose levels only in the 45 E% group at 12 weeks compared to reference group 
(Table 1).  
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Table 1: Weight status and plasma concentrations per experimental group. 
Groups 
Weight status Plasma factor 
BW at start 
of 
intervention 
(g) 
BW at 
section 
(g) 
BW 
gain 
(g) 
Liver 
Weight 
at 
section 
(g) 
Relative 
liver 
weight 
Adipo-
nectin 
(µg/ml) 
Glucose 
(μmol 
/ml) 
IL6 
(pg/ml) 
Insulin 
(pg/ml) 
Leptin 
(pg/ml) 
Resistin 
(pg/ml) 
tPAI_1 
(pg/ml) 
W0_10 E% 
26.43 
(2.47) 
26.43 
(2.47) 
.00 
(.00) 
.96 
(.12) 
.04 
(.00) 
11.76 
(4.69) 
8.95 
(-1.90) 
36.73 
(68.51) 
212.48 
(83.25) 
486.87 
(271.62) 
1920.29 
(603.31) 
945.10 
(828.41) 
W1_10 E% 
26.84 
(1.98) 
26.66 
(1.64) 
-.18 
(.75) 
.95 
(.13) 
.04 
(.00) 
10.78 
(2.21) 
8.94 
(2.78) 
8.72 
(7.70) 
184.46 
(169.13) 
566.88 
(407.48) 
1364.10 
(765.90) 
739.66 
(623.55) 
W1_20 E% 
26.27 
(1.66) 
27.33 
(1.77) 
1.06 
(.44) 
.97 
(.11) 
.04 
(.01) 
12.64 
(2.28) 
9.44 
(1.85) 
2.88 
(1.41) 
144.39 
(140.02) 
464.99 
(487.19) 
837.25 
(782.97) 
328.26 
(206.50) 
W1_30 E% 
26.33 
(1.39) 
27.83 
(1.69) 
1.50 
(.70) 
1.07 
(.18) 
.04 
(.01) 
12.45 
(3.22) 
10.54 
(2.34) 
8.30 
(3.48) 
237.06 
(136.85) 
1058.33 
(777.94) 
1687.41 
(706.54) 
712.00 
(304.62) 
W1_45 E% 
26.60 
(2.18) 
28.16 
(1.53) 
1.45 
(.74) 
.97 
(.14) 
.03 
(.00) 
13.03 
(4.23) 
9.64 
(2.23) 
13.83 
(16.82) 
270.98 
(126.06) 
1136.03 
(789.03) 
1864.62 
(763.97) 
1043.74 
(955.01) 
W4_10 E% 
26.44 
(1.85) 
27.91 
(1.86) 
1.48 
(.63) 
.97 
(.13) 
.03 
(.00) 
10.68 
(2.65) 
9.49 
(2.30) 
14.40 
(16.96) 
203.60 
(186.19) 
733.80 
(610.11) 
1458.43 
(647.62) 
728.47 
(799.44) 
W4_20 E% 
26.43 
(1.57) 
28.50 
(1.83) 
2.07 
(1.32) 
.91 
(.15) 
.03 
(.00) 
12.32 
(3.21) 
9.66 
(2.70) 
26.93 
(46.47) 
193.87 
(97.19) 
687.02 
(491.72) 
1164.47 
(667.33) 
721.98 
(859.29) 
W4_30 E% 
26.49 
(1.46) 
30.33* 
(2.81) 
3.84* 
(2.63) 
1.07 
(.12) 
.04 
(.00) 
11.92 
(2.28) 
11.78 
(2.33) 
8.21 
(5.19) 
269.05 
(173.17) 
2520.02 
(3820.22) 
1464.78 
(853.19) 
540.66 
(348.83) 
W4_45 E% 
26.26 
(1.70) 
30.58* 
(2.79) 
4.32* 
(2.15) 
1.05 
(.19) 
.03 
(.01) 
8.04 
(1.40) 
11.47 
(2.64) 
10.01 
(9.56) 
351.03 
(154.86) 
3478.59 
(4193.36) 
1729.37 
(839.90) 
674.40 
(315.58) 
W12_10E% 
26.42 
(1.27) 
28.73 
(1.53) 
2.31 
(1.32) 
1.00 
(.08) 
.03 
(.01) 
14.57 
(3.84) 
10.19 
(1.06) 
8.65 
(7.63) 
114.82 
(95.15) 
1054.66 
(1308.49) 
1208.94 
(770.43) 
341.60 
(261.12) 
W12_45E% 
26.25 
(1.53) 
38.89* 
(2.84) 
12.64* 
(2.84) 
1.28* 
(.08) 
.03 
(.00) 
15.41 
(3.58) 
13.11* 
(0.71) 
7.08 
(5.16) 
456.06 
(288.92) 
11423.67* 
(7729.92) 
2215.81 
(1191.53) 
534.25 
(319.49) 
Values are represented as mean (SD), * indicated the group was significantly different from the 
reference group (W0_10E %) at p<0.05 by Bonferroni post hoc test. 
 
Differential gene expressions in liver and WAT 
To identify genes in liver and WAT that were differential expressed during the 
development of DIO, pair-wise comparisons were made for each diet group with 
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the reference. Genes that satisfied the criteria of absolute FC>1.5 and p<0.01 
were considered to be regulated. The numbers of differentially expressed genes in 
all pair-wise comparisons are presented in Table S1.  
Generally speaking, we found that more genes were regulated in WAT than in 
liver. In adipose tissue most differentially expressed genes were identified in the 
45 E% diet group at 12 weeks (Table S1). Remarkably, many genes were found to 
be significantly regulated in WAT in 10 E% group at 12 weeks, and a substantial 
number of these genes also overlapped with 45 E% diet group (Figure S1D). The 
number of differentially expressed genes in the liver was highest in the 45 E% 
group at week 4 and 12 compared with the 10 E% and 20 E% groups. However, 
the overlap of differentially expressed genes was limited. A previous study 
showed that the majority of WAT genes are down regulated by DIO in C57BL/6J 
male mice [237]. In line with these observations we also found that overall most 
of the genes were down regulated in both tissues.  
For both tissues almost no overlap in genes regulated by dietary fat was observed 
at 1 and 4 weeks (Figures S1 and S2). In both tissues most of the differentially 
expressed genes overlapped between the 30 E% and 45 E% groups at week 4 
(Figure S1F and Figure S2F) as well as between 45 E% group at week 4 and week 
12 (Figure S1D and Figure S2D).  
 
Associated genes of both tissues with weight status indicators 
To identify genes and plasma factors that were associated with BW gain, we first 
reduced our liver and WAT transcriptome datasets by including only those genes 
that were significantly different in any of the 11 diet groups (p<0.01, limma 
moderated F-test). Using this criterion we identified 1,421 genes in liver and 5,787 
genes in WAT. Next we applied multiple factor analysis using all samples to reveal 
the associations of gene expression with weight status indicators and plasma 
factors. In this study, we considered liver and WAT gene expression levels and 
plasma factors as active variables, and the weight status indicators as 
supplementary variables.  
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Figure 2: Loading plot of the multiple factor analysis. Visualization of the correlation 
coefficients between the 3 active and 1 supplementary variables and the first 2 principal 
components. Different colors represent the different groups of variables; red: hepatic gene 
expression, green: WAT gene expression, blue: plasma parameters, dashed purple: weight status 
indicators. The first 2 principal components explain ~27% of the variation in the dataset. The 
supplemental variable ‘body weight gain’ is highly positively correlated with a subset of genes 
expressed in liver and WAT, plasma leptin and insulin, and ‘body weight at section’.  
 
 
The loading plot obtained by MFA showed that plasma leptin and insulin levels, 
and to a lesser extent glucose, were positively associated with BW gain and BW at 
section (Figure 2). This was expected since these parameters are known to be 
related to BW and adipose tissue mass [5,238]. On the other hand, plasma levels 
of tPAI-1 and IL6 were highly associated amongst each other, but they did not 
correlate with BW gain, BW at section, and plasma leptin and insulin. 
Since we were interested to identify genes in liver and WAT that play a role in 
DIO, we extracted the genes that were significantly correlated (p<0.05, r>0.4) with 
BW gain. This resulted in the selection of 2,643 genes in WAT, of which 1,037 and 
1,606 genes were positively, resp. negatively associated with BW gain. Similarly, in 
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liver we identified 250 genes that were correlated with BW gain, of which 158 
resp. 92 were positively resp. negatively associated with BW gain.  
 
Time- and dose-dependently regulated genes in liver and WAT 
Next we applied a simple linear regression model for evaluating the time- and 
dose-dependency of gene expression per organ. To this end, the 2,643 resp. 250 
genes identified in the previous step were used as input. At first the average 
expression was calculated for each of these genes in each experimental group. To 
evaluate the time dependency of gene expression, a simple linear regression 
model was run using the average expression of a gene as dependent variable Y 
and time of intervention for each diet as independent variable X. Genes with the 
highest absolute regression coefficients represented genes that were most 
sensitive to time of intervention on each diet, where the positive and negative 
sign of the slope indicated increased resp. decreased expression over time. Since 
we did not have gene expression values for the 20 E% and 30 E% groups at 12 
weeks of intervention, we excluded in the regression analyses all gene expression 
data for this specific time point. To infer the dose-dependency of the time-
dependently regulated genes, a regression model was run that used the slopes of 
the initial regression models (i.e., time-dependency) as a dependent variable and 
the fat content of the diet as independent variable. Regression coefficients of this 
second model thus reflected the time- and dose-dependency of gene regulation. 
 
 
Figure 3: Time and dose dependently regulated genes. Number of time dependently 
regulated genes in A) WAT B) liver for each diet group based on the first 3 time points of diet 
intervention, and C) their dose dependency. Red and green indicated induced resp. suppressed 
expression. For time dependency the absolute threshold for coefficients was arbitrarily set ≥0.10, and 
for dose dependency at ≥0.003.  
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A number of genes were identified in liver and WAT that were dose and time 
dependently regulated (Figure 3). It should be kept in mind that these genes were 
also significantly associated with BW gain since these were initially identified in 
the MFA. Overall, we found that the number of genes regulated during the dietary 
intervention were much larger in WAT than in liver (Figure 3 A and B). Moreover, 
we noticed that more genes were time-dependently regulated in mice that 
received diets with highest amount of fat (30 E% and 45 E% versus 10 E% and 20 
E% groups).  
 
 
Figure 4: Heat map of regression coefficients for top time and dose dependently 
regulated genes in WAT. Top 50 time and dose dependently induced (panel A) and suppressed 
(panel B) genes in WAT identified by regression analysis. Green, black and red colors indicate the 
extent of time dependency, being negative, zero and positive, respectively. The column slope_Fat 
represents the time and dose dependency. 
Gene Slope_10 E% Slope_20 E% Slope_30 E% Slope_45 E% Slope_Fat
Pnpla3 -0.109 0.179 0.221 0.485 0.016
Krt79 -0.077 0.035 0.279 0.401 0.014
Paqr9 -0.172 -0.128 0.129 0.223 0.012
Lep 0.009 0.134 0.236 0.388 0.011
Mosc1 -0.151 -0.084 0.221 0.166 0.010
Dusp10 0.063 0.129 0.201 0.397 0.010
Fgf13 0.118 0.092 0.420 0.388 0.010
Hist2h3c2 0.088 0.116 0.265 0.392 0.009
Lctl -0.056 -0.033 0.222 0.223 0.009
Mmp12 -0.086 -0.047 0.135 0.209 0.009
Sfrp5 0.205 0.170 0.398 0.477 0.009
Lhfpl2 0.004 0.046 0.196 0.298 0.009
1110059M19Rik 0.079 0.176 0.338 0.371 0.009
Mogat2 -0.046 0.056 0.153 0.257 0.009
1100001G20Rik -0.037 -0.018 0.130 0.237 0.008
Mest 0.140 0.071 0.362 0.358 0.008
Hist2h3c1 -0.001 0.028 0.204 0.250 0.008
Myl4 0.022 0.032 0.116 0.278 0.008
Ube2c -0.099 0.016 0.019 0.174 0.007
Thy1 -0.042 0.005 0.104 0.194 0.007
Fam20c 0.021 0.052 0.261 0.231 0.007
Dhcr7 -0.119 -0.027 0.078 0.119 0.007
Slc25a19 -0.132 -0.019 0.055 0.111 0.007
Paqr7 -0.064 0.051 0.134 0.168 0.007
Cdsn -0.079 0.003 0.140 0.137 0.007
Tspan17 -0.032 0.006 0.159 0.174 0.007
Pbk -0.041 -0.047 -0.014 0.184 0.007
Duoxa1 0.002 0.028 0.147 0.212 0.006
Cox7a1 0.001 -0.009 0.183 0.191 0.006
Col15a1 -0.070 -0.001 0.130 0.142 0.006
Pacs2 -0.011 0.065 0.136 0.211 0.006
Crtac1 -0.130 -0.126 0.135 0.040 0.006
Odz4 -0.121 -0.076 -0.013 0.093 0.006
Srpx2 -0.003 0.041 0.145 0.199 0.006
Bcl2l10 -0.064 -0.030 0.033 0.144 0.006
S100a8 0.049 0.043 0.186 0.234 0.006
Cdr2 -0.034 0.009 0.126 0.157 0.006
Pfkfb4 -0.001 0.065 0.200 0.190 0.006
Hspa12a -0.092 -0.003 0.043 0.119 0.006
Unc119 -0.131 -0.063 0.042 0.065 0.006
Spaca1 0.049 0.093 0.169 0.245 0.006
Ccl2 -0.006 0.041 0.008 0.212 0.006
Ccnb2 -0.017 0.016 0.034 0.185 0.006
Itgax -0.017 0.053 0.121 0.180 0.006
Grtp1 -0.052 0.056 0.107 0.149 0.006
Mpdz -0.109 -0.005 0.045 0.092 0.006
Itga7 -0.124 -0.086 -0.003 0.060 0.005
Hspg2 -0.083 -0.014 0.131 0.091 0.005
Hfe -0.063 0.000 0.054 0.129 0.005
Peg3 0.028 0.016 0.024 0.218 0.005
Gene Slope_10 E% Slope_20 E% Slope_30 E% Slope_45 E% Slope_Fat
Cish -0.038 -0.098 -0.234 -0.454 -0.012
Grem2 0.037 0.027 -0.293 -0.236 -0.009
Rgs2 -0.217 -0.051 -0.386 -0.423 -0.008
Acsm3 -0.091 -0.118 -0.312 -0.325 -0.008
Bhlhe40 0.021 -0.079 -0.093 -0.231 -0.007
Rorc -0.015 -0.072 -0.133 -0.241 -0.006
Slc5a6 -0.206 -0.260 -0.293 -0.423 -0.006
Slc43a1 -0.191 -0.184 -0.343 -0.365 -0.006
Chac1 -0.084 -0.205 -0.214 -0.295 -0.006
Gpx3 0.055 0.030 -0.049 -0.124 -0.005
Fam13a -0.106 -0.164 -0.277 -0.282 -0.005
Cyp2f2 -0.138 -0.095 -0.352 -0.270 -0.005
Chchd10 -0.048 -0.138 -0.165 -0.235 -0.005
St6galnac5 -0.091 -0.102 -0.247 -0.239 -0.005
Rassf6 -0.110 -0.088 -0.218 -0.255 -0.005
Cd14 -0.111 -0.077 -0.238 -0.246 -0.005
2210020M01Rik 0.068 0.086 0.004 -0.085 -0.005
Gprasp1 0.125 0.067 0.019 -0.043 -0.005
Mycl1 -0.136 -0.191 -0.258 -0.296 -0.005
Acad10 -0.031 -0.038 -0.144 -0.175 -0.005
2810026P18Rik -0.024 -0.036 -0.201 -0.157 -0.005
Srpx -0.061 -0.013 -0.186 -0.183 -0.005
Mcpt4 0.075 0.108 -0.119 -0.038 -0.005
Snhg1 -0.004 -0.039 -0.083 -0.162 -0.005
Gm129 -0.181 -0.239 -0.229 -0.352 -0.005
Ppl -0.004 -0.022 -0.113 -0.147 -0.004
Lrig3 -0.096 -0.082 -0.185 -0.230 -0.004
Usp54 0.009 -0.016 -0.114 -0.129 -0.004
Irf4 -0.249 -0.206 -0.305 -0.375 -0.004
Steap2 -0.027 0.047 -0.114 -0.134 -0.004
Dmkn 0.097 0.032 0.045 -0.062 -0.004
2810410L24Rik 0.003 -0.050 -0.136 -0.131 -0.004
Scn3b 0.000 -0.066 -0.159 -0.134 -0.004
Itm2a 0.013 0.035 -0.102 -0.099 -0.004
Ddb2 -0.007 0.000 -0.042 -0.140 -0.004
Dpyd 0.049 -0.014 -0.088 -0.086 -0.004
Upk1b -0.002 -0.065 -0.091 -0.146 -0.004
Rsrc2 0.053 0.043 -0.078 -0.065 -0.004
Vegfa -0.060 -0.048 -0.120 -0.183 -0.004
Sft2d3 0.063 0.008 -0.058 -0.070 -0.004
Cpa3 0.008 0.039 -0.193 -0.080 -0.004
Celsr2 -0.029 -0.027 -0.050 -0.161 -0.004
C2 -0.032 -0.017 -0.150 -0.139 -0.004
Bnc1 -0.002 -0.060 -0.249 -0.106 -0.004
NA9 -0.114 -0.047 -0.103 -0.228 -0.004
Tst -0.177 -0.100 -0.267 -0.267 -0.004
Adrb2 -0.271 -0.194 -0.381 -0.357 -0.004
Ddah1 0.313 0.222 0.268 0.159 -0.004
Fmod 0.057 0.044 0.004 -0.070 -0.004
Pdk2 0.010 -0.049 -0.046 -0.131 -0.004
Low
Zero
High
A B
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We observed that more genes were time and dose dependently regulated in WAT 
than in liver (Figure 3C). The top 50 regulated genes in WAT and top 15 regulated 
genes in liver are displayed in Figure 4 and Figure 5, respectively. The complete 
lists of regulated genes in WAT and liver are available in Table S2 and Table S3, 
respectively. Several genes were identified that were known to be regulated 
during the development of DIO, such as Pparg, Lep, Mosc1 and Mest. At the 
functional level, the identified genes in WAT were associated with increased cell 
proliferation, inflammation, and fibrosis. Similarly, genes identified in liver were 
among others involved in lipid metabolism, development of connective tissue, 
steatohepatitis, and liver fibroses, all processes known to be associated with the 
development and progression of hepatic steatosis. Overall, in both tissues most of 
the genes were highly time dependently regulated in 30 E% and 45 E% groups, but 
not in the 10 E% and 20 E% groups.  
 
 
Figure 5: Heat map of regression coefficients for top time and dose dependently 
regulated genes in liver. Top 15 time and dose dependently induced (panel A) and suppressed 
(panel B) genes in liver identified by regression analysis. Green, black and red colors indicate the 
extent of time dependency, being negative, zero and positive, respectively. The column slope_Fat 
represents the time and dose dependency. 
 
Results of the PLS-path model 
Next we investigated the association and cause-effect relationships between the 
two transcriptome datasets, plasma factors and weight status indicators through 
PLSPM (Figure 6). We assumed that latent variables ‘WAT Activity’ and ‘Liver 
Lo
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Gene Slope_10 E% Slope_20 E% Slope_30 E% Slope_45 E% Slope_Fat
9030619P08Rik -0.177 -0.182 0.043 0.233 0.013
Gpr98 -0.028 -0.038 0.125 0.247 0.009
Cfd 0.042 0.047 0.200 0.310 0.008
Mvk -0.084 -0.054 -0.035 0.173 0.007
Tlcd2 -0.021 0.020 0.090 0.223 0.007
Fitm1 0.136 0.091 0.302 0.308 0.006
Olig1 0.052 0.112 0.259 0.218 0.005
Aatk 0.015 0.015 0.143 0.171 0.005
0610012H03Rik -0.028 0.004 0.055 0.143 0.005
Trhde -0.063 0.048 0.097 0.118 0.005
Cebpe 0.062 0.060 0.129 0.206 0.004
Pparg 0.020 -0.016 0.200 0.128 0.004
2510049J12Rik -0.052 -0.033 0.014 0.097 0.004
Isoc2b -0.035 0.024 0.077 0.117 0.004
Psmb9 -0.002 0.067 0.096 0.154 0.004
Gene Slope_10 E% Slope_20 E% Slope_30 E% Slope_45 E% Slope_Fat
Serpina4-ps1 -0.219 -0.200 -0.197 -0.456 -0.007
Ugcg 0.016 -0.006 -0.075 -0.167 -0.005
Cd9 0.037 -0.015 -0.056 -0.128 -0.005
2810474O19Rik -0.049 -0.054 -0.084 -0.196 -0.004
Rnf145 -0.025 -0.043 -0.042 -0.173 -0.004
Slc16a1 0.080 -0.035 -0.024 -0.083 -0.004
Gpr110 -0.022 -0.016 -0.144 -0.139 -0.004
Ugt2b38 -0.013 0.031 -0.107 -0.122 -0.004
Plin5 0.034 -0.089 -0.022 -0.132 -0.004
Elovl6 -0.106 -0.081 -0.105 -0.227 -0.004
Mat2a -0.002 -0.022 -0.052 -0.128 -0.004
4833442J19Rik -0.077 -0.096 -0.065 -0.214 -0.004
Wsb1 -0.223 -0.100 -0.285 -0.297 -0.004
Chac1 -0.147 -0.102 -0.244 -0.225 -0.003
Cpsf6 -0.083 -0.060 -0.093 -0.181 -0.003
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Activity‘ in the PLS path model were reflected by the expression levels of selected 
genes in all conditions as determined by the microarrays. For WAT the set of dose 
and time dependently regulated genes was further filtered to include 69 
potentially secreted genes only (Table S4), whereas for liver we used the 
expression data of all 53 dose and time dependent genes. The refinement for 
WAT on extracellular location was done since we hypothesized that cross talk 
between adipose and liver tissue could only occur through secreted factors. All 
plasma and body weight measurements were used as manifest variables for the 
latent variable ‘plasma status’ and ‘weight status’. The fitted PLSPM inner model 
revealed that the latent variable ‘WAT Activity’ was more affected by ‘weight 
status’ (path coefficient = 0.63) than ‘plasma status’ (coefficient = 0.30). ‘Liver 
Activity’, in turn, was predicted to be more modulated by ‘WAT Activity’ 
(coefficient = 0.44) than by ‘plasma status’ (coefficient = 0.34) or ‘weight status’ 
(coefficient = 0.10). Thus, these outcomes indicated that especially an increase in 
‘weight status’ would result in an increased ‘WAT Activity’. Likewise, in particular 
an increase in ‘weight status’ was suggested to result in an increased ‘plasma 
status’. The outcomes from the outer (measurement) model revealed that the 
manifest variables ‘BW at section’ (loading=0.97), ‘BW gain’ (0.96) and ‘absolute 
liver weight’ (0.79) correlated highly with their latent variable ‘Weight status’. In 
contrast, ‘relative liver weight’ (-0.06) and ‘BW at start of intervention’ (0.15) only 
very weakly correlated with ‘Weight status’. For latent variable ‘plasma factors’ 
we found a high correlation with plasma levels of leptin (0.93), glucose (0.77) and 
insulin (0.76). Along the same line, a set of potentially secreted genes could be 
identified that highly correlated with the latent variable ‘WAT Activity’. Top 
positively correlated genes included Serpinf1, Lep, Col6a2, Mest and Fgf13, 
whereas Ctf1, Iqcb1 and Grem2 were among the most negatively correlated 
genes. Similarly, a subset of genes was found that highly (anti-) correlated with 
the latent variable ‘Liver Activity’ ( Figure 6 and Table S4). 
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Figure 6: PLS-path model for time and dose dependently regulated genes in WAT 
and liver, plasma factors and weight indicators. The fitted PLS path model resulted in a 
good overall fit (absolute=0.52 and inner model=0.81). Indirect effects are shown in parentheses. The 
total effect of each of the path coefficient was significant at 5% level of significance as determined by 
bootstrap sampling. The plasma factors data was transformed by taking the natural logarithm, and 
all datasets were standardized when building the model. For WAT and liver genes, absolute loadings 
greater than 0.60 are presented in the figure. The complete list is available as Table S4. For weight 
status and plasma factors all the indicators are presented. 
 
Next we checked the proportion of variability in the data set that could be 
accounted for by the model. The highest proportion of variation could be 
explained by the latent variable ‘WAT Activity’ (R2 =0.70), followed by ‘Liver 
Activity’ (R2 =0.64). Moreover, ‘WAT Activity’ was the most important variable in 
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the prediction of ‘Liver Activity’, contributing to 50.9% of the R2 (Table 2), 
followed by ‘plasma factors’ (38.1%), whereas ‘weight status’ had a very low 
contribution on the prediction of ‘Liver Activity’. On the other hand, ‘weight 
status’ (71.2%) was the most important variable in the prediction of ‘WAT 
Activity’, which suggested that weight status (especially BW gain) is an important 
determinant of gene expression in WAT during the development of DIO. 
Table 2: Explanation of ‘Liver Activity’ and ‘WAT Activity’ 
‘Liver Activity’ 
Explanatory variables 
for Liver 
Path Coefficient Correlation Contribution to R
2 
(%) 
Weight Status 0.10 0.683 10.9 
Plasma Factors 0.34 0.697 38.1 
WAT Activity 0.44 0.722 50.9 
‘WAT Activity’ 
Explanatory variables 
for WAT 
Path Coefficient Correlation Contribution to R
2 
(%) 
Weight Status 0.63 0.813 71.2 
Plasma Factors 0.30 0.691 28.9 
 
From a biological perspective the results of the PLSPM analysis thus suggested 
that an increased gene expression profile in WAT can be mainly attributed to an 
increase in BW and to a lesser extent to changes in plasma factors. In turn, in this 
model the increased levels of potentially secreted gene products in WAT, such as 
leptin, are the main effectors of gene expression in the liver. 
 
 
Discussion 
 
C57BL/6J mice fed a high fat diet at different time points represent a popular 
animal model for human obesity and insulin resistance [239]. Nonalcoholic fatty 
liver disease (NAFLD) is strongly linked to obesity, and it has been suggested that 
proteins secreted from adipose tissue may be incriminated in the etiology of 
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NAFLD [228]. Moreover, it has been reported that a tight relationship exists 
between adipose tissue dysfunction and the pathogenesis of NAFLD [4,5,228], and 
previous work of our group pointed out several novel potential predictive 
biomarkers for NASH [5]. We extend this work in the current study, and found 
that changes in weight status indicators mainly explained changes in plasma 
adipokines and gene expression in WAT, but not in liver. Moreover, we also 
identified a set of potentially secreted factors in WAT that explained most of the 
variation in hepatic gene expression. 
As expected, high-fat feeding induced body weight and adipose tissue mass that 
increased over time. This was also reflected in changes in gene expression that 
were more pronounced in adipose tissue than in liver. However, the most 
noticeable effects were observed in the 30 E% and 45 E% groups, and not in the 
20 E% group. MFA analysis identified genes in WAT and liver that correlated with 
body weight gain. Several of these are already known to be regulated during DIO, 
such as Leptin and Pparg. At the functional level, the identified genes in liver were 
among others involved in lipid metabolism, development of connective tissue, 
steatohepatitis, and liver fibroses, all processes known to be associated with the 
development and progression of hepatic steatosis. Similarly, genes identified in 
WAT were associated with increased cell proliferation, inflammation, and fibrosis.  
To identify potential causal relationships among the dose-time dependently 
regulated secreted WAT genes, liver genes, weight status indicators and plasma 
factors, we developed an inter-organ model that was analyzed by PLSPM. The 
PLSPM is a suitable multivariate statistical approach to handle multi-blocks of 
measurements and to the best of our knowledge we are one of the first to apply 
PLSPM to integrate and build a model for use with several transcriptomics and 
phenotypes related datasets. Related to our work is a study performed by Nock et 
al [240] that used structural equation modeling to define the genetic 
determinants of metabolic syndrome. Usually structural equation modeling with 
maximum likelihood (SEM-ML) approach [35] has been used to analyze multi 
block datasets, but it depends on a specific distribution pattern and needs more 
cases than variables. It is also known as hard modeling. On the other hand, a soft 
modeling technique such as PLSPM [31,34,117] does not depend on any specific 
distributional pattern and is superior for data sets that consist of fewer cases than 
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variables. In practice, omics experiments usually comprise of fewer cases than 
variables, are noisy, and suffer by multicollinearity. Therefore, the PLSPM can be 
used as a suitable approach for this kind of data. Recently, the concept of PLSPM 
has also been used by Xue et al [38] in their genetic association study. However, it 
should be realized that some biological mechanisms hidden in the gene 
expression data may not be revealed by PLSPM analysis. We have analyzed only 
linear relations among gene expression patterns, thus excluding non-linear 
relations which would need to be studied with extensions of the methods we 
used. 
 
The partial least squares path model fitted in this study gives a good overall fit 
with significant path coefficients. We found that the activity of WAT played the 
most important contribution in the prediction of liver gene expression. On the 
other hand, the weight status played the largest role to predict the WAT gene 
expression, as was expected [42]. We also observed that liver genes were causally 
highly influenced by putatively secreted WAT genes that were dose and time 
dependently regulated, followed by plasma factors. In addition, the outcomes of 
PLSPM also showed that the weight status played a more important role on 
changes in WAT gene expression and plasma factors than hepatic gene 
expression. The plasma factors were found to be higher influential variables on 
changes in WAT gene expression than on hepatic gene expression.  
 
In conclusion, we conclude that (i) dietary fat and time of intervention have a 
pronounced effect on WAT and liver as indicated by dose and time dependent 
changes in gene expression, (ii) the plasma factors leptin and glucose are 
associated with BW gain and are also associated with most of the positive 
changed time and dose dependent genes, and (iii) our data support the existence 
of a strong relationship between liver and WAT gene expression, followed by 
changes in plasma factors, including adipokines. All together, we conclude that 
the WAT gene expression profile predicts around 50% of liver gene expression 
profile. We also point out a set of liver genes that are strongly associated with a 
set of WAT secreted genes. The findings of this study give new insights on the 
exact role of WAT during the development of obesity and its effects on liver.  
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Supplementary 
Figures 
 
 
Figure S1: Venn plots representing the overlap among regulated genes per diet 
group in WAT. A-D: evolution of WAT gene regulation over time per diet group. E-G: dose-
dependency of WAT gene regulation. Genes were considered to be regulated if the absolute FC was 
larger than 1.5 and p<0.01. 
 
 
 
Figure S2: Venn plots representing the overlap among regulated genes per diet 
group in liver. A-D: evolution of hepatic gene regulation over time per diet group. E-G: dose-
dependency of hepatic gene regulation. Genes were considered to be regulated if the absolute FC 
was larger than 1.5 and p<0.01. 
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Tables 
 
Table S1: Number of regulated gene per diet group compared to the reference 
group. 
 
 1 Week 4 Weeks 12 Weeks Overlap 
Gene Liver Gene Up Down Gene Up Down Gene Up Down 
Fat 
E% 
 
10% 15 11 4 50 25 25 5 1 4 0 
20% 23 13 10 9 3 6  1 
30% 12 6 6 44 23 21  2 
45% 36 15 21 60 25 35 46 33 13 5 
Overlap Gene 0   3   0    
 WAT   
Fat 
E% 
 
10% 31 19 12 86 55 31 1675 933 742 1 
20% 20 9 11 26 10 16  1 
30% 40 18 22 193 75 118  26 
45%    58 38 20 225 114 111 1620 733 887 43 
Overlap Gene     1   8   672    
 
 
Table S2: Time and dose dependent genes in liver associated with BW gain. 
Entrez Gene (Liver) Slope_10 E% Slope_20 E% Slope_30 E% Slope_45 E% Slope_Fat 
110794 Cebpe 0.062 0.060 0.129 0.206 0.004 
68680 Fitm1 0.136 0.091 0.302 0.308 0.006 
67441 Isoc2b -0.035 0.024 0.077 0.117 0.004 
217830 9030617O03Rik -0.048 -0.001 0.029 0.085 0.004 
50914 Olig1 0.052 0.112 0.259 0.218 0.005 
67705 1810058I24Rik 0.079 0.068 0.114 0.165 0.003 
16912 Psmb9 -0.002 0.067 0.096 0.154 0.004 
226527 BC026585 0.003 0.045 0.059 0.101 0.003 
74088 0610012H03Rik -0.028 0.004 0.055 0.143 0.005 
67013 Oma1 -0.032 0.028 0.036 0.095 0.003 
19016 Pparg 0.020 -0.016 0.200 0.128 0.004 
66401 Nudt2 -0.056 -0.010 0.007 0.058 0.003 
77996 D730039F16Rik -0.011 0.038 0.026 0.127 0.004 
11537 Cfd 0.042 0.047 0.200 0.310 0.008 
380712 Tlcd2 -0.021 0.020 0.090 0.223 0.007 
16348 Invs -0.020 -0.007 0.029 0.073 0.003 
17855 Mvk -0.084 -0.054 -0.035 0.173 0.007 
20194 S100a10 -0.035 0.012 0.056 0.099 0.004 
67046 Tbc1d7 0.018 0.018 0.113 0.115 0.003 
70291 2510049J12Rik -0.052 -0.033 0.014 0.097 0.004 
11302 Aatk 0.015 0.015 0.143 0.171 0.005 
103140 Gstt3 -0.097 0.037 0.018 0.019 0.003 
53901 Rcan2 0.050 0.008 0.158 0.157 0.004 
110789 Gpr98 -0.028 -0.038 0.125 0.247 0.009 
13009 Csrp3 -0.016 -0.022 -0.040 0.089 0.003 
105892 9030619P08Rik -0.177 -0.182 0.043 0.233 0.013 
11761 Aox1 0.075 0.070 0.206 0.165 0.003 
15957 Ifit1 0.081 0.070 0.086 0.198 0.003 
237553 Trhde -0.063 0.048 0.097 0.118 0.005 
216551 1110067D22Rik 0.047 0.009 0.076 0.150 0.003 
56219 Extl1 -0.018 0.035 0.072 0.103 0.003 
68043 N6amt2 -0.014 0.032 0.023 0.110 0.003 
80860 Ghdc 0.013 0.008 0.094 0.088 0.003 
70028 Dopey2 -0.031 0.064 0.075 0.094 0.003 
67246 2810474O19Rik -0.049 -0.054 -0.084 -0.196 -0.004 
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74315 Rnf145 -0.025 -0.043 -0.042 -0.173 -0.004 
170439 Elovl6 -0.106 -0.081 -0.105 -0.227 -0.004 
77596 Gpr110 -0.022 -0.016 -0.144 -0.139 -0.004 
545487 Gm14439 0.009 0.000 -0.079 -0.072 -0.003 
69065 Chac1 -0.147 -0.102 -0.244 -0.225 -0.003 
66968 Plin5 0.034 -0.089 -0.022 -0.132 -0.004 
268822 Adck5 0.084 0.018 0.000 -0.018 -0.003 
75710 Rbm12 -0.049 -0.017 -0.077 -0.133 -0.003 
100559 Ugt2b38 -0.013 0.031 -0.107 -0.122 -0.004 
13211 Dhx9 0.012 -0.048 -0.092 -0.078 -0.003 
22234 Ugcg 0.016 -0.006 -0.075 -0.167 -0.005 
12527 Cd9 0.037 -0.015 -0.056 -0.128 -0.005 
432508 Cpsf6 -0.083 -0.060 -0.093 -0.181 -0.003 
321018 Serpina4-ps1 -0.219 -0.200 -0.197 -0.456 -0.007 
20501 Slc16a1 0.080 -0.035 -0.024 -0.083 -0.004 
232087 Mat2a -0.002 -0.022 -0.052 -0.128 -0.004 
78889 Wsb1 -0.223 -0.100 -0.285 -0.297 -0.004 
320204 4833442J19Rik -0.077 -0.096 -0.065 -0.214 -0.004 
 
 
Table S3: Time and dose dependent genes in WAT associated with BW gain 
Entrez Gene (WAT) Slope_10 E% Slope_20 E% Slope_30 E% Slope_45 E% Slope_Fat 
116939 Pnpla3 -0.109 0.179 0.221 0.485 0.016 
223917 Krt79 -0.077 0.035 0.279 0.401 0.014 
75552 Paqr9 -0.172 -0.128 0.129 0.223 0.012 
16846 Lep 0.009 0.134 0.236 0.388 0.011 
66112 Mosc1 -0.151 -0.084 0.221 0.166 0.010 
63953 Dusp10 0.063 0.129 0.201 0.397 0.010 
14168 Fgf13 0.118 0.092 0.420 0.388 0.010 
97114 Hist2h3c2 0.088 0.116 0.265 0.392 0.009 
235435 Lctl -0.056 -0.033 0.222 0.223 0.009 
17381 Mmp12 -0.086 -0.047 0.135 0.209 0.009 
54612 Sfrp5 0.205 0.170 0.398 0.477 0.009 
218454 Lhfpl2 0.004 0.046 0.196 0.298 0.009 
68800 1110059M19Rik 0.079 0.176 0.338 0.371 0.009 
233549 Mogat2 -0.046 0.056 0.153 0.257 0.009 
66107 1100001G20Rik -0.037 -0.018 0.130 0.237 0.008 
17294 Mest 0.140 0.071 0.362 0.358 0.008 
15077 Hist2h3c1 -0.001 0.028 0.204 0.250 0.008 
17896 Myl4 0.022 0.032 0.116 0.278 0.008 
68612 Ube2c -0.099 0.016 0.019 0.174 0.007 
21838 Thy1 -0.042 0.005 0.104 0.194 0.007 
80752 Fam20c 0.021 0.052 0.261 0.231 0.007 
13360 Dhcr7 -0.119 -0.027 0.078 0.119 0.007 
67283 Slc25a19 -0.132 -0.019 0.055 0.111 0.007 
71904 Paqr7 -0.064 0.051 0.134 0.168 0.007 
386463 Cdsn -0.079 0.003 0.140 0.137 0.007 
74257 Tspan17 -0.032 0.006 0.159 0.174 0.007 
52033 Pbk -0.041 -0.047 -0.014 0.184 0.007 
213696 Duoxa1 0.002 0.028 0.147 0.212 0.006 
12865 Cox7a1 0.001 -0.009 0.183 0.191 0.006 
12819 Col15a1 -0.070 -0.001 0.130 0.142 0.006 
21789 Pacs2 -0.011 0.065 0.136 0.211 0.006 
72832 Crtac1 -0.130 -0.126 0.135 0.040 0.006 
23966 Odz4 -0.121 -0.076 -0.013 0.093 0.006 
68792 Srpx2 -0.003 0.041 0.145 0.199 0.006 
12049 Bcl2l10 -0.064 -0.030 0.033 0.144 0.006 
20201 S100a8 0.049 0.043 0.186 0.234 0.006 
12585 Cdr2 -0.034 0.009 0.126 0.157 0.006 
270198 Pfkfb4 -0.001 0.065 0.200 0.190 0.006 
73442 Hspa12a -0.092 -0.003 0.043 0.119 0.006 
22248 Unc119 -0.131 -0.063 0.042 0.065 0.006 
67652 Spaca1 0.049 0.093 0.169 0.245 0.006 
20296 Ccl2 -0.006 0.041 0.008 0.212 0.006 
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12442 Ccnb2 -0.017 0.016 0.034 0.185 0.006 
16411 Itgax -0.017 0.053 0.121 0.180 0.006 
66790 Grtp1 -0.052 0.056 0.107 0.149 0.006 
17475 Mpdz -0.109 -0.005 0.045 0.092 0.006 
16404 Itga7 -0.124 -0.086 -0.003 0.060 0.005 
15530 Hspg2 -0.083 -0.014 0.131 0.091 0.005 
15216 Hfe -0.063 0.000 0.054 0.129 0.005 
18616 Peg3 0.028 0.016 0.024 0.218 0.005 
16803 Lbp 0.032 0.085 0.192 0.210 0.005 
12534 Cdk1 -0.024 -0.038 0.016 0.155 0.005 
216343 Tph2 -0.086 -0.032 0.027 0.099 0.005 
70083 Metrn -0.055 0.012 0.058 0.133 0.005 
67800 Dgat2 -0.101 -0.028 0.068 0.077 0.005 
59126 Nek6 -0.064 0.006 0.084 0.117 0.005 
77032 2610029I01Rik 0.002 0.029 0.098 0.178 0.005 
20210 Saa3 -0.041 0.029 0.077 0.144 0.005 
105892 9030619P08Rik 0.003 0.033 0.111 0.176 0.005 
20167 Rtn2 -0.031 0.032 0.091 0.149 0.005 
79221 Hdac9 -0.070 -0.029 0.038 0.105 0.005 
18430 Oxtr 0.027 0.081 0.209 0.189 0.005 
16835 Ldlr 0.005 0.058 0.129 0.178 0.005 
14086 Fscn1 -0.056 -0.001 0.088 0.113 0.005 
20379 Sfrp4 -0.008 0.010 0.076 0.160 0.005 
53313 Atp2a3 -0.013 0.053 0.090 0.167 0.005 
53867 Col5a3 -0.061 -0.029 0.059 0.103 0.005 
12575 Cdkn1a 0.000 0.037 0.068 0.176 0.005 
14118 Fbn1 0.008 0.020 0.066 0.176 0.005 
23796 Aplnr -0.026 -0.010 0.023 0.143 0.005 
53601 Pcdh12 0.014 0.062 0.078 0.188 0.005 
116847 Prelp -0.018 0.041 0.135 0.140 0.005 
17314 Mgmt -0.086 0.000 0.049 0.085 0.005 
14733 Gpc1 0.111 0.142 0.291 0.254 0.005 
257635 Sdsl -0.031 -0.005 0.114 0.117 0.005 
12832 Col5a2 -0.040 0.000 -0.016 0.137 0.005 
67717 Lipf -0.028 0.018 0.100 0.129 0.005 
12035 Bcat1 -0.019 0.019 0.071 0.142 0.005 
110075 Bmp3 0.168 0.084 0.220 0.293 0.005 
72899 Macrod2 0.016 0.172 0.050 0.224 0.005 
74186 Ccdc3 -0.065 0.011 0.047 0.101 0.005 
29818 Hspb7 0.099 0.170 0.251 0.255 0.005 
67956 Setd8 -0.069 -0.044 0.052 0.078 0.005 
110208 Pgd -0.092 -0.031 0.043 0.062 0.005 
29815 Bcar3 -0.042 -0.006 0.091 0.103 0.004 
22403 Wisp2 -0.014 0.001 0.052 0.138 0.004 
76561 Snx7 -0.099 -0.013 -0.024 0.074 0.004 
17200 Mc2r -0.084 -0.048 -0.004 0.070 0.004 
231070 Insig1 -0.072 -0.081 0.001 0.068 0.004 
17345 Mki67 -0.039 -0.022 0.023 0.111 0.004 
74107 Cep55 -0.036 0.012 -0.010 0.131 0.004 
235135 Tmem45b 0.002 0.066 0.151 0.149 0.004 
14211 Smc2 -0.028 0.031 0.012 0.139 0.004 
18391 Sigmar1 -0.062 -0.016 0.044 0.087 0.004 
18162 Npr3 0.025 0.067 0.140 0.170 0.004 
75572 Acyp2 -0.060 -0.036 0.033 0.083 0.004 
19713 Ret 0.101 0.138 0.159 0.254 0.004 
11501 Adam8 -0.051 0.044 0.077 0.108 0.004 
217431 Pqlc3 -0.068 -0.019 0.005 0.085 0.004 
109042 Prkcdbp -0.007 0.045 0.081 0.143 0.004 
72433 Rab38 -0.045 0.012 0.062 0.103 0.004 
12428 Ccna2 -0.026 -0.044 0.046 0.104 0.004 
228966 Ppp1r3d -0.103 0.051 -0.007 0.078 0.004 
72713 Angptl1 -0.071 -0.023 0.036 0.070 0.004 
20250 Scd2 -0.010 0.038 0.176 0.115 0.004 
72033 Tsc22d2 0.000 0.018 0.069 0.139 0.004 
54219 Cd320 -0.052 -0.010 0.009 0.095 0.004 
239463 Fam83a -0.071 -0.046 0.047 0.059 0.004 
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102294 Cyp4v3 0.048 0.084 0.157 0.180 0.004 
18405 Orm1 -0.047 -0.066 0.063 0.066 0.004 
69071 Tmem97 0.004 -0.043 0.046 0.122 0.004 
85308 Fam158a -0.094 0.009 -0.015 0.067 0.004 
72169 Trim29 0.020 -0.011 0.108 0.134 0.004 
11799 Birc5 -0.003 0.013 0.020 0.140 0.004 
76905 Lrg1 -0.056 0.026 -0.015 0.104 0.004 
20148 Dhrs3 -0.075 -0.025 -0.030 0.074 0.004 
21857 Timp1 0.016 0.011 0.112 0.135 0.004 
12831 Col5a1 -0.061 -0.010 0.003 0.082 0.004 
22642 Rab7l1 -0.018 0.047 0.073 0.125 0.004 
20317 Serpinf1 -0.025 0.018 0.078 0.108 0.004 
66469 2810405K02Rik -0.025 0.033 0.038 0.121 0.004 
16948 Lox 0.005 0.040 0.045 0.147 0.004 
13197 Gadd45a 0.105 0.111 0.141 0.237 0.004 
13476 Reep5 -0.047 -0.002 0.054 0.085 0.004 
67399 Pdlim7 0.208 0.202 0.194 0.345 0.004 
58996 Arhgap23 -0.031 0.010 0.070 0.099 0.004 
56496 Tspan6 0.061 0.057 0.196 0.168 0.004 
78372 Snrnp25 0.045 0.064 0.151 0.165 0.004 
12835 Col6a3 -0.067 -0.017 -0.003 0.071 0.004 
13038 Ctsk -0.090 0.038 -0.040 0.077 0.004 
16795 Large -0.101 -0.019 -0.007 0.041 0.004 
101437 Dhx32 -0.051 0.006 0.032 0.085 0.004 
12505 Cd44 -0.032 -0.028 0.022 0.091 0.004 
231123 Haus3 -0.114 -0.070 0.052 0.001 0.004 
12834 Col6a2 -0.013 0.028 0.049 0.120 0.004 
93726 Ear11 -0.005 0.015 0.091 0.115 0.004 
66240 Kcne1l -0.014 0.013 0.044 0.116 0.004 
237847 Rtn4rl1 -0.006 0.068 0.111 0.126 0.004 
16005 Igfals -0.146 -0.114 -0.072 -0.020 0.004 
67103 Ptgr1 0.161 0.185 0.108 0.310 0.004 
71452 Ankrd40 -0.055 -0.031 0.050 0.062 0.004 
17534 Mrc2 -0.055 -0.009 0.017 0.076 0.004 
107173 Gpr137 -0.019 0.020 0.081 0.102 0.004 
73379 Dcbld2 -0.063 -0.018 0.005 0.066 0.004 
17909 Myo10 -0.006 0.028 0.117 0.108 0.004 
12579 Cdkn2b -0.091 -0.037 -0.068 0.048 0.004 
12827 Col4a2 -0.053 -0.021 0.021 0.068 0.004 
20419 Shcbp1 -0.051 -0.043 -0.011 0.068 0.003 
66531 2310061C15Rik -0.018 -0.013 0.051 0.094 0.003 
114601 Ehbp1l1 0.036 -0.002 0.110 0.132 0.003 
19362 Rad51ap1 -0.030 -0.018 -0.033 0.097 0.003 
19348 Kif20a -0.047 -0.021 0.022 0.070 0.003 
14265 Fmr1 0.034 0.026 0.105 0.139 0.003 
11749 Anxa6 0.000 0.018 0.066 0.115 0.003 
75939 4930579G24Rik -0.003 0.043 0.002 0.133 0.003 
235497 Leo1 0.041 0.065 0.110 0.157 0.003 
94187 Zfp423 -0.057 0.024 0.071 0.066 0.003 
239436 Aard 0.041 0.045 0.075 0.157 0.003 
16324 Inhbb 0.003 0.055 0.127 0.117 0.003 
107373 Fam111a -0.058 0.007 -0.026 0.078 0.003 
53886 Cdkl2 -0.013 0.026 0.054 0.107 0.003 
15460 Hr -0.017 0.029 0.153 0.085 0.003 
77772 Dcst1 -0.036 -0.003 0.004 0.087 0.003 
107995 Cdc20 0.044 -0.007 0.023 0.150 0.003 
210808 9030625A04Rik -0.048 -0.021 0.013 0.067 0.003 
20657 Sod3 -0.019 0.009 0.076 0.089 0.003 
17161 Maoa -0.063 -0.020 -0.096 0.075 0.003 
26876 Adh4 -0.041 -0.010 0.047 0.067 0.003 
70546 Zdhhc2 0.031 -0.001 0.106 0.121 0.003 
83554 Fstl3 0.030 0.027 0.146 0.122 0.003 
235587 Parp3 -0.061 -0.015 -0.002 0.057 0.003 
226143 Cyp2c44 -0.039 0.037 0.083 0.077 0.003 
381903 Alg8 -0.018 0.010 0.080 0.087 0.003 
67468 Mmd -0.042 -0.028 0.029 0.062 0.003 
56401 Lepre1 -0.087 -0.021 -0.019 0.036 0.003 
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67041 Oxct1 -0.057 -0.016 0.028 0.053 0.003 
75590 Dusp9 0.058 0.048 0.176 0.144 0.003 
234729 Vac14 -0.047 -0.045 -0.003 0.058 0.003 
67260 Lass4 -0.013 -0.003 0.017 0.097 0.003 
67087 Ctnnbip1 -0.031 0.011 0.100 0.069 0.003 
16403 Itga6 -0.027 -0.012 0.031 0.079 0.003 
212111 Inpp5a -0.044 -0.001 0.024 0.069 0.003 
14314 Fstl1 -0.015 -0.018 0.016 0.089 0.003 
67486 Polr3g -0.051 -0.024 0.020 0.055 0.003 
66427 Cyb5b -0.018 0.009 0.072 0.084 0.003 
56437 Rrad -0.025 0.020 0.040 0.088 0.003 
72759 Tmem135 -0.066 -0.029 0.018 0.040 0.003 
103733 Tubg1 -0.116 -0.058 -0.042 -0.002 0.003 
212898 Dse 0.009 0.043 -0.006 0.132 0.003 
76820 Fam49a -0.032 0.016 -0.027 0.091 0.003 
434077 Gm5578 -0.027 0.017 0.068 0.075 0.003 
217830 9030617O03Rik -0.068 -0.014 -0.002 0.043 0.003 
110542 Amhr2 -0.014 0.001 0.035 0.088 0.003 
80909 Gatsl2 0.016 0.032 0.080 0.114 0.003 
12615 Cenpa -0.027 0.004 0.016 0.080 0.003 
13004 Ncan -0.032 -0.014 0.069 0.059 0.003 
73569 Vgll3 0.149 0.156 0.175 0.251 0.003 
69573 2310016C08Rik 0.081 0.046 0.107 0.169 0.003 
70472 Atad2 -0.050 -0.038 0.032 0.043 0.003 
208624 Alg3 0.023 0.012 0.119 0.105 0.003 
72349 Dusp3 -0.022 -0.010 0.002 0.081 0.003 
63993 Slc5a7 0.011 0.010 0.089 0.099 0.003 
12826 Col4a1 -0.045 -0.010 -0.013 0.064 0.003 
72345 Fam123b -0.046 0.038 -0.015 0.079 0.003 
76477 Pcolce2 -0.029 0.004 0.026 0.075 0.003 
12822 Col18a1 0.011 0.078 0.050 0.129 0.003 
16181 Il1rn -0.020 0.002 0.154 0.055 0.003 
99730 Taf13 -0.003 0.026 0.030 0.102 0.003 
12523 Cd84 -0.103 -0.035 -0.078 0.017 0.003 
15945 Cxcl10 0.039 0.039 0.043 0.140 0.003 
21991 Tpi1 -0.030 0.008 0.043 0.070 0.003 
237253 Lrp11 0.012 0.022 0.026 0.114 0.003 
108116 Slco3a1 -0.001 0.019 0.034 0.100 0.003 
22031 Traf3 0.039 0.041 0.130 0.123 0.003 
19038 Ppic 0.000 0.027 0.060 0.097 0.003 
67196 Ube2t -0.014 0.004 -0.040 0.098 0.003 
68549 Sgol2 -0.020 0.008 0.023 0.081 0.003 
68177 Ebpl -0.057 0.016 -0.007 0.058 0.003 
14251 Flot1 -0.048 0.010 0.023 0.056 0.003 
72333 Palld 0.062 0.079 0.091 0.161 0.003 
232599 Gm4876 -0.015 -0.020 0.011 0.077 0.003 
14962 Cfb -0.007 -0.006 0.028 0.085 0.003 
104718 Ttc7b -0.006 -0.003 0.086 0.075 0.003 
108000 Cenpf -0.019 -0.018 0.031 0.070 0.003 
69094 Tmem160 -0.022 0.005 0.068 0.067 0.003 
66508 2400001E08Rik -0.035 0.023413 0.059 0.063 0.003 
72119 Tpx2 -0.027 -0.043 -0.014 0.063 0.003 
74241 Chpf -0.024 0.000 0.065 0.064 0.003 
17916 Myo1f -0.061 -0.021 -0.046 0.047 0.003 
211548 Nomo1 -0.043 -0.037 0.058 0.035 0.003 
67046 Tbc1d7 -0.002 0.055 0.087 0.095 0.003 
106795 Tcf19 -0.052 -0.034 -0.017 0.042 0.003 
12843 Col1a2 -0.025 0.012 0.018 0.075 0.003 
192193 Edem1 -0.004 0.000 0.048 0.082 0.003 
20716 Bptf -0.047 -0.017 0.002 0.048 0.003 
235043 Tmem205 -0.028 -0.001 0.041 0.062 0.003 
13605 Ect2 0.035 0.022 0.036 0.125 0.003 
380711 Rap1gap2 0.058 0.090 0.099 0.155 0.003 
232201 Arhgap25 -0.088 -0.038 -0.031 0.011 0.003 
67739 Slc48a1 -0.007 0.010 0.074 0.077 0.003 
13178 Dck 0.003 0.027 -0.041 0.114 0.003 
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17855 Mvk -0.074 -0.042 -0.002 0.016 0.003 
12038 Bche -0.113 -0.060 -0.073 -0.010 0.003 
20198 S100a4 -0.020 0.037 0.003 0.087 0.003 
27214 Dbf4 -0.038 -0.005 -0.081 0.075 0.003 
72709 C1qtnf6 -0.004 0.005 0.060 0.079 0.003 
23934 Ly6h -0.002 0.080 0.123 0.093 0.003 
216974 Proca1 -0.124 -0.100 -0.099 -0.029 0.003 
19360 Rad50 0.005 0.017 0.059 0.089 0.003 
27029 Sgsh -0.041 -0.059 -0.010 0.039 0.003 
17769 Mthfr 0.038 0.131 0.090 0.150 0.003 
74198 Dtx2 0.003 0.028 0.020 0.099 0.003 
217946 Cdca7l 0.000 -0.016 0.091 0.067 0.003 
109594 Lmo1 0.012 0.005 0.066 0.090 0.003 
330260 Pon2 -0.021 0.009 0.021 0.071 0.003 
211480 Kcnj14 0.005 -0.007 0.008 0.091 0.003 
72607 Usp13 -0.005 0.006 0.041 0.079 0.003 
16874 Lhx6 0.042 -0.020 0.047 0.110 0.003 
12772 Ccr2 -0.010 0.009 -0.056 0.095 0.003 
21672 Adamts2 -0.039 -0.001 -0.034 0.063 0.003 
68043 N6amt2 -0.001 0.032 0.055 0.088 0.003 
20878 Aurka -0.003 -0.016 0.031 0.075 0.003 
12833 Col6a1 0.015 0.039 0.058 0.103 0.003 
72017 Cyb5r1 0.015 0.030 0.068 0.098 0.003 
50909 C1ra -0.031 -0.040 -0.141 -0.102 -0.003 
16497 Kcnab1 -0.002 -0.034 -0.105 -0.081 -0.003 
23808 Ash2l -0.002 -0.020 -0.048 -0.088 -0.003 
56072 Lgals12 -0.098 -0.109 -0.157 -0.180 -0.003 
66599 Rdm1 0.020 0.022 -0.040 -0.058 -0.003 
19152 Prtn3 -0.115 -0.017 -0.229 -0.150 -0.003 
269473 Lrig2 0.037 0.021 -0.035 -0.046 -0.003 
14782 Gsr -0.005 -0.015 -0.048 -0.093 -0.003 
212073 4831426I19Rik -0.181 -0.258 -0.255 -0.284 -0.003 
232236 C130022K22Rik -0.060 -0.086 -0.140 -0.145 -0.003 
13982 Esr1 -0.026 -0.033 -0.068 -0.114 -0.003 
212943 Fam46a -0.141 -0.101 -0.157 -0.219 -0.003 
329470 Accs -0.028 -0.009 -0.088 -0.104 -0.003 
270110 Irf2bp2 0.021 -0.074 -0.056 -0.090 -0.003 
59014 Rrs1 -0.008 -0.026 -0.068 -0.098 -0.003 
320299 Iqcb1 0.011 0.000 -0.085 -0.069 -0.003 
22361 Vnn1 0.120 0.028 0.023 0.013 -0.003 
235441 Usp3 0.024 0.035 -0.069 -0.050 -0.003 
234564 AU018778 -0.069 -0.088 -0.194 -0.147 -0.003 
66869 Zfp869 0.055 0.045 -0.030 -0.028 -0.003 
75750 Slc10a6 -0.134 -0.094 -0.204 -0.203 -0.003 
235050 Zfp810 -0.024 -0.028 -0.148 -0.098 -0.003 
12552 Cdh11 0.047 0.054 -0.088 -0.022 -0.003 
218820 Zfp503 0.015 0.022 -0.131 -0.052 -0.003 
217082 Hlf -0.052 -0.036 -0.092 -0.137 -0.003 
13019 Ctf1 -0.026 -0.032 -0.058 -0.120 -0.003 
93834 Peli2 -0.013 -0.049 -0.106 -0.105 -0.003 
53320 Folh1 0.255 0.198 0.234 0.141 -0.003 
67866 Wfdc1 0.020 0.017 -0.028 -0.071 -0.003 
20568 Slpi -0.049 -0.079 -0.149 -0.139 -0.003 
16601 Klf9 -0.161 -0.102 -0.250 -0.224 -0.003 
21422 Tcfcp2 0.066 0.033 -0.015 -0.030 -0.003 
106042 Prickle1 0.042 0.006 -0.056 -0.052 -0.003 
99887 Tmem56 0.055 0.119 -0.015 -0.011 -0.003 
73451 Zfp763 0.029 0.030 -0.044 -0.058 -0.003 
213393 8430408G22Rik -0.284 -0.192 -0.279 -0.357 -0.003 
242608 Podn -0.066 -0.067 -0.152 -0.152 -0.003 
12298 Cacnb4 0.051 0.032 0.004 -0.048 -0.003 
225372 Apbb3 -0.056 -0.045 -0.107 -0.145 -0.003 
270035 Letm2 -0.014 -0.023 -0.098 -0.104 -0.003 
106821 AI314976 0.054 0.012 -0.033 -0.047 -0.003 
78329 2310010J17Rik 0.010 -0.036 -0.097 -0.088 -0.003 
20563 Slit2 0.038 0.050 -0.033 -0.048 -0.003 
13078 Cyp1b1 0.094 0.108 -0.009 0.015 -0.003 
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75705 Eif4b 0.018 0.011 -0.001 -0.086 -0.003 
19260 Ptpn22 0.215 0.078 0.174 0.073 -0.003 
65099 Irak1bp1 -0.036 -0.033 -0.108 -0.126 -0.003 
56448 Cyp2d22 -0.106 -0.050 -0.147 -0.184 -0.003 
66966 Trit1 -0.123 -0.132 -0.180 -0.220 -0.003 
107227 Macrod1 -0.033 -0.013 -0.067 -0.125 -0.003 
75909 Tmem49 -0.046 -0.040 -0.086 -0.142 -0.003 
320405 Cadps2 -0.055 -0.029 -0.076 -0.149 -0.003 
66277 Klf15 -0.147 -0.145 -0.235 -0.235 -0.003 
434234 2610020H08Rik -0.118 -0.149 -0.243 -0.210 -0.003 
16169 Il15ra -0.067 -0.102 -0.151 -0.169 -0.003 
11622 Ahr 0.011 0.014 -0.069 -0.081 -0.003 
18626 Per1 -0.179 -0.175 -0.172 -0.288 -0.003 
100647 Upk3b -0.034 -0.092 -0.214 -0.126 -0.003 
230903 Fbxo44 0.015 -0.001 -0.047 -0.087 -0.003 
76454 Fbxo31 -0.129 -0.061 -0.223 -0.197 -0.003 
16392 Isl1 0.002 -0.091 -0.229 -0.092 -0.003 
20377 Sfrp1 0.092 0.108 0.027 0.001 -0.003 
66300 Prr24 0.052 0.038 0.007 -0.053 -0.003 
230751 Oscp1 -0.108 -0.095 -0.158 -0.203 -0.003 
665033 Gm7455 0.013 0.045 -0.124 -0.061 -0.003 
104582 Rprml -0.045 -0.079 -0.058 -0.165 -0.003 
78892 Crispld2 0.015 0.042 -0.066 -0.071 -0.003 
268417 Zkscan17 -0.070 -0.051 -0.120 -0.167 -0.003 
12808 Cobl 0.067 0.043 0.015 -0.045 -0.003 
20442 St3gal1 -0.082 -0.135 -0.228 -0.185 -0.003 
18595 Pdgfra 0.041 0.034 -0.040 -0.061 -0.003 
20512 Slc1a3 -0.087 -0.115 -0.213 -0.186 -0.003 
12870 Cp -0.014 -0.050 -0.057 -0.132 -0.003 
18619 Penk 0.033 0.048 -0.029 -0.065 -0.003 
68695 Hddc3 -0.009 -0.058 -0.108 -0.121 -0.003 
93737 Pard6g -0.157 -0.129 -0.236 -0.248 -0.003 
272428 Acsm5 -0.175 -0.162 -0.284 -0.265 -0.003 
14313 Fst 0.014 -0.004 -0.095 -0.087 -0.003 
13488 Drd1a -0.076 -0.038 -0.214 -0.153 -0.003 
74080 Nmnat3 -0.070 -0.064 -0.160 -0.169 -0.003 
101488 Slco2b1 -0.089 -0.076 -0.170 -0.189 -0.003 
244421 Lonrf1 -0.021 -0.038 -0.050 -0.141 -0.003 
74155 Errfi1 -0.072 -0.043 -0.104 -0.177 -0.003 
16548 Khk 0.057 0.080 0.025 -0.051 -0.003 
13170 Dbp -0.147 -0.155 -0.160 -0.270 -0.003 
77739 Adamtsl1 0.031 0.086 -0.099 -0.048 -0.003 
216505 Pik3ip1 -0.013 -0.046 -0.142 -0.124 -0.004 
109828 C7 0.038 0.099 -0.044 -0.052 -0.004 
14190 Fgl2 0.062 0.076 -0.109 -0.027 -0.004 
70503 Ddo -0.027 -0.094 -0.037 -0.176 -0.004 
15483 Hsd11b1 -0.064 -0.054 -0.137 -0.176 -0.004 
67378 Bbs2 0.051 0.016 -0.011 -0.078 -0.004 
14872 Gstt2 -0.031 -0.041 -0.093 -0.152 -0.004 
192199 Rspo1 0.036 0.012 -0.069 -0.081 -0.004 
214804 Syde2 -0.095 -0.089 -0.198 -0.203 -0.004 
67225 Rnpc3 0.006 0.020 -0.094 -0.101 -0.004 
328330 D130037M23Rik 0.057 0.033 -0.062 -0.059 -0.004 
68939 Rasl11b 0.014 -0.044 -0.103 -0.114 -0.004 
67017 2010011I20Rik -0.022 -0.068 -0.116 -0.151 -0.004 
18604 Pdk2 0.010 -0.049 -0.046 -0.131 -0.004 
14264 Fmod 0.057 0.044 0.004 -0.070 -0.004 
69219 Ddah1 0.313 0.222 0.268 0.159 -0.004 
11555 Adrb2 -0.271 -0.194 -0.381 -0.357 -0.004 
22117 Tst -0.177 -0.100 -0.267 -0.267 -0.004 
12173 Bnc1 -0.002 -0.060 -0.249 -0.106 -0.004 
12263 C2 -0.032 -0.017 -0.150 -0.139 -0.004 
53883 Celsr2 -0.029 -0.027 -0.050 -0.161 -0.004 
12873 Cpa3 0.008 0.039 -0.193 -0.080 -0.004 
67158 Sft2d3 0.063 0.008 -0.058 -0.070 -0.004 
22339 Vegfa -0.060 -0.048 -0.120 -0.183 -0.004 
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20860 Rsrc2 0.053 0.043 -0.078 -0.065 -0.004 
22268 Upk1b -0.002 -0.065 -0.091 -0.146 -0.004 
99586 Dpyd 0.049 -0.014 -0.088 -0.086 -0.004 
107986 Ddb2 -0.007 0.000 -0.042 -0.140 -0.004 
16431 Itm2a 0.013 0.035 -0.102 -0.099 -0.004 
235281 Scn3b 0.000 -0.066 -0.159 -0.134 -0.004 
100042332 2810410L24Rik 0.003 -0.050 -0.136 -0.131 -0.004 
73712 Dmkn 0.097 0.032 0.045 -0.062 -0.004 
74051 Steap2 -0.027 0.047 -0.114 -0.134 -0.004 
16364 Irf4 -0.249 -0.206 -0.305 -0.375 -0.004 
78787 Usp54 0.009 -0.016 -0.114 -0.129 -0.004 
320398 Lrig3 -0.096 -0.082 -0.185 -0.230 -0.004 
19041 Ppl -0.004 -0.022 -0.113 -0.147 -0.004 
229599 Gm129 -0.181 -0.239 -0.229 -0.352 -0.005 
83673 Snhg1 -0.004 -0.039 -0.083 -0.162 -0.005 
17227 Mcpt4 0.075 0.108 -0.119 -0.038 -0.005 
51795 Srpx -0.061 -0.013 -0.186 -0.183 -0.005 
72655 2810026P18Rik -0.024 -0.036 -0.201 -0.157 -0.005 
71985 Acad10 -0.031 -0.038 -0.144 -0.175 -0.005 
16918 Mycl1 -0.136 -0.191 -0.258 -0.296 -0.005 
67298 Gprasp1 0.125 0.067 0.019 -0.043 -0.005 
66528 2210020M01Rik 0.068 0.086 0.004 -0.085 -0.005 
12475 Cd14 -0.111 -0.077 -0.238 -0.246 -0.005 
73246 Rassf6 -0.110 -0.088 -0.218 -0.255 -0.005 
26938 St6galnac5 -0.091 -0.102 -0.247 -0.239 -0.005 
103172 Chchd10 -0.048 -0.138 -0.165 -0.235 -0.005 
13107 Cyp2f2 -0.138 -0.095 -0.352 -0.270 -0.005 
58909 Fam13a -0.106 -0.164 -0.277 -0.282 -0.005 
14778 Gpx3 0.055 0.030 -0.049 -0.124 -0.005 
69065 Chac1 -0.084 -0.205 -0.214 -0.295 -0.006 
72401 Slc43a1 -0.191 -0.184 -0.343 -0.365 -0.006 
330064 Slc5a6 -0.206 -0.260 -0.293 -0.423 -0.006 
19885 Rorc -0.015 -0.072 -0.133 -0.241 -0.006 
20893 Bhlhe40 0.021 -0.079 -0.093 -0.231 -0.007 
20216 Acsm3 -0.091 -0.118 -0.312 -0.325 -0.008 
19735 Rgs2 -0.217 -0.051 -0.386 -0.423 -0.008 
23893 Grem2 0.037 0.027 -0.293 -0.236 -0.009 
12700 Cish -0.038 -0.098 -0.234 -0.454 -0.012 
Integrative multivariate modeling of the relationships between gene expression in white adipose 
tissue and liver during the development of obesity in mice 
 
 
 
116 
 
Table S4: Loadings of the PLS path model for time and dose dependent genes in 
liver and WAT. 
Liver WAT* 
Entrez ID Loadings Entrez ID Loadings Entrez ID Loadings Entrez ID Loadings 
110794 Cebpe 0.83 67246 
2810474O19Ri
k 
-0.45 20317 Serpinf1 0.93 19152 Prtn3 -0.26 
68680 Fitm1 0.82 74315 Rnf145 -0.47 16846 Lep 0.91 17227 Mcpt4 -0.26 
67441 Isoc2b 0.80 170439 Elovl6 -0.53 12834 Col6a2 0.91 12873 Cpa3 -0.26 
217830 9030617O03Rik 0.80 77596 Gpr110 -0.53 66107 1100001G20Rik 0.90 73712 Dmkn -0.26 
50914 Olig1 0.78 545487 Gm14439 -0.54 13476 Reep5 0.90 50909 C1ra -0.32 
67705 1810058I24Rik 0.77 69065 Chac1 -0.56 17294 Mest 0.89 14313 Fst -0.37 
16912 Psmb9 0.77 66968 Plin5 -0.57 14168 Fgf13 0.89 22339 Vegfa -0.43 
226527 BC026585 0.76 268822 Adck5 -0.58 12833 Col6a1 0.88 12263 C2 -0.48 
74088 0610012H03Rik 0.75 75710 Rbm12 -0.58 
23513
5 
Tmem45b 0.86 56072 Lgals12 -0.50 
67013 Oma1 0.74 100559 Ugt2b38 -0.58 12831 Col5a1 0.86 109828 C7 -0.54 
19016 Pparg 0.74 13211 Dhx9 -0.58 70083 Metrn 0.85 18619 Penk -0.55 
66401 Nudt2 0.74 22234 Ugcg -0.59 76477 Pcolce2 0.84 20563 Slit2 -0.56 
77996 D730039F16Rik 0.73 12527 Cd9 -0.60 14962 Cfb 0.84 14264 Fmod -0.58 
11537 Cfd 0.72 432508 Cpsf6 -0.60 12827 Col4a2 0.84 230751 Oscp1 -0.58 
380712 Tlcd2 0.69 321018 Serpina4-ps1 -0.61 53867 Col5a3 0.83 14190 Fgl2 -0.61 
16348 Invs 0.68 20501 Slc16a1 -0.63 12835 Col6a3 0.82 14778 Gpx3 -0.65 
17855 Mvk 0.67 232087 Mat2a -0.68 80752 Fam20c 0.82 67866 Wfdc1 -0.66 
20194 S100a10 0.63 78889 Wsb1 -0.72 83554 Fstl3 0.81 77739 Adamtsl1 -0.67 
67046 Tbc1d7 0.63 320204 4833442J19Rik -0.75 
11684
7 
Prelp 0.80 23893 Grem2 -0.73 
70291 2510049J12Rik 0.62 
   
12832 Col5a2 0.80 12870 Cp -0.78 
11302 Aatk 0.61 
   
12822 Col18a1 0.80 320299 Iqcb1 -0.80 
103140 Gstt3 0.60 
   
20296 Ccl2 0.80 67017 2010011I20Rik -0.80 
53901 Rcan2 0.59 
   
67717 Lipf 0.80 13019 Ctf1 -0.80 
110789 Gpr98 0.58 
   
17381 Mmp12 0.79 
   
13009 Csrp3 0.57 
   
12819 Col15a1 0.78 
   
105892 9030619P08Rik 0.56 
   
12843 Col1a2 0.78 
   
11761 Aox1 0.54 
   
12826 Col4a1 0.77 
   
15957 Ifit1 0.54 
   
14118 Fbn1 0.76 
   
237553 Trhde 0.51 
   
16005 Igfals 0.76 
   
216551 1110067D22Rik 0.51 
   
20657 Sod3 0.76 
   
56219 Extl1 0.51 
   
21857 Timp1 0.75 
   
68043 N6amt2 0.48 
   
16948 Lox 0.73 
   
80860 Ghdc 0.45 
   
11007
5 
Bmp3 0.73 
   
70028 Dopey2 0.43 
   
14314 Fstl1 0.72 
   
      
18405 Orm1 0.71 
   
      
21672 Adamts2 0.70 
   
      
13004 Ncan 0.70 
   
      
72713 Angptl1 0.66 
   
      
16181 Il1rn 0.65 
   
      
16324 Inhbb 0.65 
   
      
76905 Lrg1 0.64 
   
      
22403 Wisp2 0.62 
   
      
20210 Saa3 0.59 
   
      
72832 Crtac1 0.56 
   
      
15945 Cxcl10 0.51 
   
      
69071 Tmem97 0.35 
   
*For WAT  dose-time dependent genes were categorized and only genes encoding secreted proteins were analyzed. 
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Carbohydrate, protein and fat are the major nutritional components of living 
beings and these are the major metabolic fuel sources for the body. If the intake 
of metabolic fuels is greater than energy expenditure, the surplus is stored, largely 
as triacylglycerol in adipose tissue followed by in liver, leading to the development 
of obesity and its associated diseases. The products of the digestion and 
absorption of these carbohydrate, protein and fat are mainly glucose, amino 
acids, and fatty acids and mono-acyl glycerol respectively. All the products are 
metabolized to a common product, acetyl-CoA, which is oxidized by the citric acid 
cycle. Fatty acids are the major substrate. In this thesis we only focused on fat and 
its function in liver, small intestine and white adipose tissue over time as well as 
on their integration. To do these, we performed intervention studies with diets 
differing in the amount of fat, and also used a synthetic ligand (WY14643) to 
specifically activate the peroxisome proliferator-activated receptor alpha (PPAR) 
[17,139,140,241-243]. PPARα is a ligand activated transcription factor with diverse 
function and is activated by several synthetic compounds [7,9,13,18,143]. High 
affinity natural ligands include eicosanoids, unsaturated as well as long-chain fatty 
acids, and their activated derivatives (acyl-CoA esters) [161,162,164,166]. 
Moreover, it has been demonstrated that PPARα is the major regulator of the 
effects of dietary fatty acids on gene expression in liver [166]. Since early 1990s, 
when PPARα was discovered, its function has been studied broadly [12]. Several 
studies have been performed as well in last two decades; however such studies 
haven’t been performed to integrate the function of PPARα in different organs 
over time by a nutritional systems biological (NSB) approach. Therefore in this 
study we aimed to integrate different transcriptomics data by NSB approach, 
especially to characterize the function of PPARα in different organs. NSB is the 
integrated approach for studying phenotypic variation and constructs prevalent 
models of cellular organization and function [6,46]. It also seeks to uncover how 
nutrition influences metabolic pathways and homeostasis [89].  
 
Systems biology is a holistic approach that combines the knowledge of the 
different disciplines, such as biology, computer science, mathematics, statistics, 
physics and bioinformatics. Several methods and tools have already been 
developed to analyze and integrate high throughput omics data, the so-called top-
down systems biology and model driven analysis, the so-called bottom-up 
systems biology. In chapter 1 we reported an overview of systems biology and 
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discussed several statistical analytical approaches and software tools. Statistical 
tools are the most important to analyze all kinds of data. Depending on the data, 
design and research questions of the study, different statistical tools can be 
applied. Therefore, it’s very essential to apply proper statistical tools and 
approaches in the proper design of the study. Whole genome microarray 
experiments are an essential part in genomics studies [129] and it produces 
thousands of gene expression in different experimental conditions. Many 
statistical tests and methods have been proposed for analyzing such data. Most 
tests are based on pairwise comparisons, however, the analysis of microarrays 
involves the testing of multiple hypotheses within one study, and it is usually 
known that one should control for false positives. Generally, a frequently used 
technique named is false discovery rate (FDR). However, the use of the FDR may 
be inconsistent and misleading interpretation of the comparisons across different 
experiments, especially when the effect sizes of the experiments vary 
dramatically, for instance, the case when comparing effects of potent agonists in 
wild type and transcription factor knockout models [142]. Therefore, we proposed 
an integrated statistical approach to identify transcription factor target genes 
from transcriptomics experiments by testing and integrating three hypotheses 
(contrasts) in cell means model of ANOVA (chapter 2). The three contrasts are 
based on the effect of a treatment in wild type, gene knockout, and globally over 
all experimental groups. We illustrated our approach  using one of our datasets on 
the mouse [15] that focused on the identification of target genes and biological 
processes governed by the fatty acid sensing transcription factor PPARα in liver, 
however our approach is also applicable to experiments with similar kind of 
design. The advantage of our method is that it properly adjusts for multiple 
testing while integrating data from two experiments, and it is driven by biological 
inference.  
 
Integration is the key term in nutritional systems biology. Usually, fatty acids 
resulting from the dietary fat or synthetic ligand in small intestine are absorbed 
via the lymphatic system or directly through the hepatic portal vein. Fatty acids 
may be oxidized to acetyl-CoA (-oxidation) or esterified with glycerol, forming 
triacylglycerol in the liver which is stored in adipose tissue as the body’s main fuel 
reserve. This shows that there is a clear link between small intestine and liver. To 
uncover nutritional systems biology of fat in mouse liver and small intestine, we 
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integrated transcriptomics data of PPAR activation in mouse liver and small 
intestine at the pathway level (chapter 3). To do this, we used WY14643 treated 
wild type and knock out microarray experimental data at 6h and 120h in mouse 
liver and small intestine [15,139,166,173]. At first, we developed an approach to 
collect array-wise pathway activity level by principal component analysis (PCA). 
PCA is able to reduce the dimension to create orthogonal components from the 
correlated genes. As we know in nature genes are correlated of each other, 
therefore to adjust their relationship is important to analyze the data in the 
pathway level. Since first principal component (PC) contains the most of the 
information of the data, therefore, we considered PC1 score as the pathway 
activity level or pathway score. We also developed the R code to automate the 
pathway score. If one has the list of pathway with gene names, then adjusting the 
corrected input files, it’s very convenient to automate the calculation of pathway 
scores. We assumed that if any pathway is positively associated with a reference 
gene set, in our case known PPARα target genes, then it is considered an activated 
pathway of PPARα and if negatively associated with the reference gene set then 
it’s a suppressed pathway. To find out the association we used Spearman 
correlation coefficients. We found that more pathways were regulated in liver 
than in small intestine. Afterwards, we visualized the overlapping pathways from 
the 6h (early) and 120h (late) time points experiments in mouse liver and small 
intestine to observe the temporal effects of PPAR activation. Finally, a partial 
least squares path model (PLSPM) was analyzed to identify how regulation at late 
time points was influenced by the early regulated pathways, and what the 
importance of organ cross talk might be. We show that our approach enabled the 
identification of PPARα dependent pathways as well as the type of regulation in 
mouse liver and small intestine, and that acutely induced pathways are the main 
drivers for regulation of pathways after long-term activation. 
 
The partial least squares (PLS) method was originally developed by [32,33] and 
was used to analyze multivariate data in chemometrics, econometrics and 
sociological fields. Recently, it has also been widely used in high-throughput 
genomics data as a versatile tool [36,37]. However, the PLS approach can’t handle 
multi block datasets. Therefore, PLS-path model (PLSPM) was developed by 
[31,34]. The PLSPM is an extension of PLS to handle multi block datasets to 
elucidate the causal relation among the different groups of data that includes 
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existing/prior knowledge. It is an alternate approach of structural equation 
modeling with maximum likelihood (SEM-ML) [35]. The PLSPM is also known as 
soft modeling because it doesn’t depend on any distributional pattern and doesn’t 
need more cases than variables. It is also robust against misspecification and 
multicollinearity problems. On the other hand, SEM-ML is known as hard 
modeling because it depends on distributional pattern and needs more cases than 
variables [34]. Recently, PLSPM has been used by [38] in their genome wide 
association study. Since in general the omics data are noisy and less number of 
cases than variables, therefore, PLSPM (soft modeling) can be used as a suitable 
approach for integrating and modeling multi-blocks datasets in top-down systems 
biology. To the best of our knowledge we are one of the first to apply PLSPM to 
integrate and deduce causal relationships from transcriptomics datasets based on 
existing knowledge. 
 
Time-series microarrays experiments are essential to biologists for interpreting 
the nature of biological systems over time to several research groups [208,213]. 
The change in expression patterns over time provides profound information 
instead of just observing at the terminal points of one or two time points [212]. 
Although many studies have been performed on PPARα regulation using 
transcriptome analysis, most of them incorporate only a single measurement in 
time, which often is in the order of days [139]. No study has been performed 
using early time points in hepatocytes to identify the kinetics of PPARα activation 
on target genes. This is of particular relevance for nutrition, since the natural 
activators of PPARα are rapidly metabolized. As a result, it can be envisioned that 
only for a limited time the concentrations of these agonists are sufficiently high 
levels. In other words, nutritional ligands are only briefly able to activate PPARα 
mediated gene expression. It is therefore of relevance to investigate the short-
term effects of PPARα activation in a time series experiment. We therefore aimed 
in this study to characterize the genome-wide effects of acute PPARα activation 
by detecting similar behaving genes, and analyze their biological functions, gene 
interaction network and transcription factor binding sites at early stage (chapter 
4). Overall, the results reveal that PPARα regulates a several profiles of genes over 
time in rat hepatocytes and most of the potential genes behave a quadratic 
model. Furthermore, several common transcription factors (TFs) were also 
predicted to bind together with PPARα, for instance: RXR, NR2F, EREF and CREB. 
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Finally we showed the expansion of the gene interaction networks over time. 
Taken together, our study contributed important advancement in our 
understanding of PPARα function for nutrition in hepatocytes. 
 
Besides in liver and small intestine, lipids also play an important role in white 
adipose tissue (WAT). It has been suggested that obesity starts to cause metabolic 
problems only when WAT cannot fully meet demands for additional storage of 
lipids, which may contribute to the etiology of nonalcoholic fatty liver disease 
(NAFLD) [2,4,5]. This indicates that there is a clear link between WAT and liver or 
other organ where extra fat can store resulting obesity and its associated 
diseases, also called lipotoxicity [225]. Using the concept of integration in top-
down systems biology, we used gene expression data from liver and WAT of mice 
that were subjected to diet-induced obesity. This data was integrated with data 
on plasma factors and weight status indicators (chapter 5). We identified sets of 
time- and dose-dependently induced genes in liver and WAT, and more genes 
were found to be regulated in WAT than in liver. We observed that most of the 
identified genes in liver involved in lipid metabolism, development of connective 
tissue, steatohepatitis, and liver fibroses, all processes known to be associated 
with the development and progression of hepatic steatosis. Likewise, genes 
identified in WAT were associated with increased cell proliferation, inflammation 
and fibrosis. Analysis by PLSPM showed that plasma factors (Leptin, Insulin, 
Glucose and Resistin) and the potential secreted proteins by WAT, such as leptin, 
Serpinf1, Mest, and Fgf13 etc. may regulate the gene expression in liver. The 
model also revealed that the potential set of genes from WAT that may predict 
around 50% of liver gene expression profile. Overall, the findings of this study give 
new insights on the role of WAT during the development of obesity and its effects 
on liver. 
Taken together, we conclude that our developed approaches reported in this 
thesis are useful alternative ways to analyze multivariate transcriptomics datasets. 
When implemented in easy accessible analysis platform, such as MADMAX [231], 
this will promote the use of the developed approaches.  
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Summary 
 
 
Several metabolic disorders including visceral obesity, insulin resistance, 
hypertension and dyslipidaemia, which increase the risk of cardiovascular diseases 
and diabetes are the main problems in the developed countries and are rising 
ones in the developing countries. These metabolic diseases are often associated 
with excess fat in the body. Nutritional systems biology of fat and fatty acids can 
enable the investigation of the relationship between genes and nutrients by 
integrating the organs and time specific data. One of the nuclear receptor super 
families, peroxisome proliferator activated receptors (PPARs), plays an important 
role in sensing nutrients and facilitating their effects on gene expression. PPARα is 
one of them and it is an important transcription factor which is activated by free 
fatty acids and their derivatives. It is mainly involved in the regulation of lipid 
metabolism and storage as well as regulation of inflammation and immunity. 
Therefore it is highly interesting to identify the effect of fat via PPARα by 
developing proper statistical tools and nutritional systems biological approaches. 
Nutritional systems biology is a new biological research field where several 
biological levels are monitored by several ways. The aim of nutritional systems 
biology is to discover biological systems where the components work together 
and they are connected to one another within an organ and between organs. The 
components can be genes or set of genes or organs. It is essential to detect the 
proper transcription factor target genes by combining activation experiments 
performed in wild type and knockout mice. It is reported that most tests are 
based on pairwise comparisons in separate experiments and therefore adjusting 
the false discovery rate may interpret incorrectly because of a huge different in 
the effect sizes across experiments. Therefore, at first we aimed to develop an 
integrated statistical approach in chapter 2. We conclude that our integrated 
statistical approach successfully detect the transcription factor target genes with 
correcting for the multiple testing problem. 
Analysis of gene expression data at the level of pathways is an important 
approach to unravel the biological function that is hidden in high throughput 
transcriptomics studies. We therefore developed a strategy to calculate pathway 
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activity level per arrays (chapter 3). Moreover, this data was used to study 
relationships between acute and long-term effects of PPARα activation in 
intestine and liver. We found that PPARα played a more important role in liver 
than in intestine, and that acutely induced pathways are the main drivers for 
regulation of pathways after long-term activation.  
It is also relevant to uncover the evolution of gene expression and their function 
after acute PPARα activation. Several studies have been performed to see the 
effect of treatment with the highly-specific PPARα agonist WY14643 after 
relatively long time, but no study has been performed at earlier stages to detect 
the direct effects of PPARα activation. Therefore, we conducted an experiment 
using rat hepatocytes cell cultured at 5 early time points (0, 1, 2, 3, and 4h) to 
identify the direct effect of WY14643 in chapter 4. We found that most of the 
acutely regulated genes were involved in lipid metabolism and they followed a 
quadratic pattern over time. We also found that transcription factors NR2F, CREB, 
EREF and RXR were closely bound with PERO in the genes involved in lipid 
metabolism process and these TFs may be bound with PPARα. The results also 
revealed that the gene interaction networks were expanded over time. Taken 
together the time course study provides different sets of similar behaving genes 
with their potential common transcription factors with PPARα. 
It is well known that excess dietary fat is stored in adipose tissue, but it has been 
suggested that this storage capacity is limited. Subsequently, adipose tissue 
failure or dysfunction may drive progression of hepatic steatosis toward non-
alcoholic steatohepatitis (NAFLD). However, knowledge on the functional link 
between adipose tissue dysfunction and NAFLD is currently limited. Therefore, in 
chapter 5 we aimed to find out the relationships between gene expression in liver 
and white adipose tissue (WAT), weight status as well as different plasma factors 
in terms of the time and dose dependent effects of dietary fat during the 
development of obesity in C57BL/6J mice by developing a partial least squares- 
path model (PLSPM). We found that the exchange of carbohydrate for fat in the 
diet induces major changes in gene expression in both liver and WAT. Our analysis 
identified a set of potential signaling proteins secreted from WAT that may induce 
metabolic changes in liver, thereby contributing to the pathogenesis of obesity. 
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Taken together, our studies have further detailed the role of dietary fat on the 
transcriptome in small intestine, liver and white adipose tissue. To identify the 
detailed effects of dietary fat at the level of a whole organism, additional studies 
are required that integrate transcriptomics, proteomics, metabolomics datasets 
and phenotypes over time. The works of this thesis provide new approaches to 
integrate multiple datasets related to lipid homeostasis. 
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Samenvatting 
 
Verschillende metabole afwijkingen, zoals overgewicht, insulineongevoeligheid, 
hoge bloeddruk en dyslipidemie, verhogen het risico op hart- en vaatziekten en 
diabetes; komen steeds vaker voor in zowel de westerse samenleving alsook in 
ontwikkelingslanden. Genoemde metabole ziekten zijn vaak geassocieerd met de 
aanwezigheid van overtollig vet in het lichaam. Systeembiologie is de wetenschap 
die biologische systemen als geheel bestudeerd en heeft als primair doel het 
kwantitatief achterhalen hoe moleculen, cellen en organen samenwerken om 
biologische processen te laten verlopen. Door de vooruitgang in de ‘omics’ 
disciplines komen steeds meer gegevens beschikbaar die geïntegreerd zullen 
worden in voorspellende modellen. In dit proefschrift worden systeembiologische 
benaderingen beschreven die als uiteindelijk doel hebben om de tijdsafhankelijke 
relatie tussen voeding, activiteit van genen in weefsels en fysiologische 
parameters te integreren. Dit heet nutritionele systeembiologie. In dit proefschrift 
hebben we ons gericht op de effecten van vet en vetzuren uit de voeding op de 
dunne darm en lever met speciale aandacht voor de rol van de transcriptiefactor 
PPAR hierin. Hiertoe zijn voedingsstudies uitgevoerd met gewone muizen (wild 
type muizen) en muizen die geen functioneel PPAR hebben (PPAR knockout 
muizen), waarna de activiteit van alle 20.000 genen in de darm en de lever 
bepaald is met behulp van microarrays. Deze gegevens zijn vervolgens 
geïntegreerd met resultaten van andere kwantitatieve metingen door gebruik te 
maken van voorspellende multivariate statistische modellen. 
Het is essentieel om op de juiste manier relevante genen te identificeren in grote 
datasets. Daartoe is onder andere de waarde van de zgn. false discovery rate 
(FDR) van belang. Deze FDR geeft aan wat de kans is dat er een vals-positief 
resultaat is opgepikt tijdens het analyseren van genexpressie data. Een 
veelgebruikte benadering om doelgenen van transcriptiefactoren te vinden is het 
vergelijken van genexpressieprofielen tussen wild type en knockout muizen voor 
en na activatie. Echter, de meeste statistische benaderingen die hiervoor gebruikt 
worden zijn gebaseerd op het combineren van resultaten uit paarsgewijze 
vergelijkingen van separate experimenten. Omdat de grootte van het effect van 
een behandeling per definitie verschilt tussen wild type en knockout muizen, is 
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het gebruik van de FDR als selectiecriterium voor paarsgewijze vergelijkingen niet 
geschikt. In hoofdstuk 2 stelden we een geïntegreerde benadering voor om 
relevante genen op biologisch alsook statistisch juiste manier te identificeren. Met 
behulp van gegevens van wild type en PPAR knockout muizen lieten we 
vervolgens zien dat onze geïntegreerde statistische benadering met succes juiste 
PPAR doelgenen detecteert waarbij ook wordt gecorrigeerd voor de kans op het 
includeren van vals positieven.  
Analyse van genexpressie data op het niveau van metabole en signaaltransductie 
routes is een veelgebruikte en gevoelige manier om functionele informatie die in 
genexpressieprofielen verborgen is te ontrafelen. We hebben daarom een 
strategie ontwikkeld om per array de activiteit van deze metabole en 
signaaltransductie routes te kunnen berekenen (hoofdstuk 3). Deze resultaten zijn 
verder gebruikt om relaties tussen acute (6 uur) en lange termijn (5 dagen) 
effecten van PPARα-stimulatie in de darmen en de lever te bestuderen. Wij 
vonden dat PPARα een belangrijkere rol in de lever speelde dan in de darmen. Na 
toepassing van ‘partial least squares- path modeling’ (PLSPM) vonden we dat 
acuut geactiveerde metabole en signaaltransductie routes de belangrijkste 
aanstuurders waren voor de activiteit van deze routes na langdurige stimulatie.  
Om een zo compleet mogelijk inzicht te krijgen in de rol van PPAR is het ook van 
belang om de ontwikkeling van genexpressie en hun corresponderende functie te 
ontdekken na een acute stimulatie van PPARα. Hoewel er diverse studies zijn 
gepubliceerd die het effect van behandeling met de specifieke PPARα agonist 
WY14643 na relatief lange tijd bestuderen, zijn er tot nu toe geen studies 
uitgevoerd die de directe, acute effecten van PPARα stimulatie analyseerden. 
Daarom hebben we in een experiment ratten hepatocyten gekweekt en hebben 
we na 5 vroege tijdstippen (0, 1, 2, 3 en 4 uur) na stimulatie met WY14643 
genexpressieprofielen verzameld om de directe PPAR stimulatie te bestuderen. 
Deze studie staat beschreven in hoofdstuk 4. Wij vonden dat het merendeel van 
de acuut geïnduceerde genen betrokken waren bij het metabolisme van vetten, 
en dat de expressieprofielen van deze genen een kwadratische patroon volgden in 
de tijd. Ook identificeerden we diverse transcriptiefactoren, zoals NRF2, CREB, 
EREF en RXR, die waarschijnlijk een rol speelden bij de acute inductie van genen 
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betrokken bij het vetmetabolisme. De resultaten lieten ook zien dat de gen-gen 
interactienetwerken uitgebreider werden in verloop van de tijd.  
Het is bekend dat overtollig vet uit de voeding wordt opgeslagen in het 
vetweefsel, maar het is ook gesuggereerd dat deze opslagcapaciteit beperkt is. 
Vervolgens kan het niet goed functioneren of zelfs falen van het vetweefsel leiden 
tot progressie van vervetting van de lever en tot niet-alcoholische steatohepatitis 
(NAFLD). Er is echter weinig bekend over de functionele verbinding tussen 
vetweefsel dysfunctie en NAFLD. In hoofdstuk 5 hebben we de relatie 
gemodelleerd tussen genexpressie in wit vetweefsel en de lever, gewicht status 
alsmede verschillende plasma factoren op het vlak van de tijd- en de dosis-
afhankelijke effecten van vet in de voeding tijdens de ontwikkeling van obesitas in 
muizen. Hiertoe hebben weer PLSPM toegepast. We vonden dat de het wisselen 
van koolhydraten voor vet in het dieet resulteert in grote veranderingen in 
genexpressie in zowel de lever als vetweefsel. Onze analyse identificeerde een lijst 
van mogelijke signaaleiwitten die worden afgescheiden door het vetweefsel en 
die kunnen leiden tot veranderingen in de stofwisseling in de lever, en op die 
manier bijdragen tot de negatieve effecten van overgewicht op de lever.  
Samengevat hebben de studies beschreven in dit proefschrift de rol van vet in de 
voeding op de genexpressieprofielen in de dunne darm, lever en wit vetweefsel 
verder ontrafeld. Om de gedetailleerde effecten van vet in de voeding op het 
niveau van een volledig organisme te identificeren, zijn aanvullende studies nodig 
waarbij transcriptomics-, proteomics-, en metabolomics datasets en fenotypen 
geïntegreerd worden in de tijd. De inhoud van dit proefschrift leidt tot nieuwe 
benaderingen om meerdere datasets die verband houden met lipide homeostase 
te kunnen integreren. 
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